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 Obesity is a growing concern in today’s world with about two thirds of adults and 
one third of children classified as overweight or obese. Childhood obesity is a growing 
public health concern because children who are living with obesity are more likely to live 
with obesity in adulthood. Obesity is associated with chronic low-grade inflammation 
characterized by elevating inflammatory proteins and a chronically activated immune 
system, which is maintained by circulating progenitor cells (CPCs). CPCs are a 
heterogeneous population of cells that are capable of replenishing the immune system 
after a hematopoietic stem cell transplant. CPCs reside within the bone marrow niche 
whereby upon appropriate stimuli, will be enticed into the peripheral blood. Additionally, 
CPCs can differentiate into mature immune cells of both the myeloid and lymphoid 
immune lineage. Cell surface receptors on CPCs, such as TLR4, may influence a 
myeloid bias of differentiation of CPCs. CPCs expressing CCR2 may also be primed to 
mobilize to inflamed peripheral tissue. Of interest, monocytes are a mature myeloid cell 
population and peruse the peripheral blood to which they will infiltrate inflamed 
peripheral tissue in order to differentiate into macrophages. Monocytes can also 
express both TLR4 and CCR2, and these receptors may play a role in myeloid immune 
system activation seen in persons with obesity. Both CPCs and monocytes have been 
shown to be increased in circulation in both adults and children living with obesity, 
suggesting that inflammation may play a role in CPC mobilization. On the other hand, a 
vast amount of research has shown that acute endurance exercise, possibly linked to 
exercise-induced inflammation, transiently increases CPC concentration in the 
peripheral blood. However, less is clear about the effects of exercise training on CPC 
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concentrations, given that exercise training is anti-inflammatory. To date, no research 
has examined the anti-inflammatory effects of endurance exercise training on CPCs in 
persons with obesity. Lastly, previous research has indicated a potential pro-
inflammatory effect of macronutrient composition of meals in healthy adults. Given the 
close relationship of chronic inflammation in persons with obesity, it is possible that 
there may be a relationship between macronutrient composition of meals and children 
living with overweight or obesity.  Thus, the purpose of this thesis was to investigate the 
role of exercise and nutrition on CPCs and inflammatory monocytes in obesity. 
 This dissertation is divided into four sections. First, we review the literature 
available pertaining to CPCs, CPC mobilization and potential fates of mobilized CPCs, 
inflammatory monocytes, inflammatory cytokines, and nutrition in obesity. 
Subsequently, for our first experiments we examined inflammatory monocytes and the 
relationship between HSPCs (a subset of CPCs) in children with overweight and obesity 
and cognition. We collected blood from children and measured HSPC and inflammatory 
monocyte content. Next, we correlated measures of cognition with HSPC 
concentrations and observed that overweight and obese children had a positive 
relationship with HSPC content and cognition; and that healthy weight children had a 
negative relationship with HSPC content and cognition, with a significant difference 
between the two relationships. Moreover, we found that conditioned media from 
cultured CPCs from children with overweight and obesity caused increased 
neurogenesis in vitro but not from healthy weight children. Following this, we next aimed 
to examine the effects of endurance exercise training on CPCs and their 
subpopulations, as well as those expressing inflammatory markers, in lean individuals 
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and individuals with obesity. We found that endurance exercise training decreases 
CPCs, HSPCs, and HSPCs expressing inflammatory receptors irrespective of weight 
status, further supporting the anti-inflammatory effects of exercise. In the final 
experiment, we examined the relationship between inflammatory monocytes expressing 
inflammatory receptors and the acute effects of feeding of meals of different 
macronutrients in children of differing weight status. We found that after a carbohydrate 
rich meal, children who were overweight or obese had a reduced percentage of 
intermediate monocytes expressing inflammatory markers, suggesting their infiltration to 
peripheral tissue.  
 In summary, we show that CPCs are increased in children with overweight and 
obesity; and that endurance exercise training decreases HSPCs expressing 
inflammatory receptors in adults with obesity. Additionally, inflammatory monocytes are 
increased in children with overweight and obesity. Moreover, we show, for the first time, 
that a carbohydrate rich meal causes a decrease in inflammatory monocytes in the 
peripheral blood. In turn, these data will assist in the characterization of CPCs and 
inflammatory monocytes to certain anti-inflammatory or pro-inflammatory stimuli. 
Further characterizing CPCs and their subpopulations, and inflammatory monocytes, in 
the context of obesity, will help in the formulation of interventions to optimize health 
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 The rates of obesity across Western nations have risen to epidemic levels, with 
two-thirds of adults being classified as overweight or obese (1). What is even more 
alarming is that about one-third of our childhood population is also overweight or obese 
(1), indicating nearly 25 million children overweight or obese. Obesity is defined as an 
accumulation of excess adipose tissue, which may result in health complications (2). 
Traditionally “adult” pathologies associated with obesity are becoming more prevalent in 
children who are overweight or obese, such as cardiovascular disease or metabolic 
syndrome. Obesity onset during childhood is of particular concern because of the 
increased risk of developing lifelong obesity and other cardio-metabolic disease (3). 
In both adults and children, increased adiposity is related to chronic low-grade 
inflammation (4–6). This chronic low-grade inflammation is characterized by a systemic 
increase in pro-inflammatory cytokines and inflammatory monocytes. Chronic 
inflammation is detrimental to health due to its relationship to multi-system organ failure, 
as well as causing a chronic activation of the immune system (4). The hematopoietic 
system encompasses all cells of the blood and immune lineages and is responsible for 
the turnover of about ten million cells per day (7). Circulating progenitor cells (CPCs) 
are a heterogeneous population that are used in a hematopoietic stem cell transplant 
(HSCT), and include hematopoietic stem and progenitor cells (HSPCs), hematopoietic 
stem cells (HSCs), endothelial progenitor cells (EPCs), adipose-tissue derived 
mesenchymal stem cells (AT-MSCs), and bone marrow derived mesenchymal stem 
cells (BM-MSCs) (8, 9). The CPC population is particularly important because their 
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heterogeneity allows for full reconstitution of the bone marrow after sub-lethal radiation 
(10). CPCs have become increasingly popular in recent research due to their ability to 
be more potent cytokine producers (11) or take the role of “immune surveillance” across 
the body and divide into immune cells capable of handling acute inflammation (12). 
Their concentration in circulation has even been linked to different stages of heart 
failure (13–15) and have also been proposed to play a role in combatting tissue damage 
(16, 17). Additionally, a plethora of previous research has characterized their response 
to acute endurance exercise in healthy adults (16, 18–21). However, the relationship 
between CPCs, obesity, and endurance exercise training has not previously been 
explored, warranting investigation due to the anti-inflammatory effects of exercise. 
Inflammatory monocytes are a mature innate immune system population derived 
from HSPCs (6, 22). Inflammatory monocytes circulate throughout the peripheral blood 
where upon infiltration to peripheral tissue mature into macrophages. Monocytes and 
macrophages are responsible for partially surveilling the body for foreign invaders. One 
negative affect of obesity is that monocytes are stuck in a pro-inflammatory state (23). 
Chronic increases in these inflammatory monocytes may lead to long-term activation of 
the immune system, which could lead to cardiovascular disease and metabolic 
syndrome in children. 
Two important cell surface receptors are toll-like receptor 4 (TLR4) and C-C 
chemokine receptor 2 (CCR2) and are capable of being expressed on monocytes to aid 
in their specificity towards certain inflammatory events. TLR4 is a pattern recognition 
receptor capable of recognizing lipopolysaccharide (LPS), a component of gram-
negative bacteria cell membranes. CCR2 is the cell surface receptor responsible for 
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recognizing monocyte chemoattractant protein-1 (MCP-1), and expression of CCR2 on 
monocytes facilitates their migration into tissues (24, 25) Both monocyte populations 
and CPC populations are capable of expressing both TLR4 and CCR2, and their 
expression are important mechanisms of defense against disease via TLR4 and CCR2 
mediated mechanisms. Both adults and children have been shown to have higher 
circulating monocytes and monocytes expressing CCR2 (6, 26, 27). Less research has 
focused on TLR4 expression on monocytes and CPCs in persons with obesity. 
Most previous research investigating CPCs has been exclusive to adults, while 
one previous study has investigated their levels in children (27). In addition, previous 
studies examining monocytes in children with overweight and obesity have focused on 
characterizing their concentrations in peripheral blood and have not evaluated their 
response to different stimuli. Since previous reports have shown a relationship between 
CPCs, monocytes, and cardiometabolic co-morbidities, often associated with obesity, 
there warrants further investigation into these levels in overweight and obese children. 
Investigating the effects of increased adiposity during a period where growth is 
happening rapidly, understanding the effects of adiposity on CPCs and monocytes will 
help identify potential links between the immune system, inflammation, and obesity. 
 Recent evidence has suggested that macronutrient composition of a meal, 
specifically carbohydrates, can induce an inflammatory response, both in monocytes 
and cytokines, in adults (28). On the other hand, meals high in unsaturated fats do not 
elicit this same response in adults, suggesting that different macronutrient compositions 
may play a role in inflammation (28). Acute increases in inflammation in overweight and 
obese children may exacerbate the consequences of the chronic low-grade 
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inflammation and subsequently increase the risk for developing cardio-metabolic 
diseases (3). Avoiding acute increases in inflammation by consuming meals with higher 
levels of unsaturated fatty acids and lower levels of carbohydrates may shed insight into 
mechanisms behind chronic activation of the immune system in an inflammatory state in 
healthy weight and children living with overweight/obesity.  
1.1 Purpose of Thesis 
 The purpose of this thesis was to characterize how behavioral factors (i.e. 
exercise and nutrition) alter CPCs and monocytes in obesity. Previous literature has 
shed light onto characterization of CPCs but has not examined specifically how 
exercise, nutrition, and lifestyle factors may relate. Chapter two evaluates the existing 
literature. The following chapters detail the relationship between CPCs, obesity, and 
cognition; the effects of endurance exercise training on CPCs and inflammatory 
receptors in obesity; and the effects of meals of different macronutrient composition on 
inflammatory monocytes in overweight and obese children. Together, these studies 
provide a more thorough understanding and characterization of CPCs and their 
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Review of the Literature 
 Physical inactivity, sedentary lifestyle, and over-consumption of calories are 
major contributors to the obesity epidemic in today’s world. Today, about two-thirds of 
adults and one-third of children are classified as overweight or obese (1, 2). Children 
living with obesity is also a stable predictor of obese status in adulthood. Obesity is 
associated with increased risk of cardio-metabolic co-morbidities in both adults and 
children. In addition to increased risks of diseases associated with obesity, it has also 
been shown that those who are obese are more susceptible to infection and worse 
disease prognosis, which suggests that these individuals may have an impaired 
immune system (3). Indeed, obesity is associated with an increased quantity of innate 
immune cells and inflammatory cytokines in both adults and children (3–6). These 
increases in immune cells and inflammatory cytokines play a role in cardiovascular co-
morbidities in obesity such as development of atherosclerotic plaques (7) or insulin 
resistance (8); and warrant further investigation to augment increases in immune cells in 
order to decrease cardiovascular co-morbidities seen in obesity. Exercise has been 
shown to exert anti-inflammatory effects on the immune system in both healthy weight 
and individuals with obesity (9–13). Therefore, closer investigation into short term and 
acute inflammatory events, in obesity, and nutrition are warranted. 
2.1 Obesity 
 Obesity is defined as the over-accumulation of adipose tissue to the point that it 
will have a negative effect on health, and contribute to a body mass index (BMI) >30 
kg/m2 (14). In adults, body mass index (BMI) is the gold standard for evaluating weight 
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status, which is weight in kilograms divided by height in meters squared. BMI is 
classified into four different levels, with levels <18 kg/m2 considered underweight, 18-
24.99 kg/m2 considered healthy weight, 25-29.99 kg/m2 considered overweight, and ≥30 
kg/m2 considered obese. However, because children grow very quickly, children are 
classified based on BMI percentile that is calculated based off age and sex (15). 
Children who have a BMI percentile of £5% are considered underweight, 5-84.9% are 
considered healthy weight, those between 85-94.99% are considered overweight, and 
those ≥95th percentile are considered obese (15). Children who fall above the 99th 
percentile are considered morbidly obese.  One downfall to the use of BMI is the 
inability to determine body fat percentage. Dual X-ray Absorptiometry (DXA) is a useful 
tool to measure body fat percentage, bone density, and lean mass. DXA uses low 
energy X-rays to determine soft tissue mass and bone mineral tissues. One useful 
aspect of using DXA to measure body fat percentage in children is the ability to quantify 
the relative proportion of different adipose depots, such as subcutaneous and visceral 
adipose tissue. Visceral adipose tissue is of concern, especially in children who are 
overweight or obese, because it is more closely linked with metabolic complications 
associated with obesity than subcutaneous adipose tissue (16). 
Within healthy ranges, adipose tissue is a vital organ that contributes to 
metabolism, thermal regulation, and energy storage (17). When the amount of adipose 
tissue exceeds the needs of the body, detrimental changes such as over-accumulation 
of adipose tissue can be more severe in childhood obesity. This is because the time 
before puberty is when maximum proliferation and differentiation of adipose tissue. In 
adults who are overweight or obese, adipose tissue goes through hypertrophy (increase 
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in adipose tissue cell and size) (18, 19) and is thought to contribute significantly to 
insulin resistance (19). Additionally, the total number of adipocytes is determined as 
early as childhood independent of body weight, which suggests that the number of 
adipocytes is determined during childhood; and later hypertrophy of adipocytes is one of 
the most important mechanisms for adipose tissue expansion upon weight gain (20). 
When adipose tissue cells experience hypertrophy, they start to secrete more pro-
inflammatory cytokines (19, 21, 22). These pro-inflammatory cytokines initiate 
recruitment of monocytes that will differentiate into macrophages in the adipose tissue, 
and consequently exacerbate inflammatory cytokine release by the adipose tissue by 
initiating their own pro-inflammatory cascade (3). This cycle contributes, and is thought 
to be partly responsible, for the chronic low-grade inflammation seen in obesity. 
Children are at risk because those children who are considered obese by the age of five 
have 4 times higher incidence of obesity at age 14 compared to those who are healthy 
weight (23). These pathologies are traditionally seen later in life, but the incidences of 
these occurring during childhood are increasing and are an immediate cause for 
concern.  
 Determining the amount of visceral and subcutaneous adipose tissues is useful 
in identifying underlying relationships between obesity and systemic low-grade 
inflammation. Subcutaneous adipose tissue is the fat tissue that is found just below the 
skin and is suggested to be more beneficial due to its ability to alter metabolism in a 
favorable way in persons of a healthy weight (24). When there is an increasing amount 
of energy needing to be stored within the body, such as in obesity, the subcutaneous 
adipose tissue starts to become saturated and the body must store fat in other 
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locations, such as the viscera (25). Visceral adipose tissue is particularly concerning 
because it surrounds vital organs within the trunk and secretes more fatty acids and 
inflammatory factors towards the liver (26). The proximity of visceral adipose tissue to 
the liver combined with increases in fatty acid and inflammatory factors can be a direct 
cause of metabolic dysfunction seen in obesity.  
2.2 The Hematopoietic System 
 The hematopoietic system consists of the blood and immune lineages and is 
maintained by a heterogeneous population of circulating progenitor cells (CPCs). 
Immunity is divided into two parts by the speed and specificity of each of the systems in 
responses to foreign invaders (27). The myeloid/innate immune system is responsible 
for the immediate defense against foreign antigens and/or invaders, while the 
lymphoid/adaptive immune system is slower reacting but has memory so that 
subsequent exposure of the host to the same antigens can be recognized and quickly 
neutralized. The cellular makeup of the myeloid/innate immune system includes 
neutrophils, monocytes, macrophages, and megakaryocytes; whereas the 
lymphoid/adaptive immune system includes T-cells, B-cells, and NK cells (27).  In 
obesity, there is an increase in white blood cell subsets in children (28), and the effects 
of obesity on hematopoietic progenitors is only emerging.  
 CPCs are a heterogeneous population of stem and progenitor cells responsible 
for both the long term and short term maintenance of the hematopoietic system, and 
generate up to about 10 million red blood cells per day to maintain homeostasis (29). 
CPCs are derived from progenitors located within the bone marrow cavities, where they 
possess the ability to circulate the peripheral blood in very low quantities via tightly 
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controlled mechanisms (30). Of clinical importance, this is the cellular population used 
during a hematopoietic stem cell transplant (31, 32). The heterogeneity of the CPC 
population allows for better reconstitution after transplant into the recipient and are 
identified by positive expression of CD34 (32). CPCs include hematopoietic stem and 
progenitor cells (HSPCs; CD34+/CD45dim), hematopoietic stem cells (HSCs; 
CD34+/CD45dim/CD38-), endothelial progenitor cells (EPCs; CD34+/CD45-/VEGFR2+), 
and mesenchymal stem/stromal cells (MSCs) (33).  MSCs can further be classified 
based off of their suggested organ of origin, such as adipose tissue (AT-MSCs; 
CD34+/CD105+/CD31-/CD45-) and bone marrow (BM-MSCs; CD34+/CD105+/CD31-





Figure 2.1. Overview of the Hematopoietic System. The hematopoietic system is 
maintained by HSCs and HSPCs, which make up a small proportion of the CPC 
population. These cells have the highest capacity to self-renew to maintain the 
hematopoietic stem cell pool. The multipotent progenitor population (MPP) has almost 
no self-renewal capacity but has a large proliferation capacity in order to maintain day to 
day stresses of the hematopoietic system. CMP and CLP cells are committed lineage 












































Although CPCs have the capacity to reconstitute the hematopoietic system after 
HSCT, their primary role is most likely to be involved in tissue repair via paracrine 
mechanisms or through differentiation into mature hematopoietic cells. Previous 
evidence has shown that CPCs are both more potent cytokine producers in response to 
local inflammation (35) and to play an “immune surveillance” role throughout the body in 
order to differentiate into the necessary mature immune cells needed for repair (36). 
Therefore, there exists a critical need investigating the factors regulating their 
mobilization and their relationship to inflammation.  
2.3 Factors regulating CPC mobilization 
 Because CPCs, their sub-populations, and mature immune cells, such as 
monocytes, have the ability to mobilize from the bone marrow niche, it is important to 
understand the mechanisms that control their mobilization. Researchers have shown 
that CPCs exist in a perivascular niche within the bone marrow (37). The perivascular 
niche has received more attention in recent years due to the proximity of CPCs near 
sinusoids and blood vessels (30). More quiescent CPCs and more primitive cellular sub-
populations, such as HSPCs and HSCs, are thought to be located closer to arterioles 
within the perivascular niche, with the more mature CPCs located near the sinusoids 
(37). CPC proximity to sinusoids and blood vessels allows for relatively quick 
mobilization from the bone marrow into the peripheral blood.  
2.4 Mobilization Cytokines 
In the hematopoietic stem cell transplant (HSCT) setting, bone marrow donors 
are given a variety of CPC mobilizing drugs, and their effectiveness has largely been 
based on mobilization potential of certain CPC mobilization factors. Mobilized peripheral 
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blood is the preferred source of CPCs for transplant because it has been linked to faster 
recipient reconstitution (38) and requires less invasive procedures. Three main drugs 
exist for the mobilization of CPCs and these include: Granulocyte-Colony stimulating 
factor (G-CSF; Filgrastim), granulocyte/macrophage colony stimulating factor (GM-CSF; 
Sagramostim), and AMD3100 (Plerixafor) (31, 32, 39). Although these drugs induce 
mobilization, the body is able to produce G-CSF and GM-CSF, among other 
mobilization factors, naturally. The anchoring of CPCs within the bone marrow occurs 
through the binding of CXCR4 on CPCs to CXCL12 on bone marrow stromal cells (40). 
Increased levels of CXCL12 in the blood plasma have been shown to competitively 
decrease binding of CXCL12 to CXCR4 on CPCs, causing CPC egress from the bone 
marrow (41). G-CSF is also endogenously produced by mesenchymal stromal cells 
within the bone marrow niche by a variety of ways (42). The current consensus 
regarding G-CSF mediated CPC egress from the bone marrow is through an increased 
secretion of matrix metallopeptidase-9 (MMP9) induced by G-CSF levels, thus causing 
CPC mobilization (43) (Figure 2.2). G-CSF is also thought to increase expression of β2-
adrenergic receptors in vitro and increased mobilization in vivo (44). Stem cell factor 
(SCF) is also secreted by MSCs, fibroblasts, and endothelial cells within the bone 
marrow and influences CPC egress via interactions with the cell surface receptor 
CD117 (45).  
2.5 Sympathetic Nervous System 
The sympathetic nervous system has also been shown to play a role in CPC 
mobilization, suggesting CPC mobilization is a complex communicatory network. A 
previous report has shown that CPCs in the peripheral blood are related to 
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norepinephrine release throughout the day (46). However, this relationship to 
norepinephrine is likely complex, because conflicting reports have shown that β-
adrenergic receptor agonists did not elicit CPC increase in the peripheral blood (47), nor 
are they increased in persons who have chronically increased norepinephrine (48). On 
the other hand, more recent research has shown that β2-adrenergic receptor 
antagonists repressed CPC mobilization after acute vigorous exercise in humans (49). 
Nonetheless, it is clear that the sympathetic nervous system plays an important role in 
CPC mobilization, especially after acute exercise (Figure 2.2). 
2.6 Inflammatory Cytokines 
Inflammatory cytokines are potent sources of communication between different 
organ systems via small proteins produced by almost every cell type (50). Cytokines 
represent a very broad range of proteins that are important in autocrine, paracrine, and 
endocrine signaling.  However, cytokines are not the same as hormones. While very 
specific cells and/or organs produce hormones, almost any type of cell in the body can 
produce cytokines. In addition, cytokines are not always produced, and most of the time 
their production must be preceded by a cellular stressor or event (50). Many different 
types of cytokines exist, and include those proteins secreted, such as: chemokines, 
interferons, interleukins, lymphokines, and tumor necrosis factors. After secretion, 
cytokines are recognized by the receiving cell via highly specific cell surface receptors, 
which after activation induces a potent inflammatory cascade triggering several 
transcription factors within the receiving cell. Given the complexity of cytokines, 
scientists have proposed to classify cytokines into distinct classes, such as pro-
inflammatory or anti-inflammatory (50), under the pretenses that the pro-inflammatory 
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cytokines induce inflammatory genes and anti-inflammatory suppress inflammatory 
genes. Some examples of pro-inflammatory cytokines include: IL-6, MCP-1, TNF-alpha, 
IL-1, and C-reactive protein. Some examples of anti-inflammatory cytokines are: IL-10 
and IL-13. However, not all cytokines can be classified into one class, and their naming 
should be taken with caution. For example, IL-1 can also induce high amounts of anti-
inflammatory effects (51).  
IL-6, TNF-alpha, and C-reactive protein (CRP) are specifically important 
cytokines and proteins to study because they are thought to play a major role in the 
development of chronic low-grade inflammation seen in obesity. IL-6 is an acute phase 
protein secreted during times of inflammation to stimulate an immune response, 
especially after tissue damage. IL-6 can be secreted by macrophages in response to 
pathogen associated molecular patterns (PAMPs) (52). This, in conjunction with 
PAMPs, bind to TLRs of the innate immune system, which then initiates an immune 
response. Recent evidence has suggested, however, that IL-6 can play a role in 
combating the pro-inflammatory environment it creates, as evidenced by the ability of 
IL-6 to activate macrophage populations more closely associated with wound healing 
and reduction of pro-inflammatory cytokine secretion (52–54). Despite the anti-
inflammatory potential of IL-6, it has also been linked to death prediction caused by 
cardiovascular disease (55). TNF-alpha is another important inflammatory cytokine. 
TNF-alpha is secreted by adipose tissue and is typically seen as an inhibitor of insulin 
action and a regulator of immune cells (56). Upon binding with its ligand, three 
pathways may be initiated: (1) NF-kB: inflammatory response (2) MAPK response: 
stress related response and/or (3) induction of death signaling (57–59). Lastly, C-
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reactive protein is another very important pro-inflammatory protein. CRP levels rise in 
response to inflammation and follows IL-6 secretion. It is synthesized by the liver in 
response to elevated TNF-alpha and IL-6 levels (60, 61). It is the classical inflammatory 
marker that can be detected in the blood and is intricately used to determine 
cardiovascular disease risk because of its ability in the pathophysiology of 
cardiovascular disease, such as contribution to atherosclerotic plaques (62).   
Obesity and inflammation have been shown to increase circulating CPCs in both 
adults and children (6, 63–65). Acute inflammatory events such as infection (66), stroke 
(67), myocardial infarction (68), broken bones (69), and acute endurance exercise (33, 
49, 70) have been shown to increase CPC content in the peripheral blood. Given the 
evidence of more CPCs in circulation seen in both adults and children who are living 
with overweight or obesity, the chronic low-grade inflammation associated with obesity 
may be partly responsible for the steady state increases in CPCs. Taking a speculative 
approach, increased CPCs in the peripheral blood may be indicative of increased 
demand for cells to differentiate into the myeloid lineage, to ultimately become 
monocytes/macrophages, thus contributing to the inflammatory cycle seen in obesity. 
However, in order to investigate the relationship between inflammation and CPCs, it is 
important to characterize the relationship between acute inflammation, acute 




Figure 2.2. Potential fates of mobilized CPCs. CPCs are retained within the BM 
niche, where upon mobilization stimuli (acute inflammation, exercise, G-CSF, 
sympathetic nervous system stimulation) will cause CPC egress into the peripheral 
blood and lymph nodes. From there, CPCs will mobilize towards inflamed peripheral 
tissue, such as the CNS after stroke, the heart after myocardial infarction, muscle tissue 
after exercise, or bones after being broken. If CPCs are not needed after mobilizing to 






2.7 Exercise and CPCs 
Exercise is a unique bodily stressor, in that it first induces acute inflammation, but 
in an anti-inflammatory stimulus over time (71). In addition, exercise presents a safe 
and healthy inflammatory stimulus that can be used to investigate the relationship 
between inflammation and CPCs (Figure 2.2).  
2.8 Acute Exercise and CPCs 
Acute endurance exercise has been shown to increase CPCs in the peripheral 
blood. Specifically, very intense acute endurance exercise has been shown to induce a 
robust but transient increase in CPCs (29, 33, 49, 70, 70). Additionally, resistance 
exercise has also shown to induce CPC mobilization (72). However, the exact 
mechanism of CPC mobilization after acute exercise has not yet been determined. Age, 
exercise intensity, and training status have been shown to have differing results when 
examining CPC mobilization after acute endurance exercise (29, 33, 73–76). 
Additionally, it has been proposed that CPC mobilization is related to the amount of G-
CSF present in the blood (72), suggesting exercise increases CPCs and is related to 
plasma G-CSF. However, other reports have shown that G-CSF is not related to 
exercise related CPC-mobilization (49, 77). Therefore, it is quite plausible that G-CSF is 
not related to acute increases in CPCs post-acute endurance exercise, but still plays a 
role at steady state. While reports have shown that single changes in systemic 
cytokines, hormones, or even exercise may provoke mobilization of CPCs, there likely 
exists a balance and a complex network of communication for exact mechanisms 
underlying CPC mobilization during acute exercise.  
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There is a paucity of data surrounding the mobilization of CPCs to acute 
endurance exercise in the peripheral blood in children. One previous report by Obeid et 
al. (78) has shown that healthy children experience an increase of EPCs (defined as 
CD31+/CD34bright/CD45dim/CD133+) in response to moderate intensity continuous 
exercise only, with no alterations in EPC content after high intensity intermittent 
exercise. Another report by Zaldivar and colleagues (76) showed that in both early and 
late pubertal boys, CPCs were significantly increased after acute moderate to vigorous 
endurance exercise. The authors also found that G-CSF was increased after exercise in 
both groups. However, the authors neglected to correlate changes or levels of G-CSF 
with CPC concentrations, which warrants further research investigating if mobilization 
mechanisms between adults and children after exercise are similar. 
In the context of obesity, there exists no study investigating the acute exercise 
effects on CPCs in persons with obesity. Given the numerous physical benefits of 
exercise, this warrants further investigation due to the emerging evidence that acute 
aerobic exercise induces positive changes in both the bone marrow niche and mobilized 
CPCs (30). 
2.9 Endurance Exercise Training and CPCs 
 Although many reports have shown that increases in peripheral blood CPCs are 
evident after acute exercise, the literature surrounding CPCs and exercise training are 
scarce and ambiguous. Further, many studies investigating the responsiveness of 
CPCs to chronic endurance exercise have not utilized the same paradigms, thus 
making comparisons between studies difficult. Studies that have used an ischemic 
exercise protocol (79) have shown increases in CPCs at rest. Other authors have found 
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that those who self-reported to participate in half or full marathons had higher amounts 
of circulating CPCs than sedentary controls (73). On the other hand, others studies 
investigating those who participate in exercise training utilizing lower intensity exercise, 
treadmill walking, and cycle ergometer training (80–82) have shown no changes in CPC 
content. One reason for the lack of consistent evidence regarding CPC response to 
exercise training is the lack of a standardized protocol for endurance exercise training. 
Additionally, acute exercise is known to affect CPC populations in peripheral blood up to 
24 hours after acute endurance exercise (72). Many of these previous endurance 
training studies do not specify the amount of time between the last exercise session and 
blood sampling, making it difficult to accurately compare CPC values in response to 
endurance exercise training between studies. Therefore, future studies should focus on 
eliminating acute exercise effects and utilizing a standardized protocol of endurance 
exercise training in order to accurately relate potential changes on CPCs in response to 
exercise training. 
2.10 Fates of Mobilized CPCs 
 Previous research has shown that CPCs may play an “immune-surveillance” role 
in the peripheral blood, surveying tissues for potential inflammation (36). Additionally, 
CPCs have been shown to be more potent cytokine producers than more mature cells 
of the hematopoietic system in peripheral tissue (35), suggesting that CPCs play a role 
in reducing tissue inflammation and tissue repair. Acute endurance exercise induces 
acute tissue damage in the muscle, and the transient increase in CPCs could be in 
response to tissue damage induced by exercise. Indeed, previous research has shown 
the CPCs contribute to muscle repair (83). In addition, it has been shown that CPCs are 
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mobilized to inflammatory tissues after acute inflammatory events such as myocardial 
infarction (68), stroke (67), and broken bones (69) (Figure 2.2). However, no research 
has investigated the extent to which CPCs may contribute to tissue repair after exercise 
or in obesity, and how these may be related to inflammatory or mobilization cell surface 
receptors, TLR4 and CCR2. Thus, establishing the role that CPCs play in tissue repair 
will increase understanding the mechanisms behind tissue repair via TLR4 and CCR2 
mediated mechanisms. 
2.11 Mature Hematopoietic Cells  
Inflammatory monocytes are mature myeloid/innate immune cells (Figure 2.1). 
Upon infiltration to peripheral tissue, monocytes will mature into macrophages (7). 
Inflammatory monocytes are an important cell population to study due to their ability to 
contribute to cytokine/chemokine production, infiltration into peripheral tissue, and 
vascular adhesion (84). Monocytes serve a vital purpose as a part of the immune 
system because they are also involved in the first line of defense against foreign 
invaders via phagocytosis and antigen recognition (7). In addition to playing a role in the 
first line of defense, monocytes also serve a role in tissue regeneration (85). Their 
concentration in peripheral blood is routinely used in clinical settings as indicators for 
chronic inflammation, stress responses, immune-mediated disease, necrosis, and in 
severe cases, sepsis.  
 Three sub-types of monocyte populations circulate throughout the peripheral 
blood. The classical monocyte population is indicated by CD14++/CD16- expression and 
make up about 80% of the peripheral monocyte pool (86). The second population of 
monocytes are the non-classical monocytes denoted by CD14+/CD16+ expression and 
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make up about 8-10% of the monocyte pool (86). Lastly, researchers have recently 
proposed a third subset of monocytes termed “intermediate monocytes” and are 
denoted by CD14++/CD16+ (87). This population of monocytes is thought to be in a 
“transition” state towards the non-classical type, however has also been shown to 
display unique cellular properties, such as increased antigen presenting capacity, 
specifically increased in clinical diseases, and potentially unique transcript levels of 
genes (87). Although all three populations of monocytes are increased in response to 
infection and/or inflammation, it is thought that the non-classical monocyte population 
displays and reacts in a more inflammatory manner (86).  
2.12 Inflammatory and Mobilization Receptors on CPCs and Monocytes  
Monocytes and CPCs also possess the cell surface markers Toll-like Receptor 4 
(TLR4) and C-C chemokine receptor-2 (CCR2). TLR4 is a cell surface marker that upon 
activation, leads to activation of the intracellular signaling pathway NF-kB and 
subsequent inflammatory cytokine production (88). TLR4 is most known for its 
recognition of lipopolysaccharide (LPS), a component of the cell membrane in gram-
negative bacteria, and does so through a series of protein-protein interactions with LPS-
binding protein, CD14, and MD-2 (89). Upon stimulation, TLR4 undergoes 
oligomerization and recruits its downstream adaptors through interactions with Toll-
interleukin-1 receptor domains, of which there are five domain-containing proteins. Of 
these five domain-containing proteins, there exists a MyD88 dependent pathway and a 
MyD88 independent pathway (88). Although stimulation of both pathways eventually 
leads to increases in pro-inflammatory cytokines and type-1 interferons via NF-kB, 
research is controversial in determining a set pathway for production of either pro-
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inflammatory cytokines or type-1 interferons, suggesting the pathways of TLR4 
stimulation are quite complex. However, TLR4 can also recognize saturated fatty acids, 
which can be important in obesity due to excess adipose tissue secreting excess fatty 
acids (88).  
CCR2 is a chemokine receptor for monocyte chemoattractant protein-1 (MCP-1; 
CCL2) which specifically mediates monocyte, neutrophil, dendritic cell, and lymphocyte 
migration (90). Monocytes that express CCR2 are more likely to infiltrate inflamed 
locations, such as those in rheumatoid arthritis, inflammation response against tumors, 
Alzheimer’s disease, and even obesity (91).  In mouse studies, it has been shown that 
CCR2-/- mice have a reduction in the amount of monocytes mobilized from the bone 
marrow into circulation (92), and altered monocyte activation in adipose tissue (93), 
suggesting that CCR2 plays a major role in monocyte infiltration into inflammatory sites 
and adipose tissue. 
More recent evidence has developed investigating the role that CCR2 and TLR4 
may play in CPC mobilization and differentiation potential, respectively. In acute 
inflammatory events, CCR2 is known to be the main mobilization receptor on CPCs (68, 
94). On the other hand, TLR4 stimulation on CPCs has been shown to cooperate with 
NOD-like receptor signaling (66), stimulate CPC emergence into circulation (95), and 
skew the hematopoietic system towards myelopoiesis (96, 97). Given that these two cell 
surface receptors are extremely important in recognizing pathogens and mobilizing 
towards sites of inflammation, it seems self-explanatory that these pathways would be 
stimulated during times of acute inflammation. The characteristics of CPCs expressing 
TLR4 and CCR2, on the other hand, have not been fully investigated. Previous research 
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has shown that persons with obesity have increased myeloid cell production and innate 
immune system activation (98), however much of this research has focused on the 
mature cellular populations of the hematopoietic system. It is possible that CCR2 and 
TLR4 signaling on CPCs could be influencing mature hematopoietic populations in 
persons with obesity, therefore altering their immune system’s efficacy. Thus, more 
research in needed to characterize the effects of chronic low-grade inflammation, such 
as obesity, on CPCs expressing CCR2 and TLR4. Furthermore, give the anti-
inflammatory effects of exercise training, it is important to characterize the effects of 
endurance exercise training on CPCs expressing CCR2 and TLR4 to investigate if anti-
inflammatory effects of exercise start at the CPC level. 
2.13 Nutrition and Inflammatory Responses 
Recent evidence has suggested that the macronutrient composition of a meal 
can induce an inflammatory response. In adults, it has been shown that a high 
carbohydrate meal can increase the levels of inflammatory cytokines, particularly IL-6 
and CD11a+ expressing immune cells two hours after ingestion (99, 100). On the other 
hand, a meal high in unsaturated fats does not elicit the same response in healthy 
adults (100). This is interesting because it points towards macronutrient composition as 
a possible culprit to exacerbating chronic inflammation seen in instances of obesity. The 
extent to which meals of different macronutrient composition can affect postprandial 
cytokine levels have been explored extensively (99–104). Some researchers have 
shown that meals high in unsaturated fats may induce hypertriglyceridemia in obese 
men (101), whereas others have shown no change (105, 106). Additionally, some have 
shown that insulin and glucose levels are improved in the post prandial period in 
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persons who consumed high monounsaturated fatty acid meals (106). Interestingly, 
most of these studies have been conducted in healthy weight individuals, with few 
conducted with persons who are obese. Few articles have investigated the activation 
and/or response of inflammatory cytokines and monocytes in response to a meal. 
Evidence has suggested that dietary fats increase pro-inflammatory cytokines in healthy 
subjects (107, 108), while others have shown high carbohydrate meals induce 
inflammation in healthy adult subjects (102). Although the evidence regarding 
macronutrient composition and exact postprandial events are not completely 
understood, there exists a clear indication that ingestion of differing macronutrients 
induces a response. 
If high carbohydrate meals are pro-inflammatory, then children are particularly 
susceptible because many marketing techniques of high carbohydrate meals are 
geared towards children (109, 110), particularly breakfast cereals (111). Cereals are 
very high in carbohydrates and relatively low in protein and fats. The promotion of 
sugary, high carbohydrate breakfast foods towards children may be contributing to the 
childhood obesity epidemic. Promoting the ingestion of meals higher in fats and protein 
and lower in carbohydrates may help to inhibit increases in acute inflammation in 
children, which may overtime, decrease levels of chronic inflammation by monocytes 
and inflammatory cytokines. Meals higher in protein and fat also are beneficial for 
consumption because they have been reported to increase satiety and appetite control 
and increased insulin sensitivity when consumed over time (112, 113). Increasing the 
amount of higher protein and fat meals in children who are overweight or obese could 
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result in a decreasing of the acute inflammation seen in obesity, and thus may even 
help to decrease overall cardio-metabolic risk. 
2.14 Purpose of Thesis 
Given that obesity is a growing concern in both adults and children, it is important 
to characterize the metabolic and immune consequences. It is evident that persons 
living with obesity have a chronic state of activation in the innate immune system and 
that this alters their ability to fight infection. However, the extent to which obesity may be 
related to CPCs, the cell populations responsible for maintenance of the immune 
system, remains to be characterized. Moreover, these relationships previously seen in 
adults have not been extended to children and investigating the effects obesity may 
have on children who are overweight or obese is needed. Lastly, because feeding has 
been shown to induce an inflammatory profile in adults, there remains a gap in the 
literature if this same response is evident in children who are overweight or obese. 
Given the increasing prevalence of childhood overweight/obesity, the potential role of 
meal macronutrient composition in inflammation, exercise, and the connection between 
overweight/obesity, inflammation, and cardio-metabolic risk, a strong rationale exists for 
the investigation of the effects of meal macronutrient composition on inflammation in 
overweight/obese children. Thus, the purpose of this thesis was three-fold: To 
investigate the relationship between obesity, children, and cognition; to investigate the 
relationship endurance exercise training has on CPCs in lean and obese adults; and to 
investigate the response of inflammatory monocytes to meals of differing macronutrient 
composition. The following chapters will detail research conducted by our laboratory to 
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help explain how lifestyle factors such as obesity, exercise, and feeding may interact 
with the immune system.  
The aim of the first study (Chapter 3) was to characterize CPCs, inflammatory 
monocytes, and inflammatory monocytes expressing CCR2, and how CPCs may play a 
role in cognitive outcomes in children. We hypothesized that children who were 
overweight or obese would have higher circulating inflammatory monocytes, 
inflammatory monocytes expressing CCR2, and CPCs. We also hypothesized that 
CPCs would be negatively associated with cognitive outcomes in overweight and obese 
children, and that paracrine factors released from CPCs in overweight and obese 
children would inhibit neurogenesis in vitro. 
The aim of the second study (Chapter 4) was to characterize CPCs and their 
subpopulations, as well as CPCs expressing TLR4 and CCR2, after six-weeks 
endurance exercise training in lean and obese adults. We hypothesized that endurance 
exercise training would decrease the quantity of CPCs expressing inflammatory 
markers, as well as the number of myeloid-biased progenitors in individuals with obesity 
compared to lean individuals. 
The aim of the third study (Chapter 5) was to investigate the response of 
inflammatory monocytes, monocytes expressing CCR2 and TLR4, and cytokines to see 
if there is an increase in inflammatory response after meals of different composition in 
children. We hypothesized that increased quantities of inflammatory monocytes and 
cytokines would be evident in overweight and obese children, and that inflammatory 
monocytes and cytokines would increase in response to a meal rich in carbohydrates 
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Circulating Progenitor Cells are Positively Associated with Cognitive Function 
Among Overweight/Obese Children 
Reprinted with permission from Brain, Behavior, and Immunity.  
Grace M. Niemiro, Lauren B. Raine, Naiman A. Khan, Russell Emmons, Jonathan Little, 
Arthur F. Kramer, Charles H. Hillman, and Michael De Lisio. Circulating progenitor cells 
are positively associated with cognitive function among overweight/obese children. 




Recent evidence has indicated that overweight/obese children may experience cognitive 
and immune dysfunction, but the underlying mechanisms responsible for the association 
between overweight/obesity, immune dysfunction, and cognition have yet to be 
established. The present study aimed to identify a novel link between obesity-induced 
immune system dysregulation and cognition in preadolescent children. A total of 27 male 
children (age: 8-10 years) were recruited and separated by body mass index (BMI) into 
healthy weight (HW: 5th-84.9th percentile, n=16) and overweight/obese (OW: ≥85th 
percentile, n=11) groups. Adiposity was assessed using dual energy x-ray absorptiometry 
(DXA), and aspects of executive function were assessed using the Woodcock-Johnson 
III Tests of Cognitive Abilities. Monocyte populations (CD14+CD16-, CD14+CD16+) with 
and without expression of chemokine receptor type 2 (CCR2), and circulating progenitor 
cells (CPCs: CD34+CD45dim), in peripheral blood were quantified by flow cytometry. CPCs 
were isolated by flow sorting and cultured for 24 hours for collection of conditioned media 
(CM) that was applied to SH-SY5Y neuroblastomas to examine the paracrine effects of 
CPCs on neurogenesis. OW had significantly higher quantities of both populations of 
monocytes (CD14+CD16-: 57% increase; CD14+CD16+: 95% increase, both p<0.01), 
monocytes expressing CCR2 (CD14+CD16-CCR2+: 66% increase; CD14+CD16+CCR2+: 
168% increase, both p<0.01), and CPCs (47% increase, p<0.05) than HW. CPCs were 
positively correlated with abdominal adiposity in OW, and negatively correlated in HW 
with a significant difference between correlations (p<0.05). CPC content was positively 
correlated with executive processes in OW, and negatively correlated in HW with a 
significant difference in the strength of the correlations between groups (p<0.05 for 
correlation between OW and HW). Finally, CPC-CM from OW trended to increase 
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neuroblast viability in vitro relative to HW (1.79 fold, p=0.07). These novel findings indicate 
that increased content of CPCs among OW children may play a role in preventing 
decrements in cognitive function via paracrine mechanisms.  
Highlights: 
• We compared the quantity of circulating progenitor cells and inflammatory 
monocytes in overweight/obese and healthy weight children, and related these 
quantities to cognition, and neurogenesis in vitro. 
• Higher concentrations of circulating progenitor cells and inflammatory monocytes 
were observed in the overweight/obese children. 
• Differential relationships exist between circulating progenitor cells and executive 
processing between overweight/obese and healthy weight children. 
• Secretome of overweight/obese circulating progenitor cells caused a trend for an 
increase in neuroblast viability in vitro. 
 
Keywords:   
Hematopoietic stem/progenitor cells, inflammation, executive function, neurogenesis, 
paracrine factor 
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3.1 Introduction   
The nervous and immune systems have a collaborative relationship where cross 
talk between these two systems is important for their regulation. The influence of the 
immune system on cognitive functioning and neurogenesis is becoming better 
established in both pathological and steady-state conditions (1, 2). One mechanism by 
which the immune system has been shown to influence the brain and cognition is via 
secretion of cytokines. These effects have primarily been evaluated under pathological, 
pro-inflammatory conditions, and secretion of pro-inflammatory cytokines, such as 
interleukins, interferons, and members of the tumor necrosis factor family by immune cells 
caused a decrease in hippocampal specific tasks (3–6). Additionally, conditions 
associated with immunological stress and inflammation, such as infection, obesity, or 
genetic models of immune system dysregulation are also associated with decreased 
performance on executive functioning tasks (i.e., goal directed processes underlying 
perception, cognition, and action) and negative effects on the brain (7–11). Recent work 
from our group has demonstrated that obese/overweight (OW) children have decreased 
performance on tasks of executive function compared to healthy weight (HW) controls 
(12). Additionally, obese adolescent rodents had decreased cognitive performance which 
was associated with impaired neurogenesis (13).  The role of specific immune cell 
populations on brain and cognition, and how chronic immune system dysregulation alters 
the relationship between the nervous and immune systems have not be well established. 
Although the central nervous system (CNS) was believed to be impervious to 
peripheral immune cells, recent evidence has questioned this belief. The migration of 
circulating immune cells into the CNS is exacerbated following acute inflammatory 
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conditions, such a stroke, and is facilitated by expression of the chemokine receptor type 
2 (CCR2) (14). These findings suggest that under certain conditions, peripheral immune 
cells can enter the CNS.  Immune cells are derived from hematopoietic stem/progenitor 
cells (HSPCs) primarily located within the bone marrow (15). HSPCs can also be found 
in very small quantities in circulation, and these circulating progenitor cells (CPCs) (16) 
have been shown to contribute to tissue repair via secretion of paracrine factors (17). 
Interestingly, inflammatory conditions, such as acute infection and obesity, increase the 
content of CPCs and enhance myeloid differentiation of HSPCs (16, 18, 19). The role of 
CPCs in the brain and cognition has not previously been explored in the context of 
overweight/obese children.  
In the present report, we evaluate the relationship between CPCs, monocyte 
populations, executive function, and neurogenesis in healthy weight (HW) and 
overweight/obese (OW) children using a combined in vivo and in vitro approach. OW 
children have a compromised immune system (20), decreased performance on tests of 
executive function (21, 22), and decreased hippocampal volume (23, 24). Thus, 
comparing HW to OW children allowed us to evaluate the link between immune system 
dysregulation on cognition. We hypothesized that compared to HW children, OW children 
would have higher quantities of CPCs and monocyte populations expressing CCR2 in 
peripheral blood compared to HW, and that CPC and monocyte content would be 
negatively associated with executive function in OW children. Furthermore, we 
hypothesized that paracrine factors released from hematopoietic cells isolated from OW 




Twenty-seven preadolescent (age: 8-10-years; 16 HW and 11 OW) male children 
who previously underwent cognitive testing as part of a larger study (25) participated in 
the present study.  HW and OW were matched for age, fat free VO2 max, and general 
intelligence (IQ) as determined by Woodcock Johnson III Brief Intellectual Ability tests.  
Participants provided informed written assent with parental/legal guardian consent to 
participate in the study and were compensated for their time. This project was approved 
by the Institutional Review Board of the University of Illinois at Urbana-Champaign.  
3.2.2 Anthropometric Measures, Body Composition, and Fitness 
Participants were separated into healthy weight (HW) and overweight/obese (OW) 
based on body mass index (BMI) with those having a BMI of ≥85th percentile of their age-
matched peers considered OW (26). Whole body and regional soft tissue composition 
was measured by dual-energy X-ray absorptiometry (DXA) using a Hologic Discovery A 
bone densitometer (software version 12.7.3; Hologic, Bedford, MA). DXA measures of 
interest included whole body fat mass (%) and abdominal fat mass (%). Participants 
completed a maximal exercise test to assess aerobic fitness on a motorized treadmill 
using a modified Balke protocol (27).   
3.2.3 Whole Blood Analysis  
Participants reported to the lab between the hours of 6:00-10:00AM CST after at 
least an 8-hour fast. Blood was collected from the antecubital vein into EDTA-
anticoagulant tubes. Plasma was aliquoted after Ficoll-Paque separation on EDTA-
collected blood prior to isolation of peripheral blood mononuclear cells (PBMCs) used for 
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CD34+ isolation by flow sorting. Lineage negative PBMCs were magnetically separated, 
incubated with PE-conjugated CD34 antibody (1:100 dilution), and sorted using either an 
iCyt Reflection flow sorter (iCyt; Champaign, IL) or a FACS ARIA II fluorescence activated 
sorter (BD; Franklin Lakes, NJ). All isolated CPCs from each participant were plated in 
250 μL of Serum Free Expansion Media (StemCell Technologies; Vancouver, Canada) 
for 3 hours. The average concentration of plated cells was 25,000 cells/well.  Conditioned 
media was collected and frozen at -80°C until further analysis. 
Quantification of CPCs and monocytes with and without CCR2 expression was 
conducted from whole blood (200 µL/population) collected in EDTA tubes. Samples were 
incubated with PE conjugated CD34 (1:40; Invitrogen; Grand Island, NY), FITC 
conjugated CD45 (1:200; Invitrogen; Grand Island, NY), PE conjugated CD14 (1:100; 
Invitrogen; Grand Island, NY), FITC conjugated CD16 (1:100; Invitrogen; Grand Island, 
NY), or CCR2 (CD192; 1:100; Biolegend; San Diego, CA). Gating for CPCs was 
conducted as previously described(16). Flow cytometric analysis was performed within 3 
hours of blood collection using an Attune Focusing Flow Cytometer (Life Technologies; 
San Diego, CA).   
3.2.4 Cognitive Tasks 
A subset of participants completed a subtest of the Woodcock-Johnson III Tests 
of Executive Processing (WJ III) to assess cognitive performance as described 
previously(28) as part of a larger on-going study(25). The WJ III test of Executive 
Processing is a test of fluid reasoning and decision-making, which involves making logical 
and novel decisions (29, 30) that requires input from a variety of brain regions (31). 
2.5 Neuroblastoma Cell Culture and Conditioned Media Experiments  
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SH-SY5Y cells (CRL-2266; ATCC; Manassas, VA) were plated in growth media at 
50,000 cells/well for 24 hours prior to addition of conditioned media (CM). CM was derived 
from sorted CPCs as described above.  All CM derived from CPCs sorted from healthy 
weight participants was pooled (HW-CM), while all CM derived from CPCs sorted from 
overweight/obese participants was pooled (OW-CM).  To ensure that differences in CM 
experiments were not due to different numbers of CPCs contributing to CM, we added 
serum-free media to the pooled samples to equalize the number of input CPCs to CM 
between weight classes.  In this way, the concentration (plated CPCs/mL of CM) was 
equal between HW-CM and OW-CM.  As such, we could compare differences between 
groups caused by alterations in the secretome on an individual cell basis rather than a 
population or cell quantity basis.  Neuroblastomas were then incubated with either CM 
from CD34+ cells isolated from OW or HW, or plasma from OW or HW for 24 hours prior 
to viability analysis.  
3.2.5 MTT Assay   
Neuroblastoma viability was assessed after 24 hours in CM via MTT Assay (Sigma 
Aldrich; St. Louis, MO) as previously described (32) with minor modifications to account 
for partially adherent, partially floating growth of neuroblastomas. Briefly, after addition 
and incubation of MTT solution, media was centrifuged to collect floating cells. Half the 
volume of MTT solvent was added to the adhered cells, and the other half of the solvent 
was used to resuspend the centrifuged floating cells, which were then added back into 
the original well for analysis. 
3.2.6 Statistical Analyses 
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Group differences were analyzed by t-test in Microsoft Excel. Correlations were 
conducted in SPSS software (IBM Statistics: Version 22; Armonk, NY) using Spearman’s 
rho nonparametric analysis. Partial correlations were conducted controlling for abdominal 
body fat between CPCs and cognitive task standard scores in HW and OW groups using 
Spearman’s Rho nonparametric analysis. Comparisons between within group 
correlations were conducted by comparing Spearman’s Rho values using a Fisher’s R to 
Z transformation and converting the correlation coefficient into a Z-score for comparison. 




3.3.1 OW children have greater content of circulating CCR2-expressing inflammatory 
monocytes and CPCs compared to HW 
HW and OW did not differ in age (HW: 8.7±0.8 years; OW: 9±0.8 years), fat free 
VO2 max (HW: 62.8±9.8 ml/kgLBM/min; OW: 62.1±7.9 ml/kgLBM/min), general intelligence 
(HW: 118.8±12.1; OW: 106.7±118.5). OW children had significantly higher BMI (HW: 
16.2±1.2 kg/m2; OW: 24.00±4.6 kg/m2; p<0.05), BMI percentile (HW: 51±22.7; OW: 
95.7±3.7; p<0.05), body fat percentage (HW: 24.8±3.2%; OW: 39.00±5.9%; p<0.001), 
and abdominal fat percentage (HW: 17.4±2.2%; OW: 32.9±8.3%; p<0.01).  The quantity 
of classical (CD14+/CD16-) (33) and non-classical (CD14+/CD16+) (34) monocytes in the 
OW group was significantly higher than that of HW (CD14+/CD16-: HW: 9128±519 
cells/mL vs. OW: 14351±1831 cells/mL; p<0.01; Figure 3.1A and CD14+/CD16+: HW: 
1327±172 cells/mL vs. OW: 2598±462 cells/mL; p<0.01, Figure 3.1B). The quantity of 
classical and non-classical monocytes expressing CCR2 (CD14+/CD16+/-/CCR2+), a 
phenotypic marker associated with increased migratory capacity (35) in OW children was 
significantly higher than HW (CD14+/CD16-/CCR2+: HW: 8382±626 cells/mL vs. OW: 
13947±1838 cells/mL; p<0.01, Figure 3.1C; CD14+/CD16+/CCR2+: HW: 496±101 
cells/mL vs. OW: 1331±300 cells/mL; P<0.01, Figure 3.1D, respectively).  
The quantity of CPCs, a heterogeneous population of circulating stem/progenitor 
cells that include hematopoietic and endothelial progenitors (16) in peripheral blood, was 
significantly elevated in OW compared to HW (HW: 49±7 cells/mL vs. OW: 72±9 cells/mL; 
p<0.05, Figure 3.1E) and showed differential relationships with abdominal body fat % 
between HW and OW. CPC quantity in HW was negatively correlated with abdominal 
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body fat % (Spearman’s Rho= 0.658), while CPC quantity in OW was positively correlated 
with abdominal body fat % (Spearman’s Rho = -0.433), with a significant difference in 
correlation coefficients between groups (p<0.05; Figure 3.1F).  
3.3.2 Differential relationship between CPCs and executive processes between HW and 
OW children with differential paracrine effects on neuroblast viability 
In the present investigation, scores on the WJ III Executive Processing task did not 
differ between OW and HW participants (OW: 115±9.74; HW: 108.14±14.56; data not 
shown).  Since our primary interest was to compare the relationship between CPCs and 
executive processing in OW and HW, we performed Spearman’s Rho correlation 
analyses between circulating inflammatory cell populations and the WJ III Executive 
Processing task then compared the correlations between the two populations. No 
differences were found in the correlations between circulating classical and non-classical 
monocytes, or monocytes expressing CCR2 and executive processing tasks between HW 
and OW (data not shown). Conversely, for the WJ III Executive Processing Cluster, which 
is an amalgamation of the 3 tasks in the cluster, we observed a negative correlation 
(Spearman’s Rho = -0.462) in HW, while OW had a positive correlation (Spearman’s 
Rho=0.571) with a significant difference between the two correlations (P<0.05 for 
correlations between HW and OW; Figure 3.2A).  When we examined the 3 separate 
tasks that combine to make up the Executive Processing Cluster, we observed the same 
trend in relationships between HW and OW (data not shown). Since we observed 
significant differences in the correlations between CPC quantity and executive function 
as well as CPC quantity and abdominal adiposity between OW and HW, we were 
interested in evaluating the extent to which abdominal adiposity influenced the 
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relationship between CPCs and executive function scores.  Thus, we performed partial 
correlations on these three outcomes accounting for abdominal adiposity in both weight 
groups. The significantly different correlations between CPCs and executive processing 
between HW and OW children was no longer present when abdominal adiposity was 
accounted for (data not shown). Therefore, these data suggest that abdominal adiposity 
may have a role in the relationship between CPCs and executive function in OW children. 
To examine if paracrine factors secreted from CPCs influenced the growth of 
neuroblasts in vitro, we performed conditioned media (CM) experiments where 
neuroblasts were treated with CM from CPCs isolated from HW or OW children.  We 
observed a strong trend for an increase in neuroblast viability when they were treated 
with CM from CPCs isolated from OW versus HW (1.79 fold increase; p=0.07, Figure 
3.2B). To determine if factors released from CPCs specifically, or if the general systemic 
milieu was promoting the increase in neuroblast viability, we repeated the CM 
experiments described above, but substituted plasma from OW and HW children for CPC-
CM.  No difference in viability was seen between neuroblasts treated with plasma from 




Developing a better understanding of the potential relationship between immune 
system and cognition in OW children is necessary given the increasing prevalence of 
overweight/obesity and children, and because childhood is a time of rapid brain and 
cognitive development. The main findings from our study are that: (1) the content of 
CPCs, monocytes, and monocytes expressing CCR2 were all significantly elevated in 
OW children, (2) abdominal adiposity is differentially related to CPC content in HW and 
OW preadolescents, (3) the relationship between CPC quantity and WJ III executive was 
significantly different in HW and OW, and (4) paracrine factors released from CPCs 
isolated from OW children trended to increase neuroblast viability to a greater extent than 
paracrine factors released from CPCs isolated from HW children. Contrary to our initial 
hypothesis, these data suggest that increased CPC quantity in OW children may have a 
role in combating the negative cognitive effects associated with overweight/obesity.   
Consistent with previous investigations in obese adults (35, 36), and obese 
children (37, 38), we observed a higher amount of circulating monocyte content in our 
OW population compared to HW.  A novel aspect of the present study is the additional 
evaluation of co-expression of CCR2 on monocyte populations. CCR2 is involved in cell 
migration to sites of inflammation via interaction with its ligand, chemokine ligand 2 
(CCL2; also known as monocyte chemoattractant protein [MCP]-1) (33, 35). We observed 
a significant elevation in the quantity of both classical and non-classical monocytes 
expressing CCR2 in OW. Thus, not only did we observe a higher content of total 
monocytes in OW, but a higher amount of the proportion of monocytes that express 
markers associated with homing to inflamed tissues compared to HW. Previous studies 
 50 
have examined the relationships between cognition and CD16+ monocytes in individuals 
with HIV-associated cognitive decline (39–41), older adults with Alzheimer’s disease 
and/or dementia (42), and natural cognitive decline associated with aging (43, 44). The 
present study is the first to compare the relationship between inflammatory monocytes 
and executive function between OW and HW children.  The within group correlations in 
monocytes and executive function were not different between OW and HW in our study.  
These findings suggest that the relationship between monocytes and cognition is present 
independent of BMI.   
The present investigation is the first to demonstrate that CPC content is greater in 
overweight/obese children. Furthermore, our data show that CPC content is differentially 
related to abdominal adiposity in HW and OW. These data in children are consistent with 
previous findings showing a positive correlation between CPC quantity and BMI in adults 
(16). The physiological role of CPCs has not been fully elucidated, but they have been 
suggested to be involved in tissue repair (17, 45).  To examine if CPCs had a differential 
relationship to cognitive function in OW children who have previously been shown to have 
decreased performance on executive control tasks and academic achievement tests in 
OW compared to HW children (12, 46), we compared the relationship between CPC 
content and performance on the WJ III test of Executive Processing in OW and HW. We 
observed a significant difference in the relationship between CPC content and executive 
function between OW and HW children with CPC content being positively correlated to 
performance in OW, and negatively correlated to performance in HW.  This differential 
relationship was no longer present when abdominal adiposity was accounted for.  This 
observation suggests that specific aspects associated with abdominal adipose tissue may 
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underlie this relationship. We hypothesized that differences in the CPC secretome may 
underlie the differential relationship between CPCs and cognition in OW and HW 
preadolescents.  Previous in vitro experiments have shown that certain cytokines, such 
as IL-6 and INF-γ, inhibit neuroblast proliferation but enhance neurogenesis, while others, 
such as TNF-α and IL-10, increase neuroblast proliferation and inhibit neurogenesis (47).  
Furthermore, animal studies have shown that in response to inflammatory stimuli, 
cytokine secretion by CPCs exceeds that of mature immune cells (48).  In particular, LPS-
stimulated CPCs have been shown to secrete high levels of TNF-α, IL-6, and IL-10 (48), 
which are also active regulators of neuronal progenitors in vitro (47).  Although it was not 
possible to evaluate cytokine production or secretion from isolated CPCs in the present 
investigation, our in vitro data suggest that the secretome of CPCs from OW was more 
favorable for neuroblast viability compared to the secretome of HW.  Furthermore, 
although these in vitro studies are informative for determining mechanisms, their direct 
relevance to in vivo conditions with a complex cellular and soluble factor milieu within the 
neurogenic niche is debatable.   
In conclusion, the data presented herein suggest that increased CPC content in 
OW children may play a role in maintaining cognitive performance.  Future studies will be 
necessary to determine if CPCs can enter the central nervous system in OW children, 
and the precise milieu of paracrine factors secreted by CPCs.  CPC content (15, 18), 
migration (17, 45), and cytokine secretion (48) has been shown to increase in response 
to acute inflammatory stimuli. Furthermore, the blood brain barrier is more permeable in 
older obese mice (49), and immune cells increase migration into the CNS in acute 
inflammatory conditions (50).  These data combined with data from the present study 
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suggest that CPCs may be an important cell population with a role in cognitive function 
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Figures and Figure Legends 
Figure 3.1. Inflammatory monocyte content and phenotype in HW and OW. 
Concentrations of classical (A) and non-classical monocytes (B) with and without 
expression of CCR2 (D and D), and CPCs (E) in the healthy weight (HW) and  
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Figure 3.1. (cont). overweight/obese children (OW); n=16 HW and n=11 OW for figures 
(3.1A-E). Spearman’s Rho correlations (F) between CPCs and abdominal body fat 
percentage in HW and OW; n=14 HW and n=8 OW. Data are presented as mean ± SEM, 




Figure 3.2.  Relationships between CPCs and Executive Processes in HW and OW 
and CPC conditioned media on neuroblast viability.  Spearman’s Rho correlations 
between CPC concentrations and Woodcock Johnson Tests of Executive Processes, 
specifically executive processing (A), n = 14 for HW and n = 7 for OW.  Percent cell 
viability of SH-SY5Y neuroblastomas treated with conditioned media from CPCs (B) or 
plasma (C) collected from healthy weight (HW) and overweight/obese (OW) children. For 
both experiments, cell viability is expressed at percent difference from neuroblasts grown 
in neuroblast growth media. Serum free growth media was used as a negative control. N 
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Abstract  
Circulating progenitor cells (CPCs) and subpopulations are normally found in the 
bone marrow, but can migrate to peripheral tissues to participate in local inflammation 
and/or remodeling. The purpose of this study was to characterize the inflammatory CPC 
response to a six-week endurance exercise training (EET) intervention in lean and 
obese adults. Seventeen healthy weight (age: 23.9±5.4 years, body mass index (BMI): 
22.0±2.6 kg/m2) and ten obese (age: 29.0±8.0 years, BMI: 33.1±6.0 kg/m2) previously 
sedentary adults participated in a EET. Blood was collected before and after EET for 
quantification of CPCs and subpopulations via flow cytometry, colony forming unit 
(CFU) assays, and plasma concentration of CXCL12, G-CSF, and CCL2. Exercise 
training reduced the number of circulating hematopoietic stem/progenitor cells (HSPCs), 
bone marrow-derived mesenchymal stromal cells (BM-MSCs), and adipose tissue-
derived MSCs (AT-MSCs). EET increased colony forming potential of granulocytes and 
macrophages irrespective of BMI. EET reduced the number of HSPCs expressing the 
chemokine receptor CCR2 and the pro-inflammatory marker TLR4. EET-induced 
changes in AT-MSCs and BM-MSCs were negatively related to changes in absolute 
fitness. Our results indicate that EET, regardless of BMI status, decreases CPCs and 




 Obesity is a growing concern in western countries, with approximately one-third 
of adults affected (1). Obesity can contribute to cardio-metabolic comorbidities such as 
heart disease and/or failure, respiratory disease, type 2 diabetes, and metabolic 
syndrome (2). In adults, the increased adipose tissue as a result of obesity is connected 
with chronic low-grade inflammation, characterized by overproduction of 
proinflammatory cytokines and inflammatory cells (3, 4). Monocyte and macrophage 
infiltration into adipose tissue contributes to local inflammation and subsequent 
metabolic dysfunction (5). These inflammatory cell subtypes are derived from 
hematopoietic stem/progenitor cells (HSPCs) in the bone marrow. HSPCs along with 
more primitive hematopoietic stem cells (HSCs), endothelial progenitor cells (EPCs), 
and mesenchymal stem/stromal cells (MSCs) (6), collectively referred to as circulating 
progenitor cells (CPCs) (6, 7), circulate in peripheral blood and home to extramedullary 
tissues to participate in tissue repair and inflammation (8). Persons with obesity have 
been shown to have increased CPCs (9), increased inflammatory monocytes (10, 11), 
and increased CPCs expressing toll-like receptor 4 (TLR4) and C-C chemokine receptor 
type 2 (CCR2) compared to healthy weight adults (10, 12). TLR4 stimulation has been 
shown to increase HSPC proliferation and differentiation towards myeloid lineages (13), 
and CCR2 is involved in HSPC homing towards sites of inflammation (14). In humans, 
the effects of obesity on CPC populations remains largely unclear; however, alterations 
to CPC populations in adults with obesity may have clinical importance due to their 
proposed role in contributing to inflammatory processes in peripheral tissues.   
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In obese adults, endurance exercise training (EET) contributes to improved body 
composition, metabolism, and inflammatory profiles (15). Much of the work examining 
the effects of exercise on CPCs has focused on acute exercise bouts, and the 
consensus from these studies is that acute exercise transiently increases CPCs in the 
peripheral blood in an intensity-dependent manner  (6, 16, 18, 19). However, the effects 
of EET or training status on CPC content are equivocal (8, 20). Many studies that 
focused on EET and CPCs have relied on self-reported training status and not persons 
who participated in a structured exercise training (18), or EET that resulted in moderate 
increases in cardiorespiratory fitness (20). Despite the growing body of evidence 
investigating the effects of EET on CPCs and their subpopulations, to our knowledge, 
no work has examined the effects of EET on CPCs in obese participants. Furthermore, 
the effects of EET on markers of inflammatory bias on CPCs are unknown. Investigating 
the potential anti-inflammatory effects of EET on CPCs expressing inflammatory 
markers in persons who are obese may identify novel mechanisms that explain the 
relationship between inflammation, EET, and obesity. 
Thus, the purpose of this study was to characterize the inflammatory CPC 
response to a six-week EET in lean and obese adults. We focused on a variety of CPC 
populations previously shown to be influenced by acute exercise (6), and also examined 
the expression of CCR2 and TLR4 on CPCs to determine if obesity/EET altered 
phenotypic markers associated with tissue inflammation.  We hypothesized that EET 
would decrease the quantity of CPCs expressing inflammatory markers, as well as the 




4.2.1 Ethical Approval 
This study was approved by the University of Illinois Institution Review Board and 
conformed to the standards of use of human participants in research as outlined in the 
Sixth Declaration of Helsinki. Each participant provided written informed consent prior to 
participating in this study. This study was an additional analyses of some participants 
previously described (21).   
4.2.2 Participants and Study Design 
 Twenty-seven previously sedentary (< 30 minutes of moderate or high intensity 
exercise per week and < 10 aggregate Godin-Shepard Leisure Time Physical Activity 
Questionnaire (GSLTQ) score) females and males between the ages of 20-45 years 
were recruited and divided into lean or obese groups based on body mass index (BMI); 
lean (BMI < 25kg/m2; n=17) and obese (BMI >30 kg/m2; n=10). Participant 
characteristics are shown in Table 4.1. Participants that qualified for the study were free 
of metabolic and gastrointestinal disease, were not pregnant or lactating, not taking 
medications that would impact bowel function, and not taking antibiotics for at least 
three months prior to or during the study. After two weeks of baseline testing including a 
dual x-ray absorptiometry (DXA) scan, blood draw, maximal exercise test, and dietary 
analysis, all subjects completed a six-week EET intervention for 30-60 minutes per day, 
three times per week, in which exercise intensity and duration progressed to 60 min at 
75% heart rate reserve (HRR) (21). Participants were instructed by a registered dietician 
to maintain their current diet which included maintenance of overall dietary patterns, 
maintenance of alcoholic/caffeinated beverage consumption and continuation of any 
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dietary supplement usages that occurred prior to the beginning of the study, which is 
explained in more detail by Allen and colleagues (21). 
4.2.3 Body Composition Assessments 
Height, weight, and adiposity were completed before and after the 6-week EET. 
Standing height and weight measurements were completed with participants wearing 
lightweight clothing and no shoes using a stadiometer (Seca, model 240) and a Tanita 
WB-300 Plus digital scale (Tanita, Tokyo, Japan), respectively. Whole body composition 
was measured by DXA (Hologic Discovery A bone densitometer; software version 
12.7.3; Hologic, Bedford, MA).  
4.2.4 VO2max Testing 
 Prior to and after the exercise intervention, participants completed a maximal 
oxygen uptake test to assess cardiorespiratory fitness (VO2max; Parvo Medics Tru Max 
2400, Sandy, UT). This test involved walking or running to maximal exertion on a 
treadmill using the Bruce Testing protocol as described previously (21). Heart rate (HR) 
was continuously recorded via a wireless heart rate monitor (Polar Electro, Lake 
Success, NY) and the test ended upon volitional fatigue. VO2max was verified if two or 
more of the following criteria were met: (1) rate of perceived exertion > 18, (2) HR within 
10 beats per minute (bpm) of age-predicted max HR, (3) a plateau in HR (<3 bpm 
change) over the last two intensity stages, and/or (4) respiratory exchange ratio (RER) 
of > 1.10. VO2max testing was completed after blood draws at both time points to avoid 
any effects of acute exercise on blood parameters. 
EET Protocol 
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 The EET intervention consisted of three supervised 30 to 60 minute, moderate to 
vigorous intensity (60-75% of HRR) EET sessions per week (21). Participants chose 
from a cycle ergometer or treadmill during each exercise session. Percent of HRR was 
calculated as: 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡	(%)𝑜𝑓	𝑡𝑎𝑟𝑔𝑒𝑡	𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 ∗ (𝐻𝑅𝑚𝑎𝑥 − 𝐻𝑅𝑟𝑒𝑠𝑡) + 	𝐻𝑅	𝑟𝑒𝑠𝑡 
HRmax was determined during the baseline VO2max test. During week 1 of training, 
sessions were 30 minutes at 60% HRR. Training sessions for week 2 lasted 45 minutes 
at a similar intensity. Training sessions at week 3 were increased to 60 minutes at 60% 
HRR. During weeks 4-6 of training, there was an increase in intensity of 5% HRR per 
week, progressing up to 75% of HRR for 60 minutes per session during week 6. All 
participants were 100% compliant in completing necessary EET sessions. 
4.2.5 Blood Draws 
 Participants reported to the lab 3-4 days before starting the exercise regimen and 
3-4 days after the last exercise session at least 8-10 hours fasted. Participants were 
seated in the upright position and blood was collected into EDTA tubes, and sodium 
heparin tubes.  
4.2.6 Granulocyte and Macrophage CFU assay 
 The sodium heparin tubes were used for granulocyte and macrophage colony 
forming unit assay (Methocult) as per manufacturer’s instructions. Briefly, peripheral 
blood mononuclear cells (PBMCs) were isolated using sterile Ficoll-Paque Plus (GE Life 
Sciences, Pittsburgh, PA) density gradient, per manufacturer’s instructions (400 x g 
22C, 40 minutes with the brake off) with modifications. Instead of using PBS, blood was 
mixed with Isocove’s modified Dulbecco’s medium mixed with 2% fetal bovine serum 
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(FBS). Cells were diluted to approximately 2.0 x 106 cells/mL in each tube, and 400 uL 
was added to MethoCult Methylcellulose medium (H4534, without EPO, Stem Cell 
Technologies; Vancouver, BC, Canada), and plated per manufacturer’s instructions. 
Colonies were counted 12 days after plating. To prevent variability in colony counting, 
the same researcher, who was blinded to each condition, counted all colonies in the 
study. Participants were plated in triplicate, with the average amount of granulocyte 
(CFU-G), macrophage (CFU-M), granulocyte-macrophage (CFU-GM), and total (CFU-
T) colonies per person reported.  
4.2.7 Flow cytometry  
 The EDTA-anticoagulant tubes were used for flow cytometric analysis and 
previously described (6, 7). Briefly, PBMCs were isolated using Ficoll-Paque Plus (GE 
Life Sciences, Pittsburgh, PA) density gradient, per manufacturer’s instructions. Plasma 
was collected from the Ficoll-Paque density gradient spin and stored in 500 ul aliquots 
at -80C until further analysis. PBMCs were split into three different samples: CPC, MSC, 
and common myeloid progenitors (CMP)/common lymphoid progenitors (CLP) samples. 
CPCs were quantified using previously defined protocols (6, 7). Antibodies for CPC 
(CD34+), HSPC (CD34+/CD45dim), and HSC (CD34+/CD45dim/CD38-) enumeration were 
phycoerythrin (PE)-conjugated CD34 (1:100, Invitrogen, Grand Island, NY), PE-Cy 5-
conjugated CD38 antibody (1:50, BD Biosciences, San Jose, CA), and FITC-conjugated 
CD45 (1:200, Invitrogen, Grand Island, NY). Antibodies for EPC (CD45-/CD34+/CD31+), 
EC (CD45-/CD31+), and MSC (bone marrow derived (BM-MSC): CD45-/CD34-/CD31-
/CD105+, and adipose derived (AT-MSC): CD45-/CD34+/CD31-/CD105+,) enumeration 
were PE conjugated CD34 (1:100, Invitrogen, Grand Island, NY), FITC-conjugated 
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CD45 (1:200, Invitrogen, Grand Island, NY), Vio-blue conjugated CD105 (1:200, 
Miltenyi Biotec, San Diego, CA) and PE-Cy7 CD31 (1:200; BioLegend, San Diego, CA). 
Antibodies for CMP (Lin-/CD34+/CD38+/IL3Ra-(CD123)/CD45RA-) and CLP (Lin-
/CD34+/CD38+/IL3Ralow(CD123)/CD10+), enumeration were FITC conjugated lineage 
panel cocktail (1:100; BD Pharminigen, San Jose, CA), PE-conjugated CD34 (1:100, 
Invitrogen, Grand Island, NY), PE-Cy 5-conjugated CD38 antibody (1:50, BD 
Biosciences, San Jose, CA), Brilliant violet (BV)- 510-congugated CD123 (1:100; BD 
Pharminigen, San Jose, CA), BV-605 conjugated CD45RA (1:100; BD Biosciences, San 
Jose, CA), and BV-421 conjugated CD10 (1:50; BD Pharminigen, San Jose, CA) and 
were based on previous studies (22). 
 Flow quantification was performed on an Attune Focusing Flow Cytometer (Life 
Technologies) on at least 200,000 PBMCs. The Attune Flow Cytometer conducts 
volumetric counting by calculating the concentration of events per microliter based on 
the volume of sample analyzed. Gates were established based on previously described 
protocols (6, 7, 9). 
4.2.8 Enzyme-linked immunosorbent assay  
 Human CXCL12/stromal derived factor-1a, granulocyte colony stimulating factor 
(G-CSF), and chemokine (C-C motif) ligand 2 (CCL2) were quantified in stored plasma 
using the commercially available Quantikine ELISA kits (R&D Systems, Minneapolis, 
MN) at Pre and Post time-points. ELISAs were performed according to the 
manufacturer’s instructions with samples run in duplicate. Thawed samples were 
centrifuged for 5 min at 10,000 x g before analysis to ensure platelets were eliminated 
from the plasma sample. 
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4.2.9 Statistical analysis 
 Demographics, cell populations, CFU assays, and plasma protein concentrations 
were analyzed by a 2x2 mixed-model ANOVA (between-subjects factor: weight status 
(Lean/Obese); within-subjects factor: time points (Pre/Post) in SPSS (IBM, version 25; 
Chicago, IL). Data was log transformed prior to analyses if normality was not met by 
Shapiro-Wilks. Changes in cell populations and changes in fitness were calculated by 
subtracting the Pre values from the Post values. Spearman rho analysis were 
implemented to determine relationships between exercise-induced changes in MSCs in 
paralleled changes to cardiorespiratory fitness (VO2max). Data are presented as means ± 




 Participant demographic data are presented in Table 4.1. The obese group had a 
higher BMI than the lean group in the pre and post condition (33.1±6.0 kg/m2 vs. 
22.0±2.6 kg/m2; 32.9±6.0 kg/m2 vs. 22.0±2.7 kg/m2, respectively; p<0.001); however, no 
weight changes were observed as a result of EET. The obese group also had a higher 
percent body fat compared to the lean group before and after EET (36.6±4.6% vs. 
25.2±6.4%; 35.3±4.6% vs. 24.5±6.4%, respectively; p<0.001) and EET decreased body 
fat percentage in both groups after the exercise intervention (p=0.03). Additionally, the 
obese group had a lower relative VO2 compared to the lean group before and after EET 
(31.3±5.0 kg/ml/min vs. 40.3±5.3 kg/ml/min; 34.3±5.2 kg/ml/min vs. 44.7±6.7 kg/ml/min, 
respectively; p<0.001), and both groups increased their relative VO2 and absolute VO2 
compared to before the EET (p<0.0001 and p<0.0001, respectively).  
4.3.1 Circulating CPCs, HSPCs, and CLPs are decreased following EET   
CPCs were decreased in the lean group after the EET (p=0.04, Fig. 4.1A). HSPC 
content was reduced in both the lean and obese groups (p<0.001; Fig. 4.1B). The 
reduction of CPC content was driven by the lean group difference between pre and post 
(p=0.04). EPC content did not change after the exercise intervention (p>0.05, Fig. 
4.1C). Exercise training decreased CLP content irrespective of BMI (p=0.009; Fig. 
4.1D). CMP content did not change as a result of EET (p>0.05; Fig. 4.1E). The ratio of 
CMP:CLP cells were also unaltered by EET (p>0.05; Fig. 4.1F). 
4.3.2 Colony forming units of innate immune cells are higher in obesity with more 
primitive colonies responding EET 
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 The proliferation potential of CPCs was assed using the CFU assay. Visually, the 
size of all of the CFU colonies were larger following EET (data not shown). The number 
of CFU-G were higher in the obese group compared to the lean group (p=0.01; Fig. 
4.2A), whereas CFU-M trended higher in the obese group (p=0.1, Fig. 4.2B). Neither 
CFU-G nor CFU-M were altered by EET. CFU-GM was higher in the obese group 
before and after the EET (p=0.03), and was increased following the EET irrespective of 
BMI status (p=0.05; Fig. 4.2C). CFU-T trended higher in the obese group (p=0.07; Fig. 
2H) and increased as a result of the EET (p=0.02; Figure 4.2D).  
4.3.3 Inflammatory progenitor cells are decreased after 6-weeks of EET 
 The number of CCR2+ HSPCs and level of CCR2 expression on HSPCs was 
decreased after EET in both groups (p=0.006, Fig. 4.3A; p<0.001, Fig. 4.3B; 
respectively). The percentage of HSPCs expressing CCR2 was decreased after EET in 
the obese group (p=0.02, Fig. 4.3C). The number of TLR4+ HSPCs was decreased after 
EET in both the lean and obese groups (p=0.006, Fig. 4.3D); however, the level of 
expression of TLR4 on HSPCs was increased in the lean and obese groups after the 
EET (p=0.03, Fig. 4.3E). The percentage of TLR4-expressing HSPCs did not change 
with EET in the lean and obese groups (Fig. 4.3F).  
4.3.4 CXCL12 is decreased after EET 
 CXCL12 levels decreased following EET in the obese, but not lean, participants 
(interaction effect p=0.01; Fig 4.4A). G-CSF did not significantly change as a result of 
EET but trended to decrease in adults with obesity (p=0.06; Fig. 4.4B). CCL2 was not 
altered after EET (p>0.05, Fig. 4.4C).  
Changes in cardiorespiratory fitness are related to changes in AT-MSCs 
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 BM-MSCs trended to decrease as result of EET in both the lean and obese 
participants (p=0.06; Fig 4.5A). AT-MSCs were also reduced as a result of EET in both 
the lean and obese groups (p=0.04, Fig. 4.5B). Changes in BM-MSCs and AT-MSCs 
from pre to post-EET were negatively associated to the change in absolute VO2Max 




The aim of the present study was to characterize the effects of six weeks of EET 
on CPC populations, particularly CPCs expressing pro-inflammatory markers, in lean 
and obese adults. The main findings of this study were: 1) HSPCs, AT-MSCs, and CLPs 
are decreased in both lean adults and obese adults as a result of six weeks of 
endurance exercise training, 2) EET increases more primitive CFU-GM, while adults 
with obesity have higher CFU-G colonies, irrespective of exercise and 3) EET 
decreases inflammatory markers CCR2 and TLR4 on HSPCs, particularly in adults with 
obesity. These results identify a potential novel mechanism for the anti-inflammatory 
effects of EET in obesity.  
Data regarding the relationship between physical activity level, cardiorespiratory 
fitness, and exercise training on CPC content are equivocal. Cross-sectional studies 
have shown that endurance trained athletes have elevated levels of CPCs compared to 
sedentary controls (23), while others have shown no difference in CPC content when 
individuals were stratified into high fit and low fit groups (16). Results from longitudinal 
studies indicate that EET does not alter CPC content (20, 24). However, these studies 
are limited in that they used interval training rather than steady state training (20).  
Conversely, EET under hypoxic conditions (25), or in patients with lower limb ischemia 
(26) significantly increased CPC content.  To our knowledge, this is the first study to 
describe a reduction in CPCs and HSPCs following EET in both lean and obese adults. 
Discrepancies in the literature could be due to the lack of a consistent endurance 
exercise intervention (27), variability in time of CPC quantification following the most 
recent exercise bout (with some not specified) (23, 24, 28), lack of reported dietary 
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controls, or due to the relatively high baseline CPC content in lean adults in the present 
study (17). We extend findings of previous studies by further characterizing more 
committed hematopoietic progenitors. Similar to HSPCs, common lymphoid progenitors 
decreased following EET, while CFU-GM and CFU-T colonies increased. We are not 
the first to report discrepancies between phenotypic CPCs and CFUs (29), and this is 
not surprising given that CFUs are a population of  more mature progenitors (22). 
Together, these findings suggest that EET is related to a decrease in the more primitive 
hematopoietic progenitor cell populations and an increase in more committed 
hematopoietic progenitors in circulation. Interestingly, animal studies have shown an 
increase in HSPC content in the bone marrow following exercise training (30), and that 
EET remodels the HSPC niche in the bone marrow in rodent models of obesity (31). As 
such, we speculate that EET may create a more favorable bone marrow environment 
for HSPCs resulting in increased HSPC maintenance and preservation within the bone 
marrow and an expansion of more differentiated populations in circulation. Previous 
studies have suggested that CPCs may not originate directly from the bone marrow and 
may be mobilized from a marginal pools within vasculature (17). As such, EET may 
increase CPC content in the marginal pools which could also explain their decrease in 
circulation. 
Cell surface markers have been identified that regulate HSPC recruitment and 
differentiation. Rodent studies have shown that HSPCs are recruited towards inflamed 
adipose tissue in a CCR2-dependent manner (14). Furthermore, once HSPCs are 
recruited to inflamed tissues, they can exacerbate the local inflammatory response 
through differentiation towards myeloid lineages, a process driven by TLR4 stimulation 
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(13). Since persons with obesity are in a chronic state of low-grade inflammation, we 
investigated if EET could modulate CCR2 and TLR4 expression on HSPCs. Exercise 
training significantly decreased the number of circulating HSPCs expressing CCR2. 
This decrease could have been due to a decrease in overall HSPC content, thus we 
further evaluated if the proportion of HSPCs expressing CCR2, and the level of CCR2 
expression on HSPCs was influenced by exercise training. Interestingly, we observed a 
significant decrease in the proportion of CCR2-expressing HSPCs specifically in 
persons with obesity, and a decrease in overall CCR2 expression which was 
independent of weight status.  Our research extends recent research that has shown 
that exercise can reduce the level of expression of CCR2 on inflammatory monocytes in 
persons with obesity (32) to show that CCR2 is also reduced in HSPCs; inflammatory 
monocyte precursors. The decreased proportion of CCR2+-HSPCs in obese adults 
suggests that EET influences the CCR2 regulation in HSPCs in obesity. Furthermore, 
these results suggest that circulating HSPCs have decreased homing capacity following 
EET, perhaps reflecting an increased propensity to remain within the bone marrow 
niche. Similar to our CCR2 findings, EET decreased the concentration of HSPCs 
expressing TLR4; however, TLR4 expression on HSPCs was increased by EET. These 
results suggest that the overall content of HSPCs with myeloid differentiation potential 
was decreased; however, the capacity of those remaining HSPCs in circulation to 
respond to inflammatory stimuli was increased. This aligns with our CFU findings. It will 
be interesting to investigate if these exercise-induced alterations in circulating HSPCs 
result in decreased local tissue inflammation in obesity due to decreased HSPC homing 
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and subsequent myeloid cell production. Alternatively, this could reflect an increased 
potential of individual HSPCs to directly respond to pathogens following EET.  
 To evaluate the mechanisms responsible for alterations in CPC content, we 
quantified CXCL12 and G-CSF, two chemokines involved in  CPC mobilization (6, 33). 
Our results revealed EET significantly decreased CXCL12 concentration and tended to 
decrease G-CSF concentration, specifically in adults with obesity. Interestingly, the 
change in the concentrations of these chemokines was not related to the change in 
CPC content (data not shown). These results support previous findings from acute 
exercise studies that show that exercise-induced changes in G-CSF and CXCL12 are 
only temporally related to alterations in CPC content (6, 17). We also evaluated 
circulating CCL2 levels to determine if changes in this inflammatory cytokine may be 
responsible for decreases in CCR2 expression. We did not find any changes in plasma 
levels of CCL2 after EET in both the lean and obese groups, which suggests that other 
mechanisms may be responsible for the decreased proportion of CCR2-expressing 
HSPCs. Indeed, CCR2 is known to bind other CCLs (34); however, we were not able to 
evaluate other targets due to lack of sample.  
MSCs have gained popularity as a potential source for cell therapy due to their 
multi-lineage differentiation potential, and their role in regulating tissue repair via 
paracrine mechanisms (35). Following acute exercise, MSC content has been shown to 
decrease (36), or remain unchanged (6); however, the effects of exercise training on 
circulating MSC content has not previously been evaluated. Our results reveal a 
significant decrease in the reportedly adipose tissue derived fraction of CD34+ MSCs 
(37, 38), and a trend for a decrease in the reportedly bone marrow-derived CD34- 
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fraction of MSCs (39). Interestingly, we found that the change in BM-MSCs and AT-
MSCs was negatively related to the change in absolute VO2max. These results indicate 
that increases in cardiorespiratory fitness are associated with decreases in circulating 
MSC content. However, it is important to note that while participants were encouraged 
to maintain their normal diet, there were still reductions in body fat percentage after the 
EET. Therefore, it should be noted that changes in AT-MSCs may also be influenced by 
changes in body fat percentage. Future studies should investigate the precise nature 
and physiological relevance of this relationship and investigate if these changes are due 
to changes in body fat or exercise, or a combination of both.  
 Together, our results indicate that EET decreases CPC subpopulations, 
particularly inflammatory-primed HSPCs in lean and obese adults. Our findings provide 
a better understanding of the factors regulating CPCs and suggest that EET may be 
beneficial for adults with obesity through decreases in the content of inflammatory-
primed HSPCs. Future studies should evaluate the physiological relevance of reduced 
circulating HSPCs as a result of EET, particularly if such changes parallel exercise-
induced improvements in peripheral tissue inflammation and metabolic function in 
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Tables, Figures, and Figure Legends 
 
Table 4.1. Participant demographics. Participant information are presented as 
mean±standard deviation. *main effect of exercise, p<0.05, amain effect of weight class 
p<0.05; n=17 HW, n=10 OB, bHW n=15, OB n=9. 
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Figure 4.1. Six weeks of EET decreases circulating CPCs, HSPCs, and CLPs. (A) 
CPCs are significantly decreased in lean adults after six weeks of EET (group x time 
interaction; p<0.05); (B) HSPCs are decreased with in both lean and obese adults as a 
result of six weeks of EET (main effect of exercise); (C) EPCs are not changed by six 
weeks of EET; (D) EET has no effect on CMPs; (E) EET increases circulating CLPs 
irrespective of BMI status (main effect of exercise); (F) The CMP:CLP ratio was not 
affected by six weeks of EET. *p<0.05; n=17 HW, n=10 OB; data are presented as 
mean±S.D. 
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Figure 4.2.  Colony forming unit potential of innate immune populations are 
elevated during obesity and responsive to EET. Representative CFU-GM in (A) lean 
and (B) obese participants before EET; (C) Representative CFU-GM in lean and obese; 
(D) after EET; (E) CFU-G’s are elevated in in obese adults but unaffected by EET 
(amain effect of group); (F) CFU-M are not changed by exercise nor different between 
BMI classes; (G) CFU-GM are elevated in obese participants (main effect of group) and 
increase as a result of EET in both BMI classes (main effect of exercise); (H) Total CFU 
colonies trended higher in obese adults and are increased by EET irrespective of BMI 
status (main effect of exercise). *p<0.05; ap<0.05; n=17 HW, n=9 OB; data are 
presented as mean±S.D. 
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Figure 4.3. EET modifies CCR2 and TLR4 expression on HSPCs. (A) CCR2+ HSPCs 
were significantly decreased in both groups as a result of six weeks of EET (main 
effects of exercise); (B) The percentage of HSPCs expressing CCR2 was significantly 
decreased in the obese (group x time interaction), but not lean, group as a result of six 
weeks of EET; (C) CCR2 MFI was significantly decreased after six weeks of EET in 
both groups (main effect of exercise); (D) The percentage of HSPCs expressing TLR4 
were decreased after six weeks of EET in both lean and obese adults (main effect of 
exercise); (E) The percentage of HSPCs expressing TLR4 was not changed with six 
weeks of EET in lean and obese adults (F) TLR4 MFI was significantly increased in both 
lean and obese adults after six weeks of EET. *p<0.05; n=17 HW, n=10 OB; data are 




Figure 4.4. EET attenuates circulating CPC mobilization factors. (A) CXCL12 levels 
declined in obese, but not lean, participants as a result of EET training (group x time 
interaction); (B) G-CSF trended to be decreased in the obese group as a result of the 
EET (group x time interaction); (C) CCL2 was not altered after six weeks of EET; 
*p<0.05; n=17 HW, n=10 OB; data are presented as mean±S.D. 
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Figure 4.5. MSC decrease with EET and negatively associate with improvements 
to cardiorespiratory fitness. (A) BM-MSCs trended to be decreased in both lean and 
obese adults (main effect of time); (B) AT-MSCs are decreased in both lean and obese 
adults (main effect of time); (C) Changes in AT-MSCs are significantly negatively related 
with changes in absolute VO2max. (D) Changes in BM-MSCs are significantly negatively 
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Childhood obesity is increasing at an alarming rate with about one-third of 
today’s children considered overweight or obese. Obesity is characterized by a state of 
chronic-low grade inflammation that is closely related to cardio-metabolic co-morbidities 
associated with obesity. This study aimed to assess the relationship between HSPCs, 
inflammatory monocytes, inflammatory monocytes expressing TLR4 or CCR2, and 
meals of differing macronutrient composition. Fifteen healthy weight (HW) and 11 
overweight/obese (OW/OB) participated in baseline measures, while 10 HW and 7 
OW/OB participate in the full protocol. Using a double blinded randomized cross over 
design, children came in to assess anthropometric measures (body fat analysis, height, 
and weight) and a baseline blood draw. Then, participants came back two times to 
ingest either a carbohydrate rich meal (CHO) or eggs (EGGs) and post blood draws. IL-
6 was significantly correlated to monocyte populations with and without TLR4 or CCR2 
expression at baseline. A CHO meal significantly reduced the TLR4+ intermediate 
monocytes in OW/OB children only and caused a significant decrease in TLR4 MFI 
expression on classical monocytes in OW/OB children only. Insulin and glucose were 
significantly higher after the CHO condition compared to baseline. CRP and IL-6 did not 
change after either condition. Changes in insulin were negatively related to changes in 
monocyte populations in the EGG condition only, whereas changes in glucose were 
negatively related to changes in monocyte populations in the CHO condition only. 
These data suggest that meals of differing composition alter monocyte populations in 
the blood, possibly related to changes in insulin and glucose, and mobilizing to 
peripheral tissues in order to combat acute inflammation. 
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5.1 Introduction 
 Childhood obesity in the western and developing world is increasing at an 
alarming rate, with about one-third of children living with overweight or obesity (1). This 
is a significant public health concern because traditionally “adult” pathologies, such as 
cardiovascular disease and metabolic disorders are becoming more prevalent in 
children. Increased adiposity is connected with chronic low-grade inflammation that is 
thought to be partly responsible for the cardio-metabolic co-morbidities associated with 
obesity (2). Inflammation is related to multi-system failure providing one mechanism 
linking childhood obesity with cardio-metabolic diseases (3). An additional feature of this 
chronic inflammation is that of chronic activation of the innate immune system, which is 
responsible for the body’s first line of defense (4). 
 The hematopoietic system consists of the all the blood and immune lineages. 
Circulating progenitor cells (CPCs) are the heterogeneous population of stem and 
progenitor cells that include cells responsible for the long and short-term maintenance 
of the hematopoietic system, vessel remodeling, and tissue repair (5). CPCs consist of 
many stem/progenitor populations such as the most primitive cell population, 
hematopoietic stem cells (HSCs), and the more committed hematopoietic 
stem/progenitor cells (HSPCs). CPCs are the precursor cells to all cells of the 
hematopoietic system, and can be influenced by environmental factors and bias which 
lineage they may differentiate into (6) . 
 The hematopoietic system is divided into two parts based on the speed and 
specificity of each of the systems in responses to foreign invaders. The myeloid/innate 
immune system is responsible for the immediate defense against foreign antigens 
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and/or invaders. An important mature cell population of the myeloid/innate immune are 
inflammatory monocytes. Inflammatory monocytes circulate the peripheral blood and 
infiltrate peripheral tissue where they will mature into macrophages (7). Inflammatory 
monocytes contribute to cytokine/chemokine production, infiltration into peripheral 
tissue, and vascular adhesion (7, 8). They also serve a vital purpose as part of the 
immune system because they are involved in the first line of defense against foreign 
invaders via phagocytosis and antigen presentation. Their concentration in peripheral 
blood is routinely used in clinical settings as indicators for chronic inflammation, stress 
responses, immune-mediated disease, necrosis, and in severe cases, sepsis (9). 
 There are three sub-types of monocytes that circulate throughout the peripheral 
blood. The classical monocyte population makes up about 80% of the peripheral 
monocyte pool (9). The second population of monocytes are the non-classical 
monocytes that make up about 8-10% of the monocyte pool (8). Lastly, the intermediate 
population has recently been proposed as a third, minor subset of monocytes (8). This 
population is thought to be in a transition state towards the non-classical type, but has 
also shown to display unique cellular properties, such as increased antigen presenting 
capacity (8). Although all three populations of monocytes are increased in circulation in 
response to infection and/or inflammation, it is thought that the non-classical monocyte 
populations displays and reacts in a more pro-inflammatory manner (9). 
 Monocytes also possess the cell surface markers toll-like receptor 4 (TLR4) and 
C-C chemokine receptor-2 (CCR2). TLR4 is a cell surface marker that upon activation, 
leads to activation of the intracellular signaling pathway NF-κB and subsequent 
inflammatory cytokine production (10). CCR2 is a chemokine receptor for monocyte 
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chemoattractant protein-1 (MCP-1; CCL2) which specifically mediates monocytes, 
neutrophil, dendritic cell, and lymphocyte migration (11). Monocytes that express CCR2 
are more likely to infiltrate inflamed tissues, especially in instances of obesity (12)(12). 
 Recent evidence has suggested that macronutrient composition of a meal can 
induce an inflammatory response (13). In adults, it has been shown that a high 
carbohydrate meal can increase the levels of inflammatory cytokines and CD11a 
expressing immune cells after ingestion (13). On the other hand, a meal high in 
unsaturated fats does not elicit the same response in healthy adults. This is important 
because it points towards macronutrient composition as a possible culprit to 
exacerbating chronic inflammation seen in instances of obesity. If high carbohydrate 
meals are pro-inflammatory, then children are particularly susceptive because they are 
the targets of many marketing campaigns for high carbohydrate foods (14), particularly 
breakfast cereals (15). Cereals are very high in carbohydrates and relatively low in 
protein and fats. Investigating the response of inflammatory monocytes in children of 
differing weight classes after meals of different macronutrient composition may shed 
light to smaller, more acute inflammation that may be contributing to chronic 
inflammation seen in obesity. Promoting the ingestion of meals higher in fats and 
protein and lower in carbohydrates may help to inhibit increases in acute inflammation 
in children, which may overtime, decrease levels of chronic inflammation by monocytes 
and inflammatory cytokines. 
 Thus, the purpose of this study was to investigate the response of inflammatory 
monocytes, monocytes expressing CCR2 and TLR4, and cytokines to see if there is an 
increase in inflammatory response after meals of different composition in children. We 
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hypothesized that increased quantities of inflammatory monocytes and cytokines would 
be evident in overweight and obese (OW/OB) children. Furthermore, we hypothesized 
that inflammatory monocytes and cytokines would increase in response to a meal rich in 
carbohydrates compared to a meal high in protein/fat, and this response would be 





 Thirty-six children volunteered for this study. Participants were eligible for the 
study if they were: 1) between the ages of 7-17, 2) were free of any cardio-metabolic 
disease, cancer, or diabetes, 3) were HW or above on the children’s body mass index 
(BMI) percentile scale, 4) were not allergic to eggs, 5) were not taking any anti-
inflammatory medication, and 6) provided written informed assent with 
parental/guardian written informed consent. One participant was excluded from 
participation due to difficulty in blood collection; therefore, the study had 35 children who 
volunteered. Twenty-five participants had usable data at baseline, and 17 participants 
completed the full protocol. Participants provided written informed assent with 
parental/legal guardian written informed consent to participate in the study and were 
compensated for their time. This project was approved by the Institutional Review Board 
of the University of Illinois at Urbana-Champaign.  
5.2.2 Study Design 
 This study was a double-blind randomized crossover design. Participants arrived 
at the lab on three different days at least four (4) hours fasted and at least one week 
apart. On the first day, the study was described to participants and their legal guardians 
prior to obtaining written informed assent and consent. Then, participants completed 
anthropometric measures including body composition, height, and weight. After 
completion of anthropometric variables, participants submitted to a venous blood draw. 
On visits two and three, participants consumed one of two drinks (either egg-based or 
maltodextrin based) within fifteen minutes. Participants then sat quietly for two hours 
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after ingestion. After two hours, participants submitted to a venous blood draw for the 
post time point. On visit three, the participants completed the same protocol as day 2, 
but with the shake that was not previously ingested. Shakes were randomized in which 
order each participant received, and a research team member not associated with data 
analysis administered the shakes. Both the participant and the researcher analyzing the 
data were blinded to drink condition. A visual representation of the study is presented in 
Figure 5.1. 
5.2.3 Shake Composition 
 Shakes were composed of either whole spray dried egg powder (EGG; 
Oskaloosa Food Products, Oskaloosa, IA) or Maltodextrin (CHO; NOW Foods, 
Bloomingdale, IL). The amount of spray-dried whole egg powder was 36g, equivalent to 
3 whole eggs (210 kcals; 15g of fat, 0g of carbohydrates, 18g protein). The amount of 
maltodextrin was 56g (210 kcals; 0g of fat, 56g of carbohydrates, and 0g of protein). 
The powder was dissolved in 500mL of water. The amount of calories provided was 
selected based on previous research indicating 210 kilocalories are the average intake 
for children for breakfast (16).  
5.2.4 Anthropometric Measures, Body Composition, and Fitness 
 Participants were separated into HW, OW/OB based on BMI percentile; with 
those having a BMI percentile of 5th-84.9th percentile considered HW, and those having 
a BMI percentile ³85th – 99.9th of their age-matched peers considered OW/OB. Whole 
body and regional soft tissue composition was measured by dual-energy X-ray 
absorptiometry (DXA) by either using a Hologic Discovery A bone densitometer 
(software version 12.7.3; Hologic, Bedford, MA) or a Hologic Horizon W bone 
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densitometer (APEX software version 5.6.0.5; Hologic, Bedford, MA). DXA measures of 
interest included whole body fat mass (%) and visceral fat mass (VFAT mass).  
5.2.5 Whole Blood Analysis 
 Participants subjected to a venous blood draw at least 4 hours fasted on the first 
day. Participants arrived at least 4 hours fasted on days 2 and 3. Almost every 
participant attempted to have all 3 appointments at the same time of day to avoid 
circadian influences on blood cell populations. Blood was collected into EDTA-coagulant 
tubes and followed previously defined protocols with minor modifications (17). 
Quantification of monocytes, CPCs, and CPCs expressing ROS was conducted from 
whole blood (200µl/population) collected in EDTA tubes. CPC samples were incubated 
with PE-conjugated CD34 (1:40; Invitrogen; Grand Island, NY), FITC conjugated CD45 
(1:200; Invitrogen; Grand Island, NY), and purified anti-human CD309 (vascular 
endothelial growth factor 2, VEGFR2; Biolegend, Inc.) with secondary antibody F(ab’)2-
goat anti-mouse IgG (H + L), Qdot 605 (Life Technologies).  Monocyte samples were 
incubated with PE-conjugated CD14 (1:100; Invitrogen, Grand Island, NY), FITC 
conjugated CD16 (1:100; Invitrogen; Grand Island, NY), CD192 (1:100; Biolegend; San 
Diego, CA). CPCs expressing ROS were incubated with PE-conjugated CD34 (1:40; 
Invitrogen; Grand Island, NY) and ROS. Gating for CPC populations and monocytes 
was conducted as previously described (8, 17). Flow cytometric analysis was performed 
using an Attune Focusing Flow Cytometer (Life Technologies; San Diego, CA). 
Remaining blood samples that was not used for flow quantification were centrifuged for 
plasma storage at 2400rpm for 15 minutes at 4°C. Plasma was aliquoted and stored at -
80°C until analysis. 
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5.2.6 Enzyme-Linked Immunosorbent Assay Kits 
 After all blood was collected, plasma samples were used for quantification of C-
reactive protein (CRP), insulin, glucose, and interleukin-6 (IL-6). Glucose was 
determined using a 2900D Biochemistry Analyzer (YSI Inc., Yellow Spring, OH) on 
thawed plasma samples. The same samples, without being freeze thawed after glucose 
analysis, were used for quantification of insulin at each time point (Alpco; Salem, NH). 
CRP, and IL-6 were quantified using commercially available Quantikine ELISA kits 
(R&D Systems, Minneapolis, MN) at all time points. ELISAs were performed per 
manufacturer’s instructions with samples analyzed in duplicate. 
5.2.7 Statistical Analysis 
 Anthropometric variables, cell quantities, and plasma protein concentrations were 
analyzed for normality via Shapiro-Wilks test. Variables were log transformed prior to 
analysis if normality was not met. Cell quantities and plasma protein concentrations 
were analyzed by a 2X3 repeated measures ANOVA (Weight Class, 2: HW, OW/OB) X 
(Condition, 3: Baseline, EGG, CHO) in SPSS (V. 25; IBM; Chicago, IL). Significant main 
effects were analyzed using Least Significant Differences test. Changes in cell 
populations and cytokines were calculated as non-transformed “post-CHO” or “post-
EGG” – “pre” values. Spearman’s Rho correlations were conducted on non-transformed 
baseline cell and cytokine concentrations and changes in cell populations and changes 
in glucose, insulin, and inflammatory cytokines. P<0.05 was considered statistically 





 Twenty-five (25; 14 female) children completed baseline appointments (HW: 
n=14 (7 female) and OW/OB: n=11 (8 female)). Anthropometric information is presented 
in Table 5.1. Despite the large recruitment age, no differences in age were seen 
between the HW and OW/OB group (HW: 11.23±3.79 yrs vs. OW/OB: 11.85±3.18 yrs; 
p>0.05). The OW/OB group had a significantly higher BMI (31.6±11.37 kg/m2 vs. 
18.95±1.27 kg/m2; p<0.05), BMI percentile (96.4±4.84 vs. 49.36±17.06; p<0.05), weight 
(74.53±37.82kg vs. 42.53±10.79kg; p<0.05), whole body percent fat (41.25±10.09% vs. 
21.36±4.84%; p<0.05), and visceral fat mass (875.3±982.53g vs. 137.83±57.51g; 
p<0.05). The OW/OB group had significantly higher insulin concentrations (Fig. 5.2B; 
p<0.05). No differences were seen between the HW and OW/OB group in glucose (Fig. 
5.2A; p>0.05), CRP (Fig. 5.2C; p>0.05), or IL-6 (Fig. 5.2D; p>0.05) concentrations.  
5.3.1 Classical monocyte percentage is reduced in OW/OB children 
 HSPC concentration trended to be increased in OW/OB children compared to 
HW (Fig. 5.3A, p=0.12). CPC concentration, VEGFR2+ CPC concentration, ROS+ CPC 
concentration, and EPC concentration were not different between groups (Fig. 5.3A, all 
p’s>0.05). The concentration of HSPCs trended to be positively correlated to whole 
body percent fat (Rho=0.33; Fig. 5.3B; p=0.10). Classical, intermediate, and non-
classical monocyte concentrations were not different between groups (Fig. 5.3C; 
p’s>0.05). The proportion of classical monocytes was significantly reduced in the 
OW/OB group compared to the HW group (Fig. 5.3D, p<0.05). The proportion of 
intermediate or non-classical were not different between groups (Fig. 5.3D; p’s>0.05). 
5.3.2 CCR2+ Non-classical Monocytes trend to be Higher in OW/OB Children 
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 No differences were seen in the concentration of classical, intermediate, or non-
classical monocytes expressing TLR4 (Fig. 5.4A; p’s>0.05) or CCR2 (Fig. 5.4B; 
p’s>0.05) between groups. No differences were seen in the level of TLR4 (Fig. 5.4C; 
p’s>0.05) expression on classical, intermediate, or non-classical monocytes between 
groups. The concentration of CCR2+ non-classical monocytes trended to be higher in 
the OW/OB group compared to HW (Fig. 5.4B), while no differences were seen in the 
concentration of CCR2+ classical or intermediate monocytes (Fig. 5.4B; p’s>0.05). No 
differences were seen in the percentage of classical (Fig. 5.4E), intermediate (Fig. 
5.4F), or non-classical (Fig. 5.4G) monocytes expressing TLR4 or CCR2 (all p’s>0.05). 
5.3.3 IL-6 concentration is positively related to monocyte concentrations 
 Spearman’s Rho correlations were conducted on IL-6 concentrations and 
monocyte populations to evaluate if cell concentrations were related to classic 
inflammatory markers (Table 5.2). TLR4+ non-classical monocytes and CCR2+ non-
classical monocytes were significantly positively related to IL-6 concentrations 
(Rho=0.63 and Rho=0.7, respectively; p’s<0.05). Intermediate monocytes, TLR4+ 
intermediate monocytes, and CCR2+ intermediate monocytes were significantly 
positively related to IL-6 concentrations (Rho=0.75, Rho=0.61, and Rho=0.54, 
respectively, p’s<0.05). The percentage of intermediate monocytes of total monocytes 
was significantly positively related to IL-6 concentrations (Rho=0.6, p<0.05). The 
concentration of classical monocytes was significantly positively related to IL-6 
concentrations (Rho=0.63, p<0.05). 
5.3.4 Full Protocol 
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 For the second portion of the study, a subset of 17 participants (HW: n=10, 5 
female; OW/OB: n=7; 4 female) completed the three-day experimental protocol. 
Anthropometric information for just these participants is presented in Table 5.3. No 
differences in age between the HW and OW/OB groups were found (HW: 12.29±2.45 
yrs vs. OW/OB: 11.96±3.79 yrs; p>0.05). The OW/OB group had significantly higher 
BMI (30.17±13.57 kg/m2 vs. 18.33±1.08 kg/m2; p<0.05), BMI percentile (95.60±3.84 vs. 
51.5±20.54; p<0.05), and whole body percent fat (40.85±12.48% vs. 20.90±4.58%; 
p<0.05). All 17 participants completed the full three-day protocol and consumed all 
drinks within 15 minutes. 
5.3.5 The Level of TLR4 Expression on Classical Monocytes is Decreased in OW/OB 
Children After Carbohydrate Consumption 
 The concentration of classical monocytes did not change after the carbohydrate 
or egg shake in either group (Fig. 5.5A; p>0.05). The proportion of classical monocyte 
trended to be reduced in the OW/OB group (Fig. 5.5B; p=0.07). The concentration of 
TLR4+ classical monocytes was not changed in either group after each condition (Fig. 
5.5C; p>0.05). The level of TLR4 expression on classical monocytes in the OW/OB 
group was significantly decreased after the carbohydrate condition (Fig. 5.5D; p<0.05). 
No differences were seen in either condition in the percentage of classical monocytes 
expressing TLR4 (Fig. 5.5E; p>0.05), the concentration of CCR2+ classical monocytes 
(Fig. 5.5F; p>0.05), the level of CCR2 expression on classical monocytes (Fig. 5.5G; 
p>0.05), or the percentage of classical monocytes expressing CCR2 (Fig. 5.5H; p>0.05) 
in either the HW or the OW/OB group. 
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5.3.6 The level of TLR4 expression on intermediate monocytes and percentage of 
intermediate monocytes are decreased in OW/OB children after carbohydrate 
consumption 
 No differences were seen in the concentration of intermediate monocytes in each 
condition in either the HW or OW/OB group (Fig. 5.6A; p<0.05). The percentage of 
intermediate monocytes at baseline was significantly higher from the percentage of 
intermediate monocytes after EGG consumption irrespective of weight status (Fig. 5.6B, 
p<0.05). The percentage of intermediate monocytes after the CHO condition was 
significantly higher from the percentage of intermediate monocytes after the EGG 
condition, irrespective of weight status, with a trend for a decrease in the OW/OB group 
during each condition (Fig. 5.6B; p=0.09). No differences were seen in the concentration 
of TLR4+ intermediate monocytes in each group after each condition (Fig. 5.6C; 
p>0.05). There was a trend for a decrease in TLR4 expression in the OW/OB after the 
CHO condition (Fig. 5.6D; p=0.06). The percentage of intermediate monocytes 
expressing TLR4 was significantly decreased in the OW/OB group after carbohydrate 
consumption (Fig. 5.6E; p<0.05). No differences were seen in the concentration of 
CCR2+ intermediate monocytes (Fig. 5.6F; p>0.05), level of expression of CCR2 on 
intermediate monocytes (Fig. 5.6G; p>0.05), or on the percentage of intermediate 
monocytes expressing CCR2 (Fig. 5.6H; p>0.05) after either condition in the HW or the 
OW/OB groups.   
5.3.7 Non-classical monocytes, percentage of total monocytes that are non-classical 
and TLR4+ non-classical monocytes are affected by EGG or CHO consumption 
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 The concentration of non-classical monocytes at baseline trended to be higher 
than the concentration of non-classical monocytes after the EGG or CHO condition 
irrespective of weight status (Fig. 5.7A; p=0.06). The percentage of total monocytes that 
were non-classical was significantly higher at baseline compared to either condition 
irrespective of weight status (Fig. 5.7B; p<0.05). The concentration of TLR4+ non-
classical monocytes was significantly higher after the CHO condition compared to 
baseline irrespective of weight status, with a trend for an increase in the HW group after 
the CHO condition (Fig. 5.7C, p<0.05 and p=0.6, respectively). The level of TLR4 
expression on non-classical monocytes was not changed by either condition in either 
group (Fig. 5.7D; p>0.05). The percentage of non-classical monocytes expressing TLR4 
was significantly reduced in the OW/OB group irrespective of condition (Fig. 5.7E; 
p<0.05). The concentration of CCR2+ non-classical monocytes (Fig. 5.7F), level of 
CCR2 expression on CCR2+ non-classical monocytes (Fig. 5.7G), and percentage of 
non-classical monocytes expressing CCR2 (Fig. 5.7H) were not affected by either 
condition and not different between either group (all p’s>0.05). 
5.3.8 Glucose, insulin, CRP, and IL-6 concentrations are not affected by EGG or CHO 
consumption 
 Glucose was significantly increased after the CHO condition compared to 
baseline irrespective of weight status (Fig. 5.8A, p<0.05). Insulin was significantly 
increased after the CHO condition compared to baseline irrespective of weight status 
(Fig. 5.8B, p<0.05). No changes were seen in CRP or IL-6 concentrations in either 
group or condition (Fig. 5.8C and D, p’s>0.05). 
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5.3.9 Changes in monocyte concentrations are related to changes in glucose and 
insulin 
 Spearman’s Rho analyses were conducted on changes in insulin and changes in 
cell populations after the EGG condition and are presented in Table 5.4. The change in 
the percentage of non-classical monocytes was significantly negatively related to 
changes in insulin (Rho=-0.51; p<0.05). The change in non-classical monocytes, TLR4+ 
non-classical monocytes, and CCR2+ non-classical monocytes were significantly 
negatively related to changes in insulin (Rho=-0.78, Rho=-0.88, Rho= 0.53, 
respectively; p<0.05). The change in the percentage of CCR2+ non-classical monocytes 
was significantly negatively related to changes in insulin (Rho=-0.58; p<0.05). The 
change in intermediate monocytes and TLR4+ intermediate monocytes were 
significantly negatively related to changes in insulin (Rho=-0.58 and Rho=-0.80; 
p<0.05). 
 Spearman’s Rho analyses were then conducted on changes in glucose and 
changes in cell populations after the CHO condition and are presented in Table 5.5. The 
change in classical monocytes and TLR4+ classical monocytes was significantly 
negatively related to changes in glucose (Rho=-0.54 and Rho=-0.56, respectively; 
p<0.05). The changes in the percentage of non-classical monocytes was negatively 
related to changes in glucose (Rho=-0.53; p<0.05). The change in CCR2+ non-classical 
monocytes was significantly negatively related to changes in glucose (Rho= -0.79). The 
percentage of CCR2+ non-classical monocytes was significantly negatively related to 
changes in glucose (Rho=-0.63; p<0.05). The change in TLR4+ expression on 
intermediate monocytes, percentage of intermediate monocytes, and change in CCR2+ 
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intermediate monocytes were significantly negatively related to changes in glucose 




 This study aimed to investigate the response of inflammatory monocytes with 
and without expression of TLR4 and CCR2 and inflammatory cytokines to different 
meals either carbohydrate or eggs in HW and OW/OB children. The main findings of 
this study are: 1) IL-6 concentrations are positively related to monocyte populations, 2) 
the level of TLR4 Expression on classical and intermediate monocytes and percentage 
of intermediate monocytes expressing TLR4 are decreased in OW/OB children after 
carbohydrate consumption, 3) the percentage of total monocytes that are non-classical 
were significantly decreased after feeding irrespective of macronutrient content, 4) 
TLR4+ non-classical monocyte concentration are increased by CHO consumption, 5) 
the percentage of TLR4+ non-classical monocytes were significantly lower in the 
OW/OB group at all time points, and 6) changes in insulin and glucose are negatively 
related to changes in monocyte populations in the post-prandial phase.  
 HSPCs are an important cell population that are responsible for both long term 
and day-to-day maintenance of the hematopoietic system (5). Previous reports have 
found that both adults and children who are overweight/obese have higher circulating 
HSPCs (17, 18). While our results are not significant, we corroborate these findings by 
showing there is a trend for increased HSPCs in OW/OB children. Lack of significant 
findings in the present study could be due to the wider age range used in the present 
study compared to our previous study (17), and that the participants in the study by 
Bellows and colleagues had a number of other significant co-morbid health conditions 
(18). In addition, we extend these findings by showing a trend exists between whole 
body percent fat and HSPCs, suggesting that adipose tissue may play a role in HSPC 
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concentration in the peripheral blood. CPCs reside within the bone marrow niche and 
are able to mobilize under certain conditions, such as acute exercise (19–21), 
myocardial infarction (22), and stroke (23). One such proposed mechanism of increases 
in CPCs is that of inflammation, thereby recruiting CPCs towards sites of inflammation 
to aid in tissue repair (23–25). Given that persons who are living with obesity are in a 
chronic state of low-grade inflammation (3), it is possible that this inflammation may 
contribute to increased CPCs in the peripheral blood to combat this inflammation. 
However, we did not find any relationships between CPCs and IL-6 or CRP, suggesting 
a more complex relationship exists between CPCs and inflammation at steady state in 
children. 
 IL-6 is an inflammatory acute phase protein that acts as a pro-inflammatory 
cytokine to stimulate an immune response (26). IL-6 is secreted by both macrophages 
and T-cells in order to initiate the immune response to participate in host defense 
against bacterial infections and/or tissue damage (27, 28). Previous reports have shown 
that IL-6 plays a role in recruitment of monocytes towards inflamed areas as well as 
influences their differentiation towards macrophages in order to clear out infected 
cellular debris or foreign substances (28). Here, we show that IL-6 levels in blood are 
positively related to intermediate and classical monocytes, as well as non-classical and 
intermediate monocytes expressing TLR4 and CCR2 in children. TLR4 is an important 
cell surface receptor in recognizing lipopolysaccharide (LPS), a component of gram-
negative bacterial cell membrane (10). Our results indicate that IL-6 is related to 
monocyte populations. Given that monocytes are able to secrete IL-6, future research 
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should determine if this relationship between IL-6 and monocyte populations exist in a 
continuous cycle. 
 Evidence has shown that macronutrient composition of a meal can influence 
inflammatory cell content. A high carbohydrate meal increased CD11 expressing 
immune cells in adults (13). However, this has not been evaluated in children of differing 
weight statuses. Here, we show that macronutrient composition plays a role in 
monocyte populations in OW/OB children. Our results indicate that OW/OB children 
have lower intermediate and non-classical percentages of monocytes in the post-
prandial period compared to steady state. Additionally, a carbohydrate meal decreases 
circulating classical and intermediate monocytes with higher TLR4 expression and 
contribute to a lower percentage of TLR4 expressing intermediate monocytes in OW/OB 
children only, suggesting that obesity may alter TLR4 expressing monocyte responses 
to carbohydrate meals. Interestingly, monocytes play an active role in host defense 
within the intestines driven by microbiota (29). Obesity is associated with intestinal 
inflammation (30), increased intestinal permeability, and metabolic endotoxemia (31). Of 
importance, metabolic endotoxemia causes increased gut permeability, contributing to 
higher amounts of LPS into the bloodstream (32). It is possible that the carbohydrate 
meal induces higher gut permeability and subsequent increases in endotoxemia and 
LPS in the blood in OW/OB children, thereby recruiting highly expressing TLR4 
monocytes out of the blood towards peripheral tissues, such as the intestine. Previous 
reports have shown that in healthy adults, a meal high in fat and carbohydrates induced 
higher circulating plasma LPS concentration than a meal high in fiber and fruit (33), 
supported also by animal models of obesity showing that a high carbohydrate-high fat 
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diet increases gut permeability linked to increased endotoxemia (34). Our findings 
provide evidence for future studies to investigate this possibility further. 
 Glucose and insulin homeostasis are extremely important for metabolic health, 
but have been shown to be disrupted by obesity and may be caused by innate immune 
system activation (35). Previous research has indicated that monocytes express insulin 
receptors and may play a role in obesity driven insulin resistance (36, 37). Here, we 
show that the changes in monocyte populations and percentages are negatively 
associated with changes in insulin after consuming a meal composed of eggs, but not in 
a meal composed of carbohydrates. On the other hand, we show that changes in 
monocyte content and proportions after carbohydrate consumption are negatively 
related to changes in glucose, but not after consuming a meal composed of eggs. In 
addition to expression of insulin receptors, monocytes also utilize glucose via glycolysis, 
especially when activated, and may facilitate growth and differentiation through GLUT1 
receptors (38). The findings described herein suggest that macronutrient of a meal that 
influences glucose and insulin concentrations may also indirectly influence changes in 
monocyte populations, and that these relationships may be very specific to 
macronutrient composition of the meal. Given that glucose was only increased after 
consumption of the carbohydrate meal, glucose may play a larger role in changes in 
monocytes than insulin during the post-prandial period. However, in the absence of an 
increase in glucose, insulin may still affect monocyte levels in the blood after a meal 
lower in carbohydrates. Future research should aim to delineate potential mechanisms 
that are related to insulin, glucose, and monocytes after meal consumption. 
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 In conclusion, these data show that IL-6 is related to steady state concentrations 
of TLR4 and CCR2 expressing monocytes, CHO induces a reduction in TLR4 
expression on intermediate and classical monocytes, and these monocyte changes are 
related to changes in blood glucose and insulin. These results indicate that meals of 
different macronutrient composition may contribute to underlying inflammatory disease 
associated with obesity, exacerbated by small changes in inflammation from changes in 
inflammatory monocytes induced by feeding of high carbohydrate meals. Meals high in 
carbohydrates may contribute to inflammatory profiles seen in childhood obesity and 
contribute to the increases in more adult like pathologies seen in OW/OB children. 
Promoting the consumption of meals higher in unsaturated fat and protein, such as 
eggs, could cause small reductions in alterations of monocytes in OW/OB, ultimately 
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Tables, Figures, and Figure Legends 
Figure 5.1. Representative timeline of participant appointments. Participants came to 
the lab for experimental day 1 for participants who completed baseline. Participants who 





 HW (n=14, 7F) OW/OB (n=11, 8F)) 
Variable Mean ± SD Mean ± SD 
Age (yrs) 11.23±3.79 11.85±3.18 
BMI (kg/m2) 18.05±1.27 31.6±11.37* 
BMI % 49.36±17.96 96.4±4.84* 
Weight (kg) 42.53±10.79 74.53±37.82* 
Height (cm) 152.23±15.37 150.23±14.15 
Whole Body % Fat 21.36±4.84 41.25±10.09* 
Visceral Fat Mass (g) 137.83±57.51 875.3±982.53* 
 
Table 5.1. Anthropometric information of participants who completed baseline. 





Figure 5.2. (A) Glucose concentrations (mg/dL) between both groups at baseline. No 
differences were seen between groups (HW: n=13, OW/OB: n=10); (B) Insulin 
concentrations (µIU/mL) between both groups at baseline. Insulin was significantly 
higher in the OW/OB group compared to HW (HW: n=13, OW/OB: n=11; p<0.05); (C) 
CRP concentrations between both groups at baseline. No differences were seen 
between groups (HW: n=14, OW/OB: n=11); (D) IL-6 concentrations between groups at 
baseline. No differences were seen between groups (HW: n=11, OW/OB: n=10). 
* 
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Figure 5.3. Baseline stem and progenitor cell populations, monocyte populations, and 
proportions of monocytes. (A) CPCs (HW: n=14; OW/OB: n=11), HSPCs (HW: n=14; 
OW/OB: n=11), VEGFR2+ CPCs (HW: n=12; OW/OB: n=11), ROS+ CPCs (HW: n=14; 
OW/OB: n=10), and EPCs (HW: n=12; OW/OB: n=11); No differences were seen 
between groups (all p’s>0.05). (B) Spearman’s Rho correlation between whole body % 
Fat and Concentration of HSPCs in all children (n=25; p=0.10). (C) Classical, 
intermediate, and non-classical monocyte concentrations (HW: n=15; OW/OB: n=11). 
(D) Classical, intermediate, and non-classical proportions of total monocyte population 
(HW: n=15; OW/OB: n=11). *p<0.05 by Student’s t-test between HW and OW/OB. 
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Figure 5.4. Baseline monocytes expressing TLR4 and CCR2, TLR4 and CCR2 MFI and 
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Figure 5.4. (cont). proportion of monocytes expressing TLR4 and CCR2. (A) TLR4+ 
Classical, intermediate, and non-classical concentrations of monocytes at baseline. (B) 
CCR2+ classical, intermediate, and non-classical concentrations of monocytes at 
baseline. (C) TLR4 MFI of classical, intermediate, and non-classical monocytes at 
baseline. (D) CCR2 MFI of classical, intermediate, and non-classical monocytes at 
baseline. (E) Proportion of classical monocytes expressing TLR4 and CCR2. (F) 
Proportion of intermediate monocytes expressing TLR4 and CCR2. (G) Proportion of 

















Variable IL-6 (pg/mL) P-value 
TLR4+ Non-Classical Monocytes 0.63 0.007 
CCR2+ Non-classical Monocytes 0.70 0.001 
Intermediate Monocytes 0.75 <0.001 
TLR4+ Intermediate Monocytes 0.61 0.009 
CCR2+ Intermediate Monocytes 0.54 0.02 
Intermediate Monocytes –  
% Total Monocytes 
0.60 0.006 
Classical Monocytes 0.63 0.004 
Table 5.2. Spearman’s Rho correlations between baseline cell populations and baseline 














 HW (n=10; 5F) OW/OB (n=7; 4F) 
Variable Mean ± SD Mean ± SD 
Age (yrs) 12.29±2.45 11.96±3.79 
BMI (kg/m2) 18.33±1.08 30.17±13.57a 
BMI % 51.5±20.54 95.60±3.84* 
Weight (kg) 43.37±11.0 73.41±47.40 
Height (cm) 152.65±16.33 150.15±16.64 
Whole Body % Fat 20.90±4.58 40.85±12.48* 
Visceral Fat Mass (g) 132.57±56.13 968.17±1226.32 
Table 5.3. Anthropometric information of participants who completed full protocol 
(n=17). aBMI=body mass index. *p<0.05, ap=0.06 
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Figure 5.5. Classical monocytes response to EGG and CHO in HW and OW/OB 
children. (A) Classical monocyte concentration, (B) Proportion of classical monocytes. 
(C) TLR4+ classical monocyte concentration. (D) TLR MFI on classical monocytes. (E) 
Percentage of classical monocytes expressing TLR4. (F) CCR2+ classical monocyte 
concentration. (G) CCR2 MFI on classical monocytes. (H). Proportion of classical 
monocytes expressing CCR2. *p<0.05 interaction. HW: n=10; OW/OB: n=7; TLR4 





Figure 5.6. Intermediate monocytes response to EGG and CHO in HW and OW/OB 
children. (A) Intermediate monocyte concentration, (B) Proportion of intermediate 
monocytes have a differential relationship after feeding. After an EGG meal, the 
proportion of intermediate monocytes are decreased compared to baseline (main effect 
of time: p<0.05). After a CHO meal, the proportion of intermediate monocytes is 
increased compared to after the EGG meal (main effect of time: p<0.05), (C) TLR4+ 
Intermediate monocyte concentration. (D) TLR MFI on intermediate monocytes. (E) 
Percentage of intermediate monocytes expressing TLR4 is decreased in the OW/OB 
group after a CHO meal (GroupXTime interaction: p<0.05), (F) CCR2+ intermediate 
monocyte concentration. (G) CCR2 MFI on intermediate monocytes. (H). Proportion of 
intermediate monocytes expressing CCR2. *p<0.05. HW: n=10; OW/OB: n=7; TLR4 
samples: HW: n=8; OW/OB: n=5. 
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Figure 5.7. Non-classical monocytes response to EGG and CHO in HW and OW/OB 
children. (A) Non-classical monocyte concentration, (B) Proportion of non-classical 
monocytes are decreased after feeding (main effect of time: p<0.05), (C) TLR4+ Non-
classical monocyte concentration is increased after a CHO meal (main effect of time: 
p<0.05), (D) TLR MFI on non-classical monocytes, (E) Percentage of non-classical 
monocytes expressing TLR4 is reduced in the OW/OB group (main effect of group: 
p<0.05), (F) CCR2+ non-classical monocyte concentration. (G) CCR2 MFI on non-
classical monocytes. (H). Proportion of non-classical monocytes expressing CCR2. 






Figure 5.8. Glucose, Insulin, CRP, and IL-6 levels in response to EGG or CHO 
condition. (A) Glucose concentrations are increased after a CHO meal (main effect of 
time: p<0.05; HW: n=9; OW/OB: n=6). (B) Insulin concentrations are increased after a 
CHO meal (main effect of time: p<0.05; HW: n=9; OW/OB: n=7). (C) CRP 
concentrations are not changed after feeding (HW: n=10; OW/OB: n=6). (D) IL-6 










Change in Non-classical – 
% Total Monocytes  
-0.51 0.04 
Change in Non Classical Monocytes -0.59 0.02 
Change in TLR4+ Non-classical 
monocytes 
-0.78 <0.001 
Change in CCR2+ Non-classical 
monocytes 
-0.88 <0.001 
Change in CCR2+ - 
% Non-classical Monocytes 
-0.53 0.04 
Change in Intermediate Monocytes -0.58 0.02 
Change in TLR4+ Intermediate 
Monocytes 
-0.80 <0.001 
Table 5.4. Spearman’s Rho correlations between changes in insulin and changes in cell 



















Change in Classical Monocytes -0.54 0.04 
Change in TLR4+ Classical Monocytes -0.56 0.04 
Change in Non-classical – 
% Total Monocytes 
-0.53 0.04 
Change in CCR2+ Non-classical 
monocytes 
-0.79 0.001 
Change in CCR2+ - 
% Non-classical Monocytes 
-0.63 0.01 
Change in TLR4+ MFI on Intermediate 
Monocytes 
-0.67 0.009 
Change in Intermediate Monocytes- 
% Total Monocytes 
-0.57 0.03 




Table 5.5. Spearman’s Rho correlations between changes in glucose and change sin 
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Expanded Discussion and Future Directions 
6.1 Introduction 
 The overall aim of the present thesis was to characterize the effects of behavioral 
factors such as endurance exercise training and nutrition on CPCs and their progeny in 
obesity. We began by establishing that HSPCs are higher in overweight and obese 
children, and CPC paracrine factors from overweight and obese children may positively 
affect neurogenesis (Chapter 3). We then showed that endurance exercise training 
caused a decreased in CCR2+ and TLR4+ HSPCs in both lean and obese adults, 
supporting that the anti-inflammatory effects of exercise exist at the CPC level (Chapter 
4). Lastly, we showed that a meal rich in carbohydrates causes a decrease in the 
proportion of TLR4+ intermediate monocytes in children with overweight and obesity 
only, suggesting an inflammatory response that mobilizes monocytes towards inflamed 
peripheral tissues (Chapter 5). Together, the studies outlined in this thesis demonstrate 
that CPCs and monocytes are sensitive to inflammation and possibly mobilize to 
peripheral tissues in order to decrease local tissue inflammation. The next chapter will 
discuss the overall significance of the studies presented in this thesis. 
6.2 CPC mobilization in obesity and exercise 
Obesity has been shown to be associated with increased CPCs and HSPCs, but 
less research has extended this relationship to children or endurance exercise training 
(EET). In 2011, work described by Bellows and colleagues (1) showed that adults living 
with obesity (described as having a BMI > 30 kg/m2) had higher levels of circulating 
CPCs. Since then, several studies have shown the relationship between CPCs in the 
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peripheral blood and links to heart disease risk or failure. However, not much work has 
been done investigating the relationship between obesity and CPCs since. Investigating 
the level of CPCs in persons with obesity is important because more recent research 
has found that CPC level in the blood is closely related to heart disease risk (2, 3). In 
chapter 3, we found that children who were overweight or obese had higher circulating 
HSPCs, however, our results in chapter 4 did not show a difference in CPC or HSPC 
concentration at baseline in the obese group. In the study described by Bellows and 
colleagues, participants were either severely obese or had other co-morbidities such as 
a history of cancer, smoking, or diabetes (1); while our sample of participants in chapter 
4 had no other existing conditions. While interesting, the underlying reasons for 
increased CPCs and HSPCs in circulation remain less understood. In obesity, the levels 
of chronic low-grade inflammation may play a role in influencing levels of HSPCs and 
CPCs in the blood. Since the hematopoietic system responds to inflammatory stimuli, 
both at the stem/progenitor cell level (4–7) and more mature monocyte cell level (8–10), 
it seems as if inflammation may play a role in physiological levels of CPCs and HSPCs 
in obesity. We aimed to see if a relationship exists between known contributors of 
chronic low-grade inflammation seen in obesity: visceral adipose tissue. Visceral 
adipose tissue (VAT) is a direct contributor of increased circulating inflammatory 
cytokines and proteins (11). Thus, the relationship between levels of abdominal body fat 
may have a relationship to HSPCs. Indeed, we found that in children, there exists a 
positive relationship between abdominal body fat percentage in children with OW/OB 
and a negative relationship between abdominal body fat percentage in lean children, 
with a significant difference between the two relationships. A potential mechanism for 
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this relationship is that hematopoietic activity in VAT is decreased compared to 
subcutaneous adipose tissue (12). In this study, the authors found that despite lower 
hematopoietic activity in VAT, that the total mature immune population is larger, 
suggesting a larger contribution of immune cells from the bone marrow in VAT. Our data 
supports this data in children with OW/OB, in that those who had increased abdominal 
body fat percentage had higher levels of HSPCs. Further supporting these data, in 
chapter 5, we found that there trended to be a relationship with whole body fat 
percentage and HSPCs (p=0.1). Previous data has suggested that HSPCs may play a 
role in tissue repair, especially after inflammatory events such as exercise or stroke (6, 
13). Additionally, HSPCs have been suggested to be more potent cytokine producers 
than their more mature counter parts (14). Since inflammation is a natural response, 
and is beneficial at removing unwanted or threatening stimuli, it is possible that 
increased abdominal adipose tissue in children with OW/OB may cause increased 
HSPCs in circulation, perhaps to combat inflammation associated with abdominal body 
fat. Future research should expand on previous projects investigating the exact role 
HSPCs may play on microenvironment and inflammation seen in VAT in obesity to 
delineate the relationship between VAT and HSPCs. 
Despite promising research showing a relationship between HSPCs and BMI, we 
did not find the same higher circulating CPCs and subpopulations in adults with OW/OB 
compared to lean individuals (Chapter 4). In this study, we recruited adults who were 
previously sedentary, which may influence circulating levels of HSPCs. Previous 
research has shown that persons who participated in long-term exercise had higher 
levels of HSPCs and CPCs in circulation (15), but these data are unclear, because 
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other studies have not shown the same relationships (16, 17). In addition to the effects 
of EET on stem and progenitor populations, we also investigated if there was any effect 
of EET on more committed progenitor populations, such as common lymphoid 
progenitors (CLPs) and common myeloid progenitors (CMPs). We found that EET 
caused a similar decrease in CLPs but did not affect CMPs. Furthermore, we also found 
that the colony forming unit (CFU) of granulocyte-macrophage and granulocyte colonies 
was increased, irrespective of weight status. These data suggest that EET causes a 
decrease in more primitive hematopoietic progenitor cell populations in circulation but 
causes an increase in more mature hematopoietic progenitors. Previous research has 
shown that EET can cause a more favorable bone marrow environment for CPCs and 
HSPCs in both models of lean and obesity (18, 19). Future studies should investigate 
mobilization cytokines, bone marrow microenvironment composition, and marrow 
adipose tissue content after exercise in rodent models of obesity to investigate if the 
bone marrow microenvironment is changed after EET and influence circulating CPC 
levels. 
In addition to inflammation, there exist a variety of mobilization agents that have 
shown to induce CPC mobilization and increase their quantity in the peripheral blood. 
Therefore, other mobilization factors may play a role in the levels of CPCs and HSPCs 
in circulation. In the context of hematopoietic stem cell transplant (HSCT), there are 
three main drugs that induce CPC mobilization. The main mobilization agent 
responsible for most donors before a transplant is G-CSF. G-CSF causes disruption of 
the CXCR4/CXCL12 axis in the bone marrow, which induces CPC egress from the 
niche into circulation (20). G-CSF is endogenously secreted by bone marrow stromal 
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cells (16) is able to influence the fate of CPCs and HSPCs in the bone marrow. G-CSF 
has also been shown to be related to exercise-induced changes in CPC content (21), 
suggesting that G-CSF may play a role in CPC mobilization modulated by exercise. 
CXCL12 is a chemokine protein expressed on a variety of cell types and is a strong 
chemoattractant for lymphocytes and HSPCs (22). Previous research has shown that 
CPCs migrate towards an increasing CXCL12 gradient (23, 24). Together, these two 
chemokines show strong promise for their influence on CPC mobilization at steady 
state. In chapter 4, we wanted to investigate if the levels of G-CSF and CXCL12 in the 
blood were related to changes in CPCs and HSPCs after EET, and if these relationships 
were different between lean and obese adults. CXCL12 was significantly decreased in 
adults with obesity after EET, and G-CSF trended to be decreased in adults with obesity 
after EET. However, the change in the concentrations of these cytokines were not 
related to the change in CPC content, suggesting that at steady state, CPCs are not 
related to peripheral blood levels of CXCL12 and G-CSF. These data support previous 
research we have done investigating the effects of CXCL12 on mobilization of CPCs in 
response to acute exercise (Appendix A). In our previous study, we found that the levels 
of CXCL12 were increased during and after acute endurance exercise, but the increase 
in CXCL12 was not related, or did not precede changes in CPCs in circulation. It seems 
as if CPCs may be more directly influenced by bone marrow levels of CXCL12 (25), and 
that physiological levels of G-CSF at steady state (before or after EET) may not be 
sufficient to induce changes in CPCs or HSPCs irrespective of weight status. Our 
results showing a decrease in CXCL12 in adults with obesity after EET suggests other 
mechanisms may be influencing CXCL12 levels in circulation that are affected by 
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exercise. Future research should aim to investigate the relationship between 
inflammation and mobilization cytokines that could work together in order to influence 
circulating CPC quantity. 
6.3 CPC mobilization and tissue repair 
 Given that previous research has shown that CPCs may play a role in tissue 
damage, it is possible that tissue damage induced by acute endurance exercise may be 
responsible for CPC mobilization. We found that during acute endurance exercise in 
lean, healthy adult males, that CPCs were increased in circulation 20 and 40 minutes 
into exercise compared to baseline but were not elevated after exercise. We also found 
that endothelial cells (ECs) were not affected by acute endurance exercise (Appendix A) 
A. However, when we evaluated the changes in ECs compared to the changes in 
CPCs, HSPCs, HSCs, and EPCs 60 minutes into endurance exercise, we found a 
significant positive relationship, suggesting that tissue damage is related to changes 
stem and progenitor cell populations in circulation. EC levels are routinely used as 
markers of vessel damage (26), and vessel damage induced by acute endurance 
exercise may cause increased CPCs to mobilize into the circulation. However, there 
also exists a vascular niche of CPCs, where they reside within vessel walls throughout 
the body. Therefore, the changes in CPCs and HSPCs due to exercise may come from 
the vasculature (27). Furthermore, previous research conducted by Seeger and 
colleagues showed that following acute ischemia, bone marrow derived cells, including 
HSPCs, have a higher ability to infiltrate peripheral tissue and therapeutically augment 
neovascularization (28). Based on these findings, it seems as if CPCs play a role in 
tissue repair either by clinical events (28) or by exercise (Appendix A). However, the 
 134 
direct contribution of CPCs to tissue repair remains to be elucidated. Future research 
should focus on paracrine factors secreted by HSPCs to induce tissue repair, 
differentiation and/or proliferation of HSPCs in damaged tissue, and other contributions 
of other tissue types that may influence or affect CPC mobilization in response to tissue 
damage.  
Research has shown that children who are living with overweight or obesity 
experience lower scores on tests of academic achievement compared to their healthy 
weight counter parts (29, 30), suggesting that obesity may cause decreased cognitive 
functioning. Previous reports have shown that obesity not only induces chronic low-
grade inflammation in the peripheral blood, but also induces low-grade inflammation in 
the central nervous system (CNS) (31) and causes increased immune cell entry into the 
CNS (32); ultimately causing a decrease in cognitive functioning. While novel, the role 
of HSPCs in neuro-inflammation or cognitive function in children has not been 
previously explored. Previous research has shown that HSPCs and CPCs are able to 
respond to acute CNS inflammatory events, such as stroke, and mobilize towards the 
brain (6, 33). Stroke induces high levels of inflammatory proteins and cytokines in order 
to initiate tissue repair. Since HSPCs and CPCs have been shown to participate in 
tissue repair and respond to inflammation (13, 34, 35), we aimed to investigate if 
HSPCs in children may be related to cognition, and if HSPCs may influence CNS tissue 
growth. First, we saw that children who are living with overweight or obesity have a 
positive relationship between HSPC content and cognitive tasks, which healthy weight 
children have a negative relationship between HPSC content and cognitive tasks, with a 
significant difference between the two. We speculate that increased neuro-inflammation 
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caused by obesity may be responsible for mobilization of CPCs from the bone marrow 
into peripheral blood, where they can then infiltrate CNS tissue and initiate inflammatory 
repair or secretion of paracrine factors to influence inflammatory repair. To investigate 
the direct role that CPCs may play on neural progenitors, we aimed to see if paracrine 
factors from cultured CPCs could influence neural progenitor cells in vitro. Obtaining 
neural tissue from humans is not possible, therefore we decided to use an in vitro 
approach. We used SH-SY5Y cells because this model has been derived from a child 
and would be better suited to investigate the relationship between CPCs and neural 
tissues in children (36). Utilizing a cell viability assay (MTT), we found that conditioned 
media from cultured CPCs in children with overweight or obesity caused a trend for 
increased neuronal cell growth in vitro, whereas plasma did not. Therefore, it seems as 
if the increase in CPCs in circulation may be useful in the context of childhood obesity. 
The increased concentration of HSPCs may mobilize to the brain, and may influence 
the growth of neural progenitor cells, possibly to combat negative side effects of 
increased neuro-inflammation associated with obesity.  
6.4 CPC and monocyte mobilization and tissue inflammation via CCR2 and TLR4 
We extend previous research by showing that short term EET causes a decrease 
in not only CPCs and HSPCs, but that it also caused a decrease in HSPCs expressing 
TLR4 and CCR2. These data are promising, suggesting the anti-inflammatory effect of 
exercise on the hematopoietic system. Previous research has shown that HSPCs are 
recruited towards sites of acute inflammation via the CCR2 receptor (4), and that this 
mobilization activates HSPCs. In order to evaluate if the decreased levels of HSPCs 
expressing TLR4 and CCR2 was due to a decrease in overall HSPC content, we found 
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differing relationships between CCR2 and TLR4 expressing HSPCs. The proportion of 
HSPCs expressing CCR2 was decreased in persons with obesity alone after EET. We 
also found an overall decrease in CCR2 expression on HSPCs in both lean and obese 
individuals after EET. On the other hand, we found that EET increased the TLR4 
expression on HSPCs. These data suggest that EET may alter TLR4 expression on 
HSPCs to become more sensitive to acute inflammatory stimuli. Persons living with 
obesity have been shown to have a more activated innate immune system (37) and take 
longer to recover from infections (38). Given the vast amount of previous research 
showing the anti-inflammatory effect of exercise (39–43), we extend previous research 
by showing that exercise can preferentially target more primitive hematopoietic stem 
and progenitor cell populations related to inflammation. We did not, however, 
investigate the relationships between these progenitor cell populations and abdominal 
adiposity, which would extend our previous findings in children. Nonetheless, we shown 
that HSPCs and CPCs are related to inflammation in a variety of ways in both adults 
and children. Future research should focus on the relationship between these cell 
populations, abdominal adipose tissue, and inflammatory proteins and cytokines in 
order to measure the direct influence visceral adipose tissue may have on 
hematopoietic progenitor populations.  
As previously stated, CCR2 is expressed on CPCs and HSPCs and has been 
shown to mobilize these cells to peripheral tissues in order to initiate tissue repair (4, 
34). Therefore, levels of the ligand associated with CCR2, CCL2, may influence levels 
of CPCs and HSPCs at steady state. CCL2, or monocyte chemoattractant protein-1 
(MCP-1), is responsible for mobilization of inflammatory monocytes in response to 
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inflammatory events (44). It has also been shown that individuals living with obesity 
have higher levels of MCP-1 in the blood (45, 46). Therefore, it is possible that levels of 
MCP-1 at steady state before and after EET may be related to changes in CPCs and 
responsible for their mobilization. In chapter 4, we also quantified the levels of MCP-1 in 
circulation, and found no changes after EET, which suggests that other mechanisms 
may be responsible for changes in CPCs expressing CCR2. CCR2 is also known to 
bind to other CCLs (9), which may be more responsible for CPC mobilization at steady 
state.  
6.5 Inflammatory monocytes may participate in tissue repair/inflammation  
 In addition to stem and progenitor cell populations, more mature populations 
such as inflammatory monocytes participate in tissue repair and reduce local 
inflammation (47, 48). While stem and progenitor cell populations have been shown to 
be more potent cytokine producers than their mature cell population counter-parts (14), 
it is also important to investigate the relationship of mature inflammatory monocytes and 
their relationship to both acute and chronic inflammation as these are the cell population 
most involved in host defense (49). Inflammatory monocytes are derived from the HSPC 
population. Previous literature has shown that both adults and children living with 
overweight or obesity have higher circulating monocytes (45, 50, 51). In chapter 3, we 
validate these previous findings by showing that children with overweight or obesity 
have higher circulating classical and non-classical monocytes. We extend these findings 
by also showing that there are higher circulating monocytes expressing CCR2 in 
children with overweight or obesity. Because CCR2 is involved in monocyte mobilization 
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(35, 52) we can speculate that the increased amount of monocytes expressing CCR2 
may infiltrate peripheral tissue to participate in tissue repair via CCR2 mechanisms.  
 To investigate if monocytes are related to baseline levels in inflammatory 
cytokines, we investigated if monocytes with and without CCR2 or TLR4 expression 
were related to interleukin-6 (IL-6). IL-6 is an acute inflammatory cytokine secreted for 
initiation of inflammatory processes (53, 54). Previous reports have shown that children 
living with overweight or obesity have higher circulating IL-6 levels (55). In Chapter 5, 
we found that many of the inflammatory monocyte populations were positively related to 
plasma IL-6 levels. Moreover, monocytes expressing CCR2 and TLR4 were also 
positively related to plasma IL-6 levels. These data are intriguing, given that monocytes 
have the ability to respond to IL-6 (56), as well as secrete IL-6 in order to recruit more 
monocytes to initiate tissue repair (57). Because monocytes can secrete IL-6, the 
relationship between monocytes and IL-6 seen in chapter 5 are intriguing, as it may 
shed light into an acute inflammatory cycle. Increased levels of IL-6 in overweight or 
obesity could cause increased monocytes into circulation, after which inflammatory 
monocytes may secrete more IL-6, therefore leading into a cycle of acute inflammation 
that eventually becomes chronic. Future research should determine if monocytes 
secrete IL-6 in response to IL-6, or if monocytes mobilize in response to increasing IL-6 
levels. 
 Next, we aimed to extend these findings by investigating if acute inflammation is 
evident after meals of different macronutrient composition. We found that after a meal, 
regardless of macronutrient composition, that the percentage of non-classical 
monocytes were significantly decreased in the peripheral blood in both healthy weight 
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and overweight and obese children (chapter 5), indicating that meals may cause 
mobilization of non-classical monocytes towards peripheral tissue, possibly to combat 
local tissue inflammation. In addition, we found that the percentage of total monocytes 
that were intermediate monocytes were different after meals of differing macronutrient 
composition compared to baseline. These data indicate that monocyte populations are 
perhaps altered or influenced by meals of differing macronutrient composition. 
 In order to investigate if TLR4 or CCR2 expressing monocytes may be affected 
by meals of differing macronutrient composition, we also measured the concentration, 
level of expression, and percentage of monocytes expressing TLR4 and CCR2. Acutely, 
we did not find any changes in either of these monocyte populations in response to 
meals of differing macronutrient composition (Chapter 5). At first, we were surprised by 
these findings, but these results line up with previous research showing that CCR2 is a 
main mobilization agent on monocytes (35). Therefore, the possibility of meals inducing 
large changes in monocytes expressing CCR2 could cause unwanted negative side 
effects, such as decreased immune surveillance (58, 59) that could possibly lead to 
compromised immune function.  
 On the other hand, TLR4 is a cell surface receptor that is expressed on 
monocytes in order to identify lipopolysaccharide (LPS) on the cell membrane of gram-
negative bacteria. Identification of LPS initiates a pro-inflammatory cascade, 
characterized by an increase in pro-inflammatory cytokines (60). In chapter 5, we found 
that in children with overweight or obesity, there was a decreased expression of TLR4 
on classical monocytes and a decreased percentage of intermediate monocytes 
expressing TLR4 in the CHO meal only. These results are intriguing, as at first it 
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suggests that a CHO heavy meal is anti-inflammatory. Although concentrations of 
monocytes in the peripheral blood are indicators of disease (61), the role of monocytes 
is to infiltrate peripheral tissue in order to differentiate into macrophages and initiate 
tissue repair (49). Thus, it seems as if intermediate monocytes may be specifically 
recruited out of the peripheral blood to participate in TLR4 mediated tissue repair. 
Intermediate monocytes are a newly proposed population of monocytes thought to be in 
a transition state towards the non-classical phenotype. Intermediate monocytes have 
been shown to have increased antigen presenting capacity compared to classical and 
non-classical monocytes (62), suggesting intermediate monocytes may play a larger 
role in both innate and adaptive immunity (49). Therefore, the selective decrease in the 
proportion of TLR4+ intermediate monocytes only suggests that these monocytes are 
more primed to target foreign antigens, such as gram-negative bacteria. 
 Previous research has shown individuals who are living with overweight or 
obesity experience intestinal inflammation (63), increased intestinal permeability and 
metabolic endotoxemia (64). Monocytes serve an important and unique role in the gut, 
because they play an active role in host defense within the intestines by replenishing 
macrophage populations (47). Metabolic toxemia is of particular importance because it 
is characterized by low levels of gut-derived endotoxin (LPS) (65), suggesting that TLR4 
expressing immune cells play a role in controlling metabolic toxemia. Furthermore, a 
previous report has shown that a high carbohydrate and high fat diet can increase gut-
permeability linked to increased endotoxemia (66). Taken together, we speculate that 
the reduction in the percentage of TLR4+ intermediate monocytes is due to increased 
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infiltration of these monocytes in the gut to possibly combat inflammation induced by 
lower gut permeability and higher amounts of endotoxemia caused by the meal.  
 We also aimed to investigate if these changes in cell populations were mediated 
or related to changes in glucose, insulin, inflammatory proteins, or cytokines. At 
baseline, we found that children living with overweight or obesity had higher circulating 
insulin compared to healthy weight children, but these concentrations were not related 
to circulating monocyte cell content. We then found that after the CHO meal that 
glucose and insulin were significantly higher in both weight groups. Despite an increase, 
both group were within normal range. Additionally, we found that CRP and IL-6 were not 
changed by meals of differing macronutrient composition, suggesting that the changes 
in monocyte populations were not due to changes in circulating inflammatory proteins. 
Despite no relationship with insulin and glucose at baseline, we found that changes in 
monocyte populations and percentages are negatively associated with changes in 
insulin after consuming a meal composed of eggs, but not in a meal composed to 
carbohydrates. We also show that changes in monocyte concentrations and 
percentages are negatively associated with changes in glucose after consuming a meal 
high in carbohydrates. Interestingly, monocytes express insulin receptors and may play 
a role in obesity driven insulin resistance (67). Monocytes are also able to utilize 
glucose via the GLUT1 receptor (68). Our findings suggest that monocytes may be 
influences by the macronutrient composition of a meal via glucose and insulin 
concentrations. However, given the negative relationship between these populations 
and glucose and insulin, more research is needed to fully elucidate this relationship, 
given that the EGG condition did not induce changes in insulin or glucose. Future 
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research should investigate if monocytes, specifically TLR4+ intermediate monocytes, 
are recruited to the gut in response to a high carbohydrate meal and if this relationship 
is driven by changes in glucose. Delineating these relationships would create more 
understanding for the role of inflammation and monocytes in the gut in persons with 
OW/OB, and if alterations in chronic meal ingestion could alter the negative 
associations of metabolic endotoxemia and leaky gut associated with obesity. 
 Overall, our work has demonstrated that obesity is associated with CPC and 
monocyte mobilization, potentially related to tissue inflammation and repair either from 
EET or acute feeding. Future studies are necessary to determine the full extent to CPC 
and monocyte contributions to peripheral tissue, such as the gut, in obesity. 
Furthermore, additional work is needed to investigate these cells are able to mobilize to 
the central nervous system, and if they play a role in cognition. Previous research has 
not investigated the true potential of these cells and their relationship to cognition or the 
gut, but rather have focused on relationships via correlations or speculation. Increased 
recognition of the co-morbidities associated with obesity outside of the traditional cardio-
metabolic comorbidities has gained traction into investigating these relationships. 
Although preliminary, our results highlight the critical need for future investigations into 
the relationships that immune cells expressing TLR4 and CCR2, both mature and stem 
and progenitor populations, may play in tissue repair and inflammation. 
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Figure 6.1. Overview of fates of HSPCs and monocytes in obesity. In persons with 
obesity, we found that while there were no differences between HSPCs at baseline, that 
in response to EET, the number of CPCs, HSPCs, and TLR4 and CCR2 expressing 
HSPCs were decreased in both lean and obese individuals. We also saw a decreased 
proportion of TLR4+ inflammatory monocytes in the blood after a CHO meal in 
overweight and obese children, which may cause these monocytes to mobilize to the 
gut. We also found that conditioned media from CPCs caused an increase in 
neurogenesis in vitro, suggesting that if CPCs are mobilized to the brain they can 







Obesity is a complex disease affected nearly two-thirds of adults and one-third of 
children today (69, 70) and is associated with numerous cardio-metabolic co-morbidities 
(37). Circulating progenitor cells (CPCs) circulate the peripheral blood where they are 
influenced by inflammatory cytokines, proteins, and events that may influence their fate 
and participate in tissue repair and inflammation. Monocytes are a more mature 
progenitor population that circulate the peripheral blood in order to participate in host 
defense via the innate immune system and can be altered by chronic inflammation and 
carbohydrate meals. Alterations in the levels of these cell populations in the peripheral 
blood are routinely used for disease progression and status (2, 3, 61). Changes in these 
cell populations results in peripheral tissue infiltration and tissue repair. Thus, future 
research is needed to investigate the exact relationship and contribution these cells 
have in tissue repair. 
 Continuing previous research demonstrating the influence of exercise and 
obesity on CPCs (1, 71), the purpose of the present thesis was to characterize how 
behavioral factors (exercise and nutrition) alter CPCs and monocytes in obesity. We 
demonstrate that obesity is associated with increased HSPCs and are differentially 
related to visceral adipose tissue and cognition based on weight status (chapter 3). 
Furthermore, we show that endurance exercise training causes a reduction in CPCs, 
HSPCs, and these cells expressing CCR2 and TLR4, supporting the anti-inflammatory 
effects of exercise training (Chapter 4). Lastly, we showed that different meals of 
different macronutrient composition, specifically carbohydrate heavy meals, 
disproportionately affect monocytes in children with OW/OB, and may play a role in gut 
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initiated metabolic endotoxemia (Chapter 5). We successfully demonstrate that obesity 
affects CPCs and their subpopulations in both children and adults, and that exercise 
modulates the concentration of cells in circulation independent of weight status. 
Furthermore, we show that inflammatory monocytes in children with overweight and 
obesity are influenced by carbohydrate heavy meals. 
 Overall, we highlighted a critical need to for future research to focus on 
mechanisms behind mobilizing CPCs into peripheral tissue in both healthy weight and 
obese persons, and how this might work in conjunction with monocyte infiltration to 
peripheral tissues. The results from our experiments further highlight exercise as a 
potential therapy to combat chronic inflammation associated with obesity, and insight 
into how exercise may directly affect the sensitivities of CPCs expressing TLR4. While 
the results of our experiments are promising, further investigations are needed to 
specifically track CPCs or monocytes in peripheral tissue in response to exercise or 
feeding. Future studies should focus on local tissue inflammation as a potential 
mobilization attractant of CPCs towards inflamed tissue to understand the underlying 
mechanisms of their mobilization. In conclusion, our data highlights an exciting direction 
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Circulating progenitor cells (CPCs) are a heterogeneous population of 
stem/progenitor cells in peripheral blood that includes hematopoietic stem and progenitor 
cells (HSPCs and HSCs), endothelial progenitor cells (EPCs), and mesenchymal stem 
cells (MSCs) that are involved in tissue repair and adaptation.  CPC mobilization during 
exercise remains uncharacterized in young adults.  The purpose of this study was to 
investigate the kinetics of CPC mobilization during and after submaximal treadmill running 
and their relationship to mobilization factors.  Seven men (age=25.3±2.4 years, 
BMI=23.5±1.0 kg/m2, V̇O2peak=60.9±2.74 ml/kg/min) ran on a treadmill for 60 minutes 
at 70% V̇O2peak.  Blood sampling occurred before (Pre), during (20 min [20e], 40 min 
[40e], 60min [60e]), and after (15 min [15p], 60 min [60p], 120 min [120p]) exercise for 
quantification of CPCs (CD34+) HSPCs (CD34+/CD45low), HSCs (CD34+/CD45low/CD38-
), CD34+MSCs (CD45-/CD34+/CD31-/CD105+), CD34-MSCs (CD45-/CD34-/CD31-
/CD105+), and EPCs (CD45-/CD34+/CD31+) via flow cytometry.  CPC concentration 
increased compared to Pre at 20e and 40e (2.7 and 2.4 fold respectively, p<0.05).  
HSPCs and HSCs increased at 20e compared to 60p (2.7 and 2.8 fold respectively, 
p<0.05), while EPCs and both MSC populations did not change.  CXCL12 (1.5 fold; 
p<0.05) and SCF (1.3 fold; p<0.05) were increased at 40e, and remained elevated post-
exercise.  The peak increase in CPCs was positively correlated to concentration of ECs 
during exercise with no relationship to CXCL12 and SCF.  Our data show the kinetics of 
progenitor cell mobilization during exercise that could provide insight into cellular 
mediators of exercise-induced adaptations, and have implication for the use of exercise 
as an adjuvant therapy for CPC collection in hematopoietic stem cell transplant.  
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New and Noteworthy:  
Using a comprehensive evaluation of circulating progenitor cells (CPCs) we show that 
CPC mobilization during exercise is related to tissue damage, and not plasma 
concentrations of CXCL12 and SCF.  These data have implications for the use of exercise 
interventions as adjuvant therapy for CPC mobilization in the context of hematopoietic 
stem cell transplant, and also support the role of mobilized progenitor cells as cellular 
mediators of systemic adaptations to exercise. 
 
Key Words: Hematopoietic stem and progenitor cell, mesenchymal stem cell, endothelial 




The bone marrow is an abundant source of adult stem/progenitor cells, primarily 
involved in the maintenance of the hematopoietic system.  Under homeostatic conditions, 
bone marrow-derived stem/progenitor cells circulate in peripheral blood in low quantities 
(1); however, in response to various physiological and pathophysiological conditions, 
these cells can be stimulated into circulation (2, 3).  This heterogeneous cell population 
consists of various sub-populations of progenitor cells, including hematopoietic 
stem/progenitor cells (HSPCs), more primitive hematopoietic stem cells (HSCs), 
endothelial progenitors (EPCs), and mesenchymal stem/stromal cells (MSCs).  MSCs 
may also be derived from adipose tissue, and it has been demonstrated that the bone 
marrow-derived MSCs can be distinguished from the adipose-derived MSCs via 
differential expression of CD34 (4).  Pharmacologically mobilized CPCs are the most 
commonly used source of donor cells for hematopoietic stem cell transplant (HSCT) (5).  
However, up to 30% of patients fail to mobilize sufficient quantities of CPCs to allow for 
successful transplantation resulting in multiple mobilization attempts, increased burden 
on the patient and health care system, and increased risk of inability to perform 
transplantation as a treatment option (6).   
 Recent evidence has been accumulating that exercise increases stem/progenitor 
cell quantity within the bone marrow (7–10), and CPC quantity in peripheral blood (10–
16). However, the majority of previous studies have only assessed CPC quantity in 
circulation before and after the cessation of maximal exercise in healthy adults (9–11, 13, 
15).  In the only previous study to examine the time course of CPC mobilization in 
response to exercise, Möbius-Winkler and colleagues (12) examined the time course of 
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CPC release during and after 4 hours of strenuous cycling.  The authors observed a 
significant increase in CPCs and EPCs late into their cycling exercise bout, but did not 
include circulating MSCs or primitive HSCs in their analyses.  To date, no studies have 
evaluated the kinetics of CPC and a comprehensive panel of CPC subpopulation 
mobilization during a shorter duration exercise bout using running exercise.  These data 
would be important because, in the clinical setting of HSCT, a shorter exercise duration 
may be more feasible for both autologous and allogeneic donors.  Determining the 
kinetics would inform clinical practice by defining the optimal time point to begin CPC 
collection.  Additionally, running may produce different mobilization kinetics as compared 
to cycling. This information would support further investigation into the use of exercise as 
an adjuvant therapy to enhance CPC mobilization efforts during transplantation.  
The mechanisms underpinning exercise-induced CPC mobilization remain to be 
fully elucidated, but several growth factors, cytokines, and chemokines are likely involved 
(9, 10).  Stem cell factor (SCF) and stromal derived factor-1α (SDF-1α/CXCL12) are 
potent cytokines that are secreted by various cell types for maintenance and homing of 
progenitor cells in the bone marrow (17, 18).  CPCs express CXCR4, the receptor for 
CXCL12 which is involved in CPC migration from and homing to the bone marrow (19).  
Disruption of the CXCR4-CXCL12 axis, either through elevated plasma CXCl2 levels or 
CXCR4 antagonists causes release of CPCs into the peripheral blood (20).  Similarly, 
SCF is a cytokine that is secreted by a variety of cell types, specifically endothelial cells, 
fibroblasts, and MSCs (21, 22).  CPCs express the cell surface receptor CD117 which 
interacts with SCF to stimulate CPC motility (23).  Bone marrow progenitors express 
chemokine receptors that facilitate their homing and mobilization, particularly towards 
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increasing concentrations of CXCL12 (24, 25).  Exercise can increase production and 
secretion of known CPC mobilizing factors (12, 26); however, the kinetics of changes in 
plasma SCF and CXCL12 during and after exercise and their relationship to exercise-
induced CPC mobilization have not been previously examined in vivo in humans.  In 
addition to CPC chemoattractants, tissue damage and the resulting inflammatory 
response may also be a potent signal for CPC mobilization.  Evidence in support of this 
notion is derived from pathological conditions that are accompanied by either acute or 
chronic tissue damage and inflammation, such as stroke (27), myocardial infarction (28), 
and obesity (29, 30).  In this context, mobilized CPCs may contribute to tissue repair by 
participating in neovascularization (16, 31–33), differentiating into tissue-resident immune 
cells (24), or via the release of paracrine factors that stimulate local repair processes (30, 
34).  Developing a better understanding of the mechanisms responsible for CPC 
mobilization during and in recovery from exercise may provide new targets for increasing 
cell content in the context of HSCT, and also provide novel insights into the role of CPCs 
in systemic adaptations to exercise.   
As such, the purpose of this study was to examine the time course of CPC, and 
CPC subpopulation mobilization induced by submaximal treadmill running for 1 hour at 
70% V̇O2peak in physically fit, young adults.  Additionally, in order to further investigate 
potential mechanisms responsible for exercise-induced CPC mobilization, we assessed 
the dynamics of SCF, CXCL12, and endothelial cells (ECs), a marker of vascular damage 
(29, 35), in peripheral blood.  We hypothesized that CPC content in peripheral blood 
would increase during exercise and remain transiently elevated during post-exercise 
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recovery.  In addition, increases in CXCL12, SCF, and ECs would both be increased in 






 Eight healthy young men volunteered for this study.  One participant was excluded 
from analysis due to technical difficulties during blood collection, thus final analyses were 
performed on n=7 participants (age: 25.3 ± 2.4 years, height: 173.2 ± 3.2 cm, weight: 71.2 
± 3.13 kg, BMI: 23.5 ± 1.0 kg/m2, body fat percentage: 14.5 ± 1.6%, and V̇O2peak: 60.9 
± 2.7 ml/kg/min).  Participants were physically fit, regularly active, young adults with a 
V̇O2peak >50 mL/kg/min and exercised at least 3 times/week.  Each participant 
completed a routine medical screening questionnaire, was informed of the purpose of the 
study, experimental procedures, and all its potential risks prior to providing written 
consent to participate.  The study was approved by the University of Illinois Institutional 
Review Board and conformed to standards for the use of human participants in research 
as outlined in the sixth Declaration of Helsinki.   
A.2.2 Anthropometric Measures and Body Composition 
Standing height and weight measurements were completed with participants 
wearing lightweight clothing and no shoes, using a stadiometer (Seca; model 240) and a 
Tanita WB-300 Plus digital scale, (Tanita, Tokyo, Japan), respectively.  Whole body and 
regional soft tissue composition was measured by dual-energy X-ray absorptiometry 
(DXA) using a Hologic Discovery A bone densitometer (software version 12.7.3; Hologic, 
Bedford, MA).  Precision for DXA measurements of interest are 1-1.5% in our laboratory.   
A.2.3 Maximal Exercise Test 
Participants completed a maximal exercise test on a motorized treadmill using a 
modified Balke protocol (36).  The test involved participants running on a treadmill at a 
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self-selected constant speed with incremental grade increases of 1% every minute until 
volitional exhaustion (36).  Participants were fitted with a polar heart rate monitor (Polar 
Heart Rate Monitor Model T31; Lake Success, NY) and oxygen consumption was 
measured using an indirect calorimetry system (Parvomedics TrueOne 2400 Metabolic 
Measurement; Sandy, UT) every 15 seconds.  Heart rate and ratings of perceived 
exertion were assessed every 2 minutes using the Borg scale (36).   
A.2.4 Habituation Trial 
 A habituation trial was conducted to familiarize participants with the exercise 
protocol, and to calculate correct treadmill speed equal to 70% of their individual 
V̇O2peak.  Treadmill speeds were adjusted during the first 5 minutes to elicit 70% 
V̇O2peak while participants ran at 1% incline for 60 minutes on a treadmill.  Speed 
settings were recorded and used during the experimental trial.   
A.2.5 Experimental Trial  
 Participants reported to the laboratory at ~0700 h after an overnight fast.  
Participants refrained from physical activity, alcohol, and caffeine for at least 2 days prior 
to the trial.  Prior to beginning the exercise trial, participants were fitted with a heart rate 
monitor (Polar Heart Rate Monitor Model T31; Lake Success, NY) and a Teflon catheter 
(BD; Franklin Lakes, NJ) was inserted into an antecubital vein of one arm and kept patent 
with 0.9% saline drip for repeated blood sampling.  For all samples, the initial blood drawn 
(3mL) was discarded to avoid any dilution effects from the saline.  The exercise trial 
consisted of running on a motorized treadmill at 70% V̇O2peak for 60 minutes.  During 
the trial, ratings of perceived exertion were collected every 20 minutes using the Borg 
scale, and VO2 was monitored using an indirect calorimetry system (Parvomedics 
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TrueOne 2400 Metabolic Measurment; Sandy, UT).  The average RPE reported for our 
exercise protocol was 13.0±2.9, suggesting our exercise stimulus was “somewhat hard”, 
or “moderate” according to the Borg scale (37). Immediately after the cessation of 
exercise, participants ingested a liquid meal (465 kcal; 18g protein, 60g carbohydrate, 
17g fat).   
A.2.6 Blood Analysis 
 Blood samples (~3 mL) were collected from an antecubital vein into EDTA-
anticoagulant tubes (BD; Franklin Lakes, NJ) at the following times: immediately before 
exercise (Pre), at 20 minutes (20e), 40 minutes (40e), and 60 minutes (60e) during 
exercise, and at 15 minutes post-exercise (15p), 60 minutes post-exercise (60p), and 120 
minutes (120p) post-exercise.  Samples collected at Pre, 20e, 40e, 60e, and 15p were 
stored on ice and processed after collection of 15p.  60p and 120p were stored on ice 
and processed after collection of 120p sample.  Cell viability was between 94-97% for all 
time points.  Peripheral blood mononuclear cells (PBMCs) were isolated using Ficoll-
Paque Plus (GE Life Sciences; Pittsburgh, PA) density gradient, per manufacturer’s 
instructions (400xg, 22°C, for 40 minutes with the brake off).  Plasma was collected from 
the Ficoll-Paque density gradient spin and stored in 500 μl aliquots at -80°C until further 
analysis.  PBMCs were incubated in 5 μl FC receptor block (FcX, BioLegend Inc.; San 
Diego, CA) in 5% fetal bovine serum (Atlanta Biologicals; Flowery Branch, GA) in 
phosphate buffered saline solution for 10 minutes.  CPCs were quantified using previously 
defined protocols (29, 38–40).  Antibodies for CPC (CD34+), HSPC (CD34+/CD45dim), and 
HSC (CD34+/CD45dim/CD38-) enumeration were PE conjugated CD34 (Invitrogen; Grand 
Island, NY), PE-Cy 5 conjugated CD38 antibody (BD Biosciences; San Jose, CA), and 
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FITC conjugated CD45 (Invitrogen; Grand Island, NY).  Antibodies for EPC (CD45-
/CD34+/CD31+), EC (CD45-/CD31+), and MSC (Bone marrow derived: CD45-/CD34-
/CD31-/CD105+, and adipose derived: CD45-/CD34+/CD31-/CD105+) enumeration were 
PE conjugated CD34 (Invitrogen; Grand Island, NY), FITC conjugated CD45 (Invitrogen; 
Grand Island, NY), CD105 (Miltenyi Biotec Inc.; San Diego, CA) and CD31 (BioLegend 
Inc.; San Diego, CA).  Aqua Cell Dead Cell Stain (Life Technologies; San Diego, CA) was 
added to each sample immediately prior to flow analysis for exclusion of dead cells.  Flow 
quantification was performed on an Attune Focusing Flow Cytometer (Life Technologies; 
San Diego, CA), on at least 13,000 viable PBMCs. The average range of events for each 
cell population were; CPCs: 384-1314, HSPCs: 272-593, HSCs 204-387, CD34+ MSCs: 
0.7-2.57, CD34- MSCs 6-24, EPCs 49-104, and ECs 73-172. The Attune Flow Cytometer 
conducts volumetric counting by calculating the concentration of events per microliter 
based on the volume of sample analyzed. Data are expressed with units of ev/µL which 
we converted to the more commonly reported, cells/mL.  
A.2.7 Enzyme-linked Immunosorbent Assay Kits 
 Human SCF and Human CXCL12/SDF-1α were quantified in stored plasma using 
the commercially available Quantikine ELISA kit (R&D Systems; Minneapolis, MN) at the 
following time points: Pre, 20e, 40e, 60e, 15p, and 60p.  Since there were no changes in 
CPC concentration relative to baseline at 120 minutes post-exercise, this time point was 
omitted to allow for inclusion of all time points for each participant on the same plate.  
ELISAs were performed according to manufacturer’s instructions with samples run in 
triplicate.  Thawed samples were centrifuged for 5 minutes at 1400xg prior to analysis to 
eliminate platelets from the plasma sample.   
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A.2.8 Statistical Analysis 
 Anthropometric variables, cell quantities, and plasma protein concentrations were 
analyzed by repeated measures ANOVA with repeated measures on time in SigmaPlot 
12.5 (Systat Software, Inc., San Jose, CA).  Significant main effects were analyzed using 
Tukey’s post-hoc test.  Data that failed to meet the assumptions of normality were 
analyzed using Friedman’s repeated measures of analysis of ranks.  Spearman’s Rho 
correlation analyses were conducted in SigmaPlot 12.5 (Systat Software, Inc., San Jose, 
CA).  Progenitor cell ‘responsiveness’ was calculated as a 2-factor ANOVA with repeated 
measures on time on GraphPadPrism (Version 5.02; La Jolla, CA). A Bonferroni post-hoc 




A.3.1 Response of CPCs, and CPC subpopulations to acute exercise  
CD34+ CPC quantity was significantly increased 2.7 and 2.4 fold respectively at 20 
and 40 minutes into exercise compared to pre values (Fig. A.1; Pre: 342.2±76.0 cells/mL, 
20e: 908.3±255.5 cells/mL, 40e: 831.8±195.9 cells/mL; p<0.05). CD34+ CPC content was 
significantly increased at 20e compared to both 60p and 120p (Fig.  A.1; 60p: 373.0±104.1 
cells/mL, 120p: 432.4±105.2 cells/mL; p<0.05). CD34+ CPC content was also significantly 
increased at 40e compared to 60p (Fig. A.1; p<0.05).  Circulating HSPC quantity was 
significantly increased 2.7 fold at 20e compared 60p (Fig. A.2A; 20e: 762.8±275.8 
cells/mL vs. 60p: 281.0±76.8 cells/mL; p<0.05).  Circulating HSC quantity was 
significantly increased 2.8 fold at 20e compared to 60p (Fig. A.2B; 20e: 613.8±250.0 
cells/mL vs. 60p: 222.7±70.6 cells/mL; p<0.05).  Circulating EPC or EC quantity was not 
changed at any time point during or after exercise.  Both CD34- (reportedly bone marrow-
derived) and CD34+ (reportedly adipose tissue-derived) MSCs were rare in circulation, 
and the quantity of either population was not altered by exercise (Fig. A.4A and B).   
A.3.2 SCF and CXCL12 are increased during and after acute exercise but are not related 
to changes in CPC content 
 The concentration of CXCL12 in plasma was significantly elevated 1.5 fold at 40e, 
and remained significantly elevated until 15p (Fig. A.5A; Pre: 663.2±47.3 pg/mL vs. 40e: 
973.9±46.9 pg/mL; 60e: 1083.9±81.0 pg/mL; 15p: 1028.2±82.9 pg/mL; all p<0.05 vs. Pre).  
Similarly, the concentration of SCF in plasma was significantly elevated 1.3 fold at 40e, 
and remained significantly elevated until 60p (Fig. A.5B; Pre: 309.9±24.0 pg/mL vs. 40e: 
397.5±43.9 pg/mL; 60e: 397.7±30.8 pg/mL; 15p: 405.87±25.3 pg/mL; 60p: 382.0±27.0 
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pg/mL; all p<0.05 vs. Pre).  The peak change in all cell populations analyzed were not 
significantly correlated to the changes in CXCL12 concentration at that same time point 
during exercise (data not shown).   
A.3.3 The increase in ECs is positively correlated with the increase in CPCs and CPC 
subpopulations during exercise  
 The increased concentration of ECs, a marker of vascular damage (29, 35), from 
Pre to 20e was significantly positively correlated with the increase in CPCs (Rho = 0.96, 
p<0.0001; Fig. A.6A) and HSCs (Rho = 0.75, p=0.038; Fig. A.6C) from Pre to 20e.  We 
also observed a trend for a significant positive correlation between the increase in EC 
concentration from Pre to 20e and the increase in HSPC concentration from Pre to 20e 
(Rho = 0.64, p=0.096; Fig. A.6B).  The increase in EC concentration from Pre to 60e was 
also significantly positively correlated to the increase in EPC concentration from Pre to 
60e (Rho = 0.86, p<0.01; Fig. A.6D).   
A.3.4 Comparison of Progenitor Cell ‘Responsiveness’ to Exercise 
 Fold changes were calculated for each progenitor cell population compared to their 
respective Pre values. CPCs were significantly higher than BM-MSCs at 20e (p<0.01), 
40e (p<0.01), and 60e (p<0.001), and AT-MSCs at 20e (p<0.001), 40e (p<0.05), and 60e 
(p<0.001). HSCs were significantly more responsive than AT-MSCs at 20e (p<0.05) and 
60e (p<0.05); and BM-MSCs at 60e (p<0.05). EPCs were significantly more responsive 




 The kinetics of CPC and CPC subpopulation mobilization during moderate 
intensity exercise, as well as the mechanisms responsible for their release into circulation, 
have not been well described.  A better understanding of these processes could provide 
further insight into the mechanisms responsible for exercise-induced adaptations 
throughout the body, as well as provide support for therapeutic strategies utilizing 
exercise for stem cell collection in the context of HSCT.  The main findings from the 
present study are: (1) CPCs are significantly increased compared to baseline at 20 and 
40 minutes into submaximal treadmill exercise, (2) SCF and CXCL12 are significantly 
increased 40 minutes into submaximal treadmill exercise in humans, (3) increases in CPC 
quantity positively correlate to ECs during exercise, and (4) CPCs are more responsive 
than BM-MSCs and AT-MSCs during exercise.  These data suggest that submaximal 
treadmill exercise induces CPC mobilization during the exercise bout, which is more likely 
related to exercise-induced peripheral tissue damage or local factors within the bone 
marrow niche, rather than circulating CXCL12 and SCF.   
 The majority of previous studies have shown that CD34+ CPCs are transiently 
increased following acute exercise (13, 38, 41), although this effect may be dependent 
on exercise intensity and modality (15, 41).  In the current study, we observed a significant 
increase in CD34+ CPCs during exercise that peaked at 20 minutes, remained elevated 
at 40 min, and exhibited a strong trend to remain elevated at 60 minutes (p=0.068) into 
submaximal treadmill exercise in young men.  Only one previous study has investigated 
the kinetics of CD34+ CPC mobilization during exercise, and determined that CD34+ 
CPCs and EPCs were significantly increased at 180-210 minutes into a 4-hour cycling 
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protocol at 70% of the individual’s anaerobic threshold (IAT) and remained elevated until 
cessation of exercise (12).  Our data follow a slightly different time course, peaking at 20 
minutes into exercise; however, they are similar to the findings of Möbius-Winkler and 
colleagues in that CD34+ CPC concentrations remained elevated throughout the rest of 
the exercise bout.  The more rapid increase in CD34+ CPCs observed in the present study 
could have been due to mechanical stimulation of bone, or the larger overall muscle mass 
engaged in the running exercise used in the present study provided an additional stimulus 
that accounted for an earlier increase in CPC mobilization.   
 A particularly novel aspect of the present investigation is the evaluation of two 
different populations of circulating MSCs: adipose tissue-derived CD34+ MSCs (AT-
MSCs), and bone marrow-derived CD34- MSCs (BM-MSCs) (4).  In agreement with 
previous reports (11, 29) circulating MSCs were quite rare in our young, lean participants.  
A single previous report showed that following  moderate intensity treadmill running, 
circulating MSC content was significantly decreased in young athletes (11). Our data 
indicate a numerical, but not statistically significant decrease in circulating MSC content 
post-exercise.  A slight difference between our study and the previous report was that 
Marycz and colleagues (11) used positive expression of CD51 as a phenotypic marker of 
MSCs, while we used positive expression of CD105 as suggested by the International 
Society for Cellular Therapy (39), and was previously established to identify MSCs in 
peripheral blood (42).  CD51 is a cell-adhesion molecule, thus it is possible that the 
decrease in MSCs observed by Marycz and colleagues (11) could be due to a decreased 
cell-surface expression of CD51 which would be expected in mobilized cells, rather than 
a decrease in the MSC population.  MSC populations are not stimulated by our exercise 
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protocol, whereas other progenitor populations are. One explanation for this lack of 
increase of MSCs by this exercise protocol is that MSCs are stimulated by a hypoxic 
environment as evidenced by their proliferation increase ex vivo proliferation in hypoxic 
conditions (43), and their role in promoting angiogenesis in hypoxic tissues (44, 45). As 
such, higher intensity exercise sufficient to induce hypoxia in muscle may be required for 
an increase in MSC mobilization. 
 To compare the relative responsiveness of each stem/progenitor cell population 
to exercise, we compared fold changes from pre in each cell population across our time 
course. We found that during exercise, CPCs increased relative to BM-MSCs and AT-
MSCs. HSCs were increased versus AT-MSCs at 20e and 60e, and increased versus 
BM-MSCs at 60e. Lastly, EPCs increased versus both BM-MSCs and AT-MSCs at 60e. 
These data suggest differential responses to acute exercise among the different 
stem/progenitor cell populations.  Acute exercise mobilized CPCs, HSCs, and EPCs 
being into circulation, with CPCs and HSCs being mobilized more rapidly.  Conversely, 
relative to other cell populations, MSCs are removed from circulation during exercise 
perhaps indicating that these cells are more involved in early adaptive responses 
occurring during exercise.  The physiological relevance, and the mechanisms 
responsible for these differential mobilization effects are unknown and require further 
investigation.       
Mobilized progenitor cell populations have been shown to participate in tissue 
repair, in both exercise and disease (16, 29).  The mechanisms by which these cell 
populations contribute to tissue repair remain controversial; however, they may include 
participating in neovascularization (16, 31–33), differentiating into tissue-resident immune 
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cells (24), or via the release of paracrine factors that stimulate local repair processes (30, 
34).  Since acute exercise has been shown to cause tissue damage (46), stimulate vessel 
remodeling (47, 48), and increase systemic inflammation in healthy participants (49), it is 
possible that these mobilized stem/progenitor cell populations are contributing to tissue-
specific exercise induced adaptations.  Interestingly, the mobilization of the various CPC 
populations during exercise was significantly correlated to increases in EC content, a 
marker of vessel damage (29, 35).  Additionally, the positive relationship between 
mobilization of various CPC populations and EC concentrations but not plasma levels of 
CXCL12 and SCF during exercise suggests that tissue damage may be a stronger 
stimulus for mobilization than the levels of these two chemo-attractants in circulation.  
This notion is supported by previous studies that, similar to the present investigation, 
show that plasma concentration of CXCL12 and SCF factors did not correlate to CPC 
quantity after exercise (38) suggesting that these chemoattractants are only temporally 
related to CPC mobilization.  Additionally, both SCF and CXCL12 remained significantly 
elevated in the present study at 15 minutes post-exercise when CPC content was already 
starting to decrease.  Conversely, previous evidence showing that that exercise-induced 
CPC release is related to muscle damage (26), and that incorporation of bone marrow-
derived cells into skeletal muscle is increased following muscle damage induced by 
downhill running (28) in combination with our findings of positive relationships between 
CPC mobilization and EC content suggests that other systemic factors and/or tissue 
damage, are playing a role in exercise-induced CPC mobilization.   
In the context of HSCT, it is possible that the increased inflammation and tissue 
damage response to running may result in collection of samples that are not ideal for 
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transplantation.  From a clinical perspective, it is important to note that  G-CSF, the most 
common clinical mobilizing agent, increases inflammatory cytokines, specifically IL-6, 
MMP-9, and TNF-α (50).  Since administration of G-CSF itself increases inflammatory 
cytokine levels, it is likely that CPCs mobilized by exercise may not be deemed unsafe 
for use.  However, it will be important to fully characterize both phenotypically and 
functionally the heterogeneous CPC population mobilized by exercise before potentially 
implementing exercise protocols in HSCT donors.  It is possible that the inflammatory 
conditions produced by exercise impairs the function of collected cells.  To better 
understand these effects, it will be important to characterize the CPC population that is 
being mobilized by acute exercise to ensure that these cells not functionally impaired in 
their regenerative capacity.  Along these lines, Krüger et al., showed that acute exercise 
associated with varying degrees of muscle damage, all increased CD34+/CD45+ CPCs 
immediately post-exercise (26).  The increase in CPC content was positively correlated 
with markers of muscle damage.  Additionally, colony forming unit assays were 
significantly elevated immediately post, 3 hours post, and 24 hours post exercise, 
suggesting exercise increased the amount of CPCs in the blood capable of producing 
colonies.  These data suggest that CPCs mobilized by exercise are safe in the context of 
HSCT.  On the other hand, Kroepfl and colleagues demonstrated that CPCs collected 10 
minutes after exercise displayed decreased colony-forming capacity, suggesting 
decreased function (51).  An important difference between these two studies is that the 
exercise protocol used by Kroepfl and colleagues was a maximal exercise test to 
exhaustion.  As such, there is likely a balance between enhancing mobilization versus 
causing cellular damage to HSPCs.  In the present study, we chose a continuous running 
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protocol at 70% VO2max to attempt to optimize this balance based on previously 
published protocols. 
 A limitation of this study is the limited number of circulating factors that were 
evaluated which could be involved in CPC mobilization.  Many previous studies have 
investigated the relationship between catecholamines (52), cortisol (53), inflammatory 
and tissue damage markers (10, 13, 54, 55) to exercise-induced CPC mobilization.  We 
focused on CXCL12, SCF, and endothelial damage as potential mechanisms responsible 
for CPC mobilization because these biomarkers are well-known to be involved in CPC 
mobilization, we have shown CXCL12 and SCF to be increased in rodent muscle 
following exercise (10), but have not been well-characterized in the context of exercise.  
Now that we have established a time-course for CPC mobilization, future studies in the 
lab will be able to perform multiplex analyses using specific time points to better 
understand the mechanisms responsible for exercise-induced CPC mobilization.  
 In conclusion, our data demonstrate that CPCs are mobilized during, and shortly 
after, submaximal exercise and return to basal levels within 1 hour after exercise.  
Additionally, mobilization of various CPC subpopulations is related to markers of tissue 
damage and not plasma levels of CXCL12 and SCF.  These data suggest that CPCs may 
play a role in the physiological response to exercise, potentially acting as cellular 
mediators of exercise-induced adaptations.  Furthermore, the increase in CPCs during 
submaximal exercise supports the potential for investigation of exercise interventions as 
an adjuvant therapy for stem cell mobilization in the context of bone marrow 
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Figures and Figure Legends 
 
 
Figure A.1. Time course of CPC accumulation in blood.  CPCs (CD34+) were quantified 
from isolated PBMCs by flow cytometry at the reported time points during and after 
exercise.  p<0.05 compared to Pre is denoted by “a”, p<0.05 compared to 60p is denoted 
by “b” and p<0.05 compared to 120p is denoted by “c”.  Data are presented as mean ± 
SEM for n=7. 
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Figure A.2. Time course of HSPC and HSC accumulation in blood.  HSPCs 
(CD45dimCD34+) (A) and HSCs (CD45dimCD34+CD38-) (B) were quantified from isolated 
PBMCs by flow cytometry at the reported time points during and after exercise.  *P<0.05 








Figure A.3. Time course of EPC and EC accumulation in blood.  EPCs (CD45-
CD34+CD31+) (A) and ECs (CD45-CD31+) (B) were quantified from isolated PBMCs by 
flow cytometry at the reported time points during and after exercise.  Data are presented 






















Figure A.4. Time course of CD34- and CD34+ MSC accumulation in blood.  CD34- MSCs 
(CD45-CD34-CD31-CD105+) (A) and CD34+ MSCs (CD45-CD34+CD31-CD105+) (B) were 
quantified from isolated PBMCs by flow cytometry at the reported time points during and 





















Figure A.5. Time course of changes in CXCL12 and SCF concentrations in blood.  
Plasma was isolated via Ficoll density gradient for analysis of CXCL12 (A) and SCF (B) 
at the reported time points during and after exercise by ELISA.  *P<0.05 compared to Pre.  








Figure A.6. Relationship between ECs and peak change in CPC subpopulations.  The 
peak increase in CPC (A), HSPC (B), HSC (C), and EPC (D) concentrations were related 
to the increase in EC concentrations at the time point corresponding to the peak change 
in each respective subpopulation (i.e. 20e for CPCs, HSPCs, and HSCs, and 60e for 





Figure A.7. Progenitor cell ‘responsiveness’ during and after exercise. CPCs increased 
relative to BM-MSCs (a; p<0.01 for 20e and 40e, p<0.001 for 60e) and AT-MSC (b; 
p<0.001 for 20e, p<0.05 for 40e, and p<0.001 for 60e) during exercise. HSCs increased 
relative to AT-MSC (c; p<0.05) at 20e and 60e, and BM-MSCs (d; p<0.05) at 60e. EPCs 
increased relative to BM-MSCs (e; p<0.01) and AT-MSCs (f; p<0.01) at 60e. Data are 
presented as fold changes compared to Pre values of each respective progenitor cell 
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Abstract  
INTRODUCTION: Circulating progenitor cells (CPCs) are a heterogeneous population 
of stem/progenitor cells in peripheral blood that participate in tissue repair. CPC 
mobilization has been well characterized in able-bodied persons, but has not been 
previously investigated in wheelchair racing athletes. The purpose of this study was to 
characterize CPC and CPC sub-population mobilization in elite wheelchair racing 
athletes in response to acute, upper-extremity aerobic exercise to determine if CPC 
responses are similar to ambulatory populations. METHODS: Eight participants (3 
female; age=27.5±4.0 years; supine height=162.5±18.6cm; weight=53.5±10.9kg, 
VO2peak=2.4±0.62 L/min; years post injury=21.5±6.2 years) completed a 25 km time trial 
on a road course. Blood sampling occurred before (Pre) and immediately post (Post) 
exercise for quantification of CPCs (CD34+), HSPCs (CD34+/CD45dim), HSCs 
(CD34+/CD45dim/CD38-), CD34+ adipose tissue-derived (AT)-MSCs (CD45-
/CD34+/CD105+/CD31-), CD34- bone marrow-derived (BM)-MSCs (CD45-/CD34-
/CD105+/CD31-), and  EPCs (CD45dim/CD34+/VEGFR2+) via flow cytometry. Blood 
lactate was measured Pre- and Post-trial as an indicator of exercise intensity. 
RESULTS: CPC concentration increased 5.7 fold post-exercise (P=0.10). HSPCs, 
HSCs, EPCs, and both MSC populations were not increased post exercise. Baseline 
HSPCs were significantly positively correlated to absolute VO2peak (Rho = 0.71, P<0.05) 
with HSCs trending to positively correlate to VO2peak (Rho = 0.62, P=0.10). AT-MSCs 
were trending to be negatively correlated to baseline VO2peak (Rho = -0.62, P=0.058).  
The change in CPCs, EPCs, and AT-MSCs Pre-Post exercise significantly positively 
correlated to the change in lactate concentrations (Rho = 0.91 p = 0.002, 0.71 p = 
0.047, 0.81 p = 0.02, respectively, all P<0.05). CONCLUSION: These data suggest that 
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CPC content in wheelchair racing athletes is related to cardiorespiratory fitness and 
responses to exercise are positively related to exercise intensity.  
Keywords: Wheelchair Racing, Hematopoietic Stem and Progenitor Cells, Exercise, 
mesenchymal stem cell, endothelial progenitor cell  
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B.1 Introduction 
The bone marrow is home to a variety of stem and progenitor cell populations 
that can mobilize through the circulatory system to distant organs in order to participate 
in tissue repair (1,2). These mobilized circulating progenitor cells (CPCs) are a 
heterogeneous population, and include various subpopulations such as: hematopoietic 
stem and progenitor cells (HSPCs), hematopoietic stem cells (HSCs), and endothelial 
progenitor cells (EPCs). These subpopulations have been shown to participate in blood 
vessel repair and remodeling (3), and have clinical relevance as the cell population 
used for hematopoietic stem cell transplant (4). Mesenchymal stromal cells (MSCs) also 
circulate throughout the blood and are derived from both bone marrow (BM-MSCs) and 
adipose tissue (AT-MSCs) (5). MSCs are multipotent stem cells with the capacity to 
differentiate along the adipogenic, osteogenic, and chondrogenic lineages, and also 
produce a variety of trophic factors involved in stimulating repair processes in tissue-
resident cells (6). In pathological conditions, mobilized CPCs participate in tissue repair 
(7–9), and emerging data is outlining the relationship between CPCs and a reduction in 
adverse cardiovascular events and vessel abnormalities (10). A plethora of previous 
reports show that circulating CPC content is negatively related to cardiovascular risk 
(8,11–14). Given the potential role that CPCs may have in tissue damage response and 
repair, these data suggest that CPCs mobilized following exercise might have a similar 
function acting as cellular mediators of systemic health benefits and tissue damage from 
exercise.  
The role of cardiorespiratory fitness (e.g. VO2peak) and endurance training 
programs in altering circulating CPC populations are equivocal (15,16); although 
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interventions that use higher intensity endurance or resistance exercise programs seem 
to induce basal increases in CPCs (16). What is noteworthy is that acute endurance 
exercise, such as running or cycling, has consistently been shown to transiently 
increase the quantity of CPCs within both the bone marrow and peripheral blood in 
healthy participants (15–18).  The signals responsible for CPC egress from the bone 
marrow in response to exercise remain to be fully elucidated; however, recent evidence 
suggests that exercise intensity (15), tissue damage (19,20), and sympathetic nervous 
system stimulation (16) may be relevant components in determining the degree of CPC 
mobilization following acute exercise.   
Previous literature examining baseline CPC content and subsequent CPC 
mobilization in response to acute exercise or exercise training has been conducted in 
able-bodied participants performing exercise modalities involving large amounts of 
muscle mass, such as running, rowing, resistance exercise, or cycling (16). To date, no 
study has examined the relationship between cardiorespiratory fitness and the content 
of CPC subpopulations at rest, nor following acute aerobic exercise in non-ambulatory 
individuals performing only upper-body exercise. What remains unknown is whether 
similar relative exercise-induced responses in CPC content and mobilization are present 
in non-ambulatory individuals performing only upper-extremity exercise. This 
information would be clinically important because upper extremity exercise might be the 
only option for achieving health and fitness benefits for some individuals. Indeed, 
previous literature has shown that upper body exercise is beneficial in this population, 
specifically with increases in angiogenic factors (21), and decreases in both systemic 
inflammation (22), and traits of depression (23). In addition, examining CPC content in 
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wheelchair racing athletes provide unique insight to mechanisms of exercise-induced 
adaptations and their relationship to cardiorespiratory fitness and CPC mobilization. 
Previous literature has pointed towards multiple factors that could affect CPC 
mobilization after exercise in able bodied persons; such as increases in known 
mobilization factors (19), exercise induced inflammation (24), and exercise-induced 
adrenaline (25). In addition, CPC mobilization has also been shown following 
myocardial infarction (8), stroke (7), and obesity (26) suggesting that many different 
mechanisms play a role in CPC mobilization. Persons with spinal cord injury exhibit 
altered catecholamine release after exercise (27), however have similar increases in 
angiogenic factors (21). As such, determining the basal levels of CPCs and their 
response to acute aerobic exercise in wheelchair athletes provides a unique perspective 
into the mechanisms responsible for CPC mobilization. 
The purpose of this study was to relate baseline levels of CPC and CPC 
subpopulations to cardiorespiratory fitness, and to examine the CPC and CPC 
subpopulation response to acute endurance exercise in elite wheelchair athletes during 
a 25 km road time trial with the blood lactate response as an indicator of exercise 
intensity (28). We hypothesized that CPC content would be positively related to 
cardiorespiratory fitness (VO2peak), that acute exercise would increase CPC content, and 
the exercise-induced increases in CPC content would be positively related to exercise 




 Eight elite wheelchair racing athletes were recruited from an elite wheelchair 
racing team (5 male, 3 female). Participants were recruited by a member of the 
research team during a team meeting without coaches present to avoid coercion. Elite 
athletes were used to ensure a maximal response to upper-body exercise in a highly 
trained, exercise-habituated population. Eligible participants were ages 19-40 years, 
minimal risk for engaging in physical activity (e.g. answered “no” to all questions on the 
Physical Activity Readiness Questionnaire (PAR-Q) (29)), and actively training for and 
competing in wheelchair racing. Participants were excluded if they smoked, had been 
diagnosed with any gastrointestinal tract disease or arthritic conditions, or if they were 
pregnant. All participants provided written informed consent. This study was approved 
by the Institutional Review Board at University of Illinois at Urbana-Champaign and 
conformed to standards for the use of human participants in research as outlined in the 
seventh revision of the Declaration of Helsinki.   
B.2.2 Participant Demographics 
 Participant demographic information is provided in Table B.1. Five participants 
had spinal cord injuries ranging from T6 to L3 and were on average 19.4±6.9 years 
post-injury, and 3 participants were born without lower body ambulation (acute 
transverse melitis, spina bifida, and arthrogryposis). All together, participants had an 
average of 21.5±6.2 years since spinal cord injury; including three participants who 
experienced these since birth. Participants had been competing in wheelchair racing for 
an average of 13.5±6.8 years and were training to compete in the 2016 Paralympic 
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Games.  Supine height was recorded with the participant laying on an examination table 
and was measured using measuring tape. Weight was measured with a digital 
wheelchair scale (Health-O-Meter, Professional 2400KL, Pelstar LLC, McCook, IL) in 
which the chair weight was subtracted from the total weight measured. Body fat 
percentage and fat mass were recorded using Dual X-ray Absorpitometry (DXA; 
Hologic). Participants were instructed to lie still with minimal clothing and no metal or 
shoes. Cardiorespiratory fitness was assessed using an incremental exercise protocol 
performed on a wirelessly controlled wheelchair roller system and participants using 
their own racing chair to complete the test. The exercise protocol began at a relative 
resistance of 10% and was increased in 5% increments each minute. The athletes were 
asked to maintain a minimum target speed of 21-24 k/hr. Expired gases were recorded 
using a two-way, non-rebreathable valve (Hans Rudolph Inc., Shawnee, KS) connected 
to an open circuit spirometry system (TrueOne 2400, Parvo Medics, Sandy, UT). Heart 
rate (BPM, Polar Electro Oy, Kempele, Finland) and ratings of perceived exertion (RPE, 
Borg scale) were recorded every minute (30,31). The test was concluded upon volitional 
exhaustion or inability to maintain target speed. VO2peak was recorded as the highest 20-
second VO2 value and expressed as L/minute. Participants were instructed to avoid 
alcohol, and exercise for 12 hours prior to VO2 testing, and caffeine 4 hours prior to 
testing. 
B.2.3 Road Time Trial 
 All 8 participants reported to the lab on the day of a simulated half-marathon (a 
25 km time trial). The race course was predetermined and participants’ were monitored 
throughout the 25 km road course by members of the research team by car. Average 
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time for race completion was 51.9±6.6 minutes. Blood was collected from the 
antecubital vein approximately 20 minutes prior to the start of the trial, and immediately 
after completion of the trial (2.0 ± 0.5 mins post). Blood was collected into sterile 10 mL 
EDTA tubes (BD; Franklin Lakes, NJ).  To maintain each athlete’s normal training and 
nutrition, participants’ were instructed to follow their preferred pre-race nutritional 
routine. 
B.2.4 Blood Analysis 
 The venous blood collected for flow cytometric analysis was quantified as 
previously described (20). Briefly, peripheral blood mononuclear cells (PBMCs) were 
separated by Ficoll-Paque PLUS density gradient (GE Life Sciences; Pittsburgh, PA). 
The buffy coat was washed twice with PBS and stained with the following antibodies: 
PE-conjugated anti-CD34 (1:100; Invitrogen; Grand Island, NY), FITC-conjugated anti-
CD45 (1:200; Invitrogen; Grand Island, NY), PE-Cy 5-conjugated anti-CD38 (1:50; BD 
Biosciences; San Jose, CA), VioBlue conjugated anti-CD105 (1:200; Miltenyi Biotec 
Inc.; San Diego, CA), PE-Cy7 conjugated anti-CD31 (1:200; BioLegend Inc.; San Diego, 
CA), and VEGFR2 (1:200; BioLegend Inc.; San Diego, CA) for 20 minutes on ice 
protected from light. All samples were washed, and the samples containing VEGFR2 
were resuspended in secondary antibody (1:50,000; Life Technologies, Grand Island, 
NY). CPCs were quantified using previously defined protocols (6,26,32–34). CPCs 
(CD34+), HSPC (CD34+/CD45dim), and HSC (CD34+/CD45dim/CD38-) enumeration was 
conducted using the following antibodies: PE conjugated anti-CD34 (Invitrogen; Grand 
Island, NY), PE-Cy 5 conjugated anti-CD38 (BD Biosciences; San Jose, CA), and FITC 
conjugated anti-CD45 (Invitrogen; Grand Island, NY).  Antibodies for EPC 
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(CD45dim/CD34+/VEGFR2+) and MSCs (Bone marrow derived: CD45-/CD34-/CD31-
/CD105+, and adipose derived: CD45-/CD34+/CD31-/CD105+) enumeration were PE 
conjugated anti-CD34 (Invitrogen; Grand Island, NY), FITC conjugated anti-CD45 
(Invitrogen; Grand Island, NY), VioBlue conjugated anti-CD105 (Miltenyi Biotec Inc.; 
San Diego, CA), PE-Cy7 conjugated anti-CD31 (BioLegend Inc.; San Diego, CA), and 
purified anti-human CD309 (Vascular Endothelial Growth Factor Receptor 2; VEGFR2; 
Biolegend; San Diego, CA) with secondary antibody F(ab’)2-Goat anti-Mouse IgG 
(H+L), Qdot 605 (Life Technologies; Grand Island, NY).  All cell populations were gated 
as previously described (20,35), and concentrations were determined by volumetric 
counting on the Attune acoustic focusing flow cytometer (Life Technologies) from 
analysis of at least 139,500 PBMCs.  Gates and compensation were established based 
on single and unstained control samples. Representative flow plots obtained from pre 
and post exercise time points have been provided (Figure B1). Lactate concentration 
were analyzed in whole blood using an automated analyzer (YSI 2300 Stat Plus, Yellow 
Springs Instruments, USA).  
B.2.5 G-CSF and CXCL12 Enzyme Linked Immunosorbent Assays 
 Human granulocyte-colony stimulating factor (G-CSF) and human 
CXCL12/stromal cell derived factor-1a were quantified in stored plasma using 
commercially available Quantikine ELISA kit (R&D Systems, Minneapolis, MN) at the 
pre and post time points. ELISAs were performed per manufacturer’s instructions with 
samples analyzed in duplicate.  
B.2.6 Statistical Analysis 
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 Cell quantities were analyzed by a paired t-test conducted in Microsoft Excel. 
Correlations between the absolute cell change (pre/post) all cell populations analyzed 
and the absolute change in blood lactate concentration were conducted using 
Spearman’s Rho Nonparametric Correlations in SPSS (IBM SPSS Statistics Version 
24). Data are presented as individual values or as mean±SD with p<0.05 considered 




B.3.1 CPCs and subpopulations relationships to baseline fitness and fat mass 
 HSPCs significantly positively correlated to baseline absolute VO2peak (Rho=0.71, 
P=0.047; Figure B.2A) while HSCs positively correlated to baseline absolute VO2peak 
(Rho=0.62, P=0.10; Figure B.2B). AT-MSCs negatively correlate to baseline absolute 
VO2peak (Rho=-0.62, P=0.058; Figure B.2C). AT-MSCs were not correlated to fat mass 
(Rho=-0.119, p=08; Figure B.2D) 
B.3.2 CPC and subpopulations response to acute aerobic exercise 
CD34+ CPC quantity increased 5.9±8.9 average fold change across all 
participants after acute aerobic exercise (Figure B.3A, Pre: 5.7±4.9 cells/µL vs. Post: 
11.5±9.2 cells/µL, P=0.10). EPC (Figure B.3B), HSPC (Figure B.3C), HSC (Figure 
B.3D), BM-MSC (Figure B.3E), and AT-MSC (Figure B.3F) quantity was not significantly 
altered by exercise.  
B.3.3 CPCs and subpopulations relationship to exercise intensity 
 To determine the relationship between the change in CPCs and CPC 
subpopulations to exercise intensity, we correlated the change in CPCs and CPC 
subpopulations to the change in blood lactate. The changes in CPCs (Rho=0.91, 
P=0.002, Figure B.4A), and AT-MSCs (Rho=0.81, P<0.02, Figure B.4C) were 
significantly positively correlated to the change in blood lactate concentration, while the 
change in EPCs (Rho=0.72, P=0.0547, Figure B.4B) was positively correlated to the 
change in blood lactate. 
B.3.4 Relationship between CPCs and known mobilizing factors 
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 To determine the potential mechanisms responsible for the change in CPC 
populations following exercise, we evaluated known mobilizing agents: G-CSF, 
CXCL12, and endothelial cell content. G-CSF was only reliable detected in 2/8 
participants (data not shown), CXCL12 significantly increased following exercise (Fold 
change: 1.36; pre: 750.85±133.67 pg/mL vs. post: 1021.86±149.88 pg/mL; p<0.001); 
Figure B.5A) but was not correlated to changes in CPC content (data not shown). 
Endothelial cell content did not change following exercise (Fold change: 1.55, p=0.4; 




 The CPC and CPC subpopulation response during and post-acute aerobic 
exercise has been well described in able-bodied individuals (15,19,20,36). The majority 
of studies have shown that CPCs are transiently increased in peripheral blood in 
response to various modalities of exercise such as running (19,20,36), cycling 
(15,19,36), resistance exercise (19,35), and rowing (37). The present study is the first to 
characterize the response of CPCs and their various subpopulations before and after a 
25 km road time trial in elite wheelchair racing athletes. The main findings from this 
study are: (1) HSPCs are significantly positively correlated to baseline levels of 
cardiorespiratory fitness, (2) CPCs increased by an average of 5.9±8.9 fold after a 25 
km road time trial (p=0.10), and (3) CPC, EPC, and AT-MSC mobilization is positively 
correlated to changes in blood lactate during exercise.  
 Few studies have investigated the relationship between cardiorespiratory fitness 
and CPC subpopulation content, and the results from these studies are equivocal. 
Some cross-sectional studies show that endurance trained athletes have increased 
CPC content compared to sedentary controls (24), while others show no difference in 
CPC content when individuals are stratified into high fit and low fit groups (15). Similarly, 
longitudinal training studies have reported no increase in CPC content after exercise 
training (38), while others have shown that exercise training increases CPC content 
(39). Both of these training studies showed substantial inter-individual variability in the 
CPC and fitness responses; however, neither study correlated the CPC response to 
training-induced changes in cardiorespiratory fitness. In the present study, we observed 
significant positive correlations between baseline circulating HSPC content and a trend 
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for a positive correlation in HSC content with cardiorespiratory fitness. Our study differs 
from previous reports in that our study involved an elite athlete population and we 
specifically related CPC subpopulations to cardiorespiratory fitness. Thus, our findings 
suggest that variable inter-individual responses in CPC subpopulations to training 
reported in previous studies (39) may be related to variability in individual improvements 
in cardiorespiratory fitness, at least in non-ambulatory, elite athlete populations. Our 
participants were in the middle of their competitive season, were participating in training 
programs that were designed by expert coaches, and specifically tailored to each 
athlete. In addition, athletes would have been highly motivated during their training as 
many were attempting to qualify for the Paralympics. Another relevant difference 
between our study and previous work is that previous studies have used more 
heterogeneous marker for CPC identification, such as CD34 (15,24,38,39), and not 
delineated the relationships between specific CPC subpopulations and cardiorespiratory 
fitness. The finding that HSPCs and HSCs positively correlated, or trended to positively 
correlate, to cardiorespiratory fitness may indicate enhanced regenerative capacity in 
higher fit elite wheelchair athletes but future studies will have to investigate this 
hypothesis further. Conversely, we observed a trend for a significant negative 
correlation between AT-MSCs and cardiorespiratory fitness. This negative relationship 
was not due to decreased adipose tissue mass in higher fit participants. We speculate 
that the negative correlation between AT-MSCs and cardiorespiratory fitness could be 
related to adaptations in adipose tissue, such as decreased inflammation with increased 
cardiorespiratory fitness, that maintain AT-MSCs in their natural environment.  
 198 
Recent evidence has also shown that persons with spinal cord injury release 
various angiogenic factors in response to acute exercise, such as vascular endothelial 
growth factor (VEGF) (21), a factor that is heavily involved in vessel formation by CPCs 
in vitro (40) and in vivo (41). CPCs have been shown to play a role in tissue 
regeneration after exercise (20), and this may possibly be related to angiogenic factor 
increases after exercise (21), further supporting the notion that CPCs play a role in 
tissue regeneration. CPCs have been shown to play a role in vascularization, and 
potentially play a protective role against cardiovascular disease (10). Future work will 
need to examine if the relationship between CPCs and cardiorespiratory fitness in 
wheelchair athletes underlies the beneficial health effects of increased participation in 
exercise in these individuals. 
Despite the large body of evidence demonstrating that acute exercise results in 
CPC mobilization, no previous studies have examined the CPC response in non-
ambulatory athletes. Similar to findings from Bonsignore and colleagues (5) who 
evaluated CPC content in able-bodied athletes immediately after a half-marathon, we 
did not detect significant changes in any of the CPC populations evaluated in our non-
ambulatory population. In both our study, and the study from Bonsignore and 
colleagues (5), a large amount of inter-individual variability existed in CPC mobilization. 
The large degree of inter-individual variability in our study was confounded by the 
relatively small sample size; a result of our highly specialized study population. 
However, when the relative magnitude of change in CPCs in our non-ambulatory 
population is compared to previously published data from ambulatory participants 
(20,37), the relative change in CPC content is similar. These data suggest that CPCs 
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are similarly mobilized in ambulatory and non-ambulatory adults, which suggests that 
CPC mobilization is possible in populations that cannot perform lower body exercise. An 
important caveat is that our study involved elite wheelchair athletes to ensure a maximal 
exercise response, and future studies will be necessary to determine if our findings are 
generalizable to non-elite or sedentary non-ambulatory individuals.  
Few studies have directly investigated the optimal exercise conditions for 
inducing CPC mobilization. Recently, Baker and colleagues (15) completed the first 
study to directly compare the CPC response to two different exercise intensities in the 
same participants. They showed that CPCs (CD34+) and HSCs (CD34+/CD38-) were 
increased in the peripheral blood after moderate, but not low intensity exercise (15) 
suggesting that exercise intensity is a key mediator of CPC mobilization. In the present 
study, we extend these findings to non-ambulatory participants by demonstrating that 
the degree of CPC mobilization is related to exercise intensity, as measured by blood 
lactate concentration. Participants who displayed a decrease in CPC content following 
the time trial also exhibited the smallest increase in blood lactate concentrations. This 
further supports our suggestion, which has also been demonstrated by others (15), that 
exercise intensity is an important factor in CPC mobilization. Additionally, in our recent 
report (18), we demonstrated that CPC content peaked early during an acute exercise 
bout, then decreased later in exercise. It is possible in the present study that some 
participants started the time trial at a higher pace that they were not able to maintain 
throughout the duration of the exercise test. This could have resulted in peak CPC 
content early in the race that had declined by the end of the race. Conversely, those 
who showed the largest increase in CPC could have applied a different race strategy 
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that involved a sprint to the finish. This could have accounted for a large increase in 
lactate and a large increase in CPC content close to the end of the race. Unfortunately, 
since this was a road time trial, we were not able to collect blood samples at multiple 
time points throughout the study to confirm this hypothesis. Combined, these finding 
suggests that exercise recommendations with the goal of maximizing CPC mobilization 
should focus on higher intensity forms of exercise, and that relative intensities 
determined from able-bodied individuals could be applied to individuals who are non-
ambulatory.  
 Evaluating the response of CPCs to upper-extremity exercise in patients with 
spinal cord injury or congenital diseases affecting neuromuscular function may provide 
more specific insights into the mechanisms responsible for CPC mobilization. 
Evaluating CPC mobilization in long-term elite wheelchair provides a unique perspective 
because long term wheelchair racing causes similar cardiorespiratory adaptations as 
running (42). Previously examined exercise modalities for CPC mobilization, such as 
running, cycling, rowing, and resistance exercise recruit large amounts of muscle mass 
and result in force transduction to the pelvis and femur, which are the main location of 
adult hematopoiesis, with minor contributions from the sternum, ribs, and vertebral 
column (43). Mechanical stimulation of these tissues may be partly responsible for 
exercise-induced CPC mobilization. In wheelchair racing, mechanical stimulation of the 
upper body, mainly the shoulders and arms, could induce CPC egress from the bone 
marrow of the humerus, a site of active hematopoiesis in adults (44). As such, our study 
provides novel insight into exercise modalities that do not involve the use of lower limbs 
as our relative increases in CPC populations are similar to relative increases in CPCs 
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previously reported in able-bodied populations performing primarily lower-body exercise 
(15,20).  
Conversely, sympathetic nervous system (SNS) activation could contribute to 
CPC mobilization from the humerus or from hematopoietically active tissue remaining in 
the femur and hips of the wheelchair racing athletes. Previous research has indicated 
that SNS stimulation may be partly responsible for CPC mobilization; however, these 
data are conflicting in humans (16). The lumbar plexus is the set of nerves stemming 
from T12 through L4 of the spine, and is responsible for the SNS innervation of the 
large muscle groups within the lower limbs. Most of our participants had an injury at L3 
or above; therefore, it is possible that SNS innervation of the lower body in these 
participants was compromised. However, we cannot rule out the role that SNS 
innervation may play in CPC mobilization, since the upper body also experiences SNS 
innervation. Specifically, the brachial plexus is responsible for SNS innervation in the 
arms and shoulder and stems from C5-T1. Since our participants did not have an injury 
higher than T6, the SNS innervation into the arms and shoulders could have provided 
SNS stimulation to mobilize CPCs from the humerus. On the other hand, recent 
evidence has shown that mid-level and low-level SCI patients have similar resting levels 
of norepinephrine and epinephrine (27), but have a blunted response of these 
catecholamines to exercise compared to able-bodied individuals (45). Although human 
literature is equivocal regarding catecholamine induced CPC mobilization (16), given 
that our study showed similar changes in CPCs content as able-bodied individuals 
despite a possibly blunted release of adrenaline in wheelchair athletes, this may 
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potentially rule out exercise-induced increases in adrenaline contributing to CPC 
increase in wheelchair racing athletes after acute exercise.  
To determine potential mechanisms responsible for the trend for an increase in 
CPCs following exercise, we evaluated paracrine factors suggested to be involved in 
CPC mobilization. G-CSF is used clinically to induce CPC mobilization in the context of 
CPC harvest for hematopoietic cell transplant (46), and has recently been shown to be 
correlated to CPC mobilization following resistance exercise (19). We were only able to 
reliably detect G-CSF in 2/8 participants in the present study, with concentrations of G-
CSF in the two participants with detectable levels being lower than what has been 
previously reported (19). We also quantified CXCL12, which has also been implicated in 
regulating CPC mobilization (47,48). CXCL12 content significantly increased post-
exercise; however, the concentration of CXCL12 was not related to a change in CPC 
content. Similar to our previous finding in able-bodied participants (18), these data 
suggest that CXCL12 concentration in peripheral blood may not be a signal for CPC 
mobilization. Since we previously determined that CPC mobilization was positively 
correlated to changes in endothelial cell content, a marker of vascular damage, in able-
bodied participants, we performed a similar analyses in these elite wheelchair racing 
athletes. We did not detect a change in endothelial cell content, and endothelial cell 
content was not correlated to the change in CPCs. There could be a number of potential 
reasons for the discrepancies between the present data and our previous study. First, in 
the present study, the participants were elite athletes in peak training season. 
Therefore, their vasculature may have been more highly adapted to the sheer stress 
that in induced by exercise than the recreationally active in our previous study resulting 
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in less vascular damage. Second, in our previous manuscript, the correlation between 
CPC mobilization and endothelial cells occurred early during exercise (i.e. 15 min into 
the exercise bout). Since the conditions of this field test did not allow for blood collection 
during exercise, the time discrepancy between blood collection could also account for 
the differences. It is possible that these factors, in combination with the added nature of 
a spinal cord injury, could result in different mechanisms responsible for CPC 
mobilization in this population. A limitation of our study is that we did not measure 
catecholamines or other growth factors possibly involved in CPC mobilization. Recent 
evidence has shown an increase in VEGF (21) and a blunted response of adrenaline 
(45) in persons with spinal cord injury following exercise. Further research is needed to 
fully elucidate the mechanism responsible for CPC mobilization in wheelchair racing 
athletes.  
In conclusion, the present study shows that CPC subpopulation content is related 
to baseline cardiorespiratory fitness, and that the CPC response to exercise is related to 
exercise intensity in wheelchair racing athletes. These data provide a deeper 
understanding of the relationship between CPC subpopulations and cardiorespiratory 
fitness, as well as the CPC subpopulation response to exercise by extending findings 
from able-bodied individuals to non-ambulatory participants. Having a full understanding 
of CPC mobilization in response to exercise will allow for a further understanding of the 
mechanisms responsible for CPC mobilization, and provide further insight into their role 
in exercise-induced adaptations.  
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Table B.1. Participant demographics.  
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Figure B.1. Representative flow cytometry gating strategy. Representative gating 
strategies for CPCs, HSPCs, and HSCs are shown pre (A) and post (B) exercise. 
Peripheral blood mononuclear cells (PBMCs) were identified based on forward and side 
scatter. Total CPCs (CD34+), HSPCs (CD34+/CD45dim), and HSCs 
(CD34+/CD45dim/CD38-) were identified from PBMCs. Representative gating strategies 
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Figure B.1. (cont). for EPCs, BM-MSCs and AT-MSCs are shown pre (C) and post (D) 
exercise. Peripheral blood mononuclear cells (PBMCs) were identified based on forward 
and side scatter. EPCs were quantified in the CD45dim/CD34+VEGFR2+ population. 
MSCs were quantified in the CD45-CD31-CD105+ population as bone marrow-derived 
(BM-MSCs: CD34-) or adipose tissue-derived (AT-MSCs: CD34+). Detailed flow 





Figure B.2. The relationship between fitness and fat mass and basal CPC 
subpopulations before and after a 25 km time trial in elite wheelchair athletes. 
Spearman’s Rho correlations were conducted on the content (cells/µL) of HSPC (A), 
HSC (B), AT-MSC (C) pre values and participant’s absolute VO2peak (L/min) (n=8). 
HSPCs were significantly positively correlated to VO2peak, while trends for correlations 
were observed between HSCs and AT-MSCs. (D) AT-MSC content (cells/µL) at 
baseline was not significantly related to fat mass (g) (n=8). 
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Figure B.3. CPC and subpopulation mobilization before and after a 25 km time 
trial in elite wheelchair athletes. CPC (A), EPC (B), HSPC (C), HSC (D), BM-MSC 
(E), and AT-MSC (F) enumeration by flow cytometry before and after a 25 km time trial 
(n=8). CPCs trended to increase post-exercise in wheelchair racing athletes (p=0.10), 
while EPC, HSPC, HSC, BM-MSC, and AT-MSC content did not change. Individual data 





Figure B.4. Change in CPC content and its relationship to the change in blood 
lactate before and after a 25 km time trial in elite wheelchair athletes. Spearman’s 
Rho correlations were conducted to relate the change (post-pre) in all CPC 
subpopulations (cells/uL) to the change (post-pre) in lactate concentrations (mmol/L) 
(n=8).  The change in blood lactate significantly positively correlated to the change in 
CPC (A), EPC (B), and AT-MSC (C) content. 
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Figure B.5. CXCL12 and endothelial cell response to 25 km time trial in elite 
wheelchair athletes. CXCL12 concentration (A) and endothelial cell (EC) content (B) 
before and after a 25 km time trial (n=8). CXCL12 significantly increased (*p<0.001) 
post-exercise, while endothelial cell content did not change. Individual data points for 






Representative Flow Plots for Appendix A 
 











Representative Flow Plots for Chapter 3 























Representative Flow Plots for Chapter 4 
 
Figure E.1. CPC, HSPC, TLR4+ CPCs, CCR2+ CPCs, TLR4+ HSPCs, CCR2+ HSPCs 
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Representative Flow Plots for Chapter 5 
Figure F.1. Inflammatory Monocytes 
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Protocols for Experiments Conducted During Thesis 
CD 14/CD16/CD192 
Prior to blood draw 
1. Turn on flow cytometer (15 min warm up) and run the performance test 
2. Label tubes appropriately and compensation tubes and unstained sample. 
a. Do not need bead compensation for Sytox Aadvance 
3. Set up lasers and experiment 
a. CD 16 FITC – BL1 
b. CD 14 PE – BL2 
c. Sytox Aadvance – BL3 
d. CD 192 Brilliant Violet – VL1 
4. Prepare 1X lysing solution 
a. Dilute 10X to 1X with DI water 
Post Blood Draw 
Antibody Preparation 
1. Add 200 ul of blood per sample tube 
2. Add 1ul CD14 to each sample except unstained and sytox aadvance 
compensation tube 
3. Add 1ul CD16 to each sample except unstained and sytox aadvance 
compensation tube 
4. Add 1ul of CD192 to each sample except unstained and sytox aadvance 
compensation tube 
5. 20 minute incubation at room temperature protected from light. 
6. Add 4mL of 1X lysing solution to every sample 
7. Incubate for 10 minutes at room temperature protected from light. 
8. Add 1ul of 10% Triton to the Sytox Aadvance tube only. Incubate for 10 minutes 
at room temperature protected from light 
9. Add 1ul of Sytox Aadvance to sample of interest and the sytox aadvance tubes. 5 
minute incubation at room temperature protected from light 
10. Place into ice protected from light; run experiment 
Gating Strategies 
• Set R1 to draw 15,000 monocyte events 
• Set quadrant Gate on a CD14+ H vs CD16 H 
• Set R6 on CD192+ events 




Neuroblastoma Cell Culture Protocol 
Taken from: Neuronal Cell Culture – Methods and Protocols. Adapted with 
Protocol from:  
Fernanda Martins Lopes et al. Comparison between proliferative and neuron-like SH-





• 1:1 Ham’sF12 and DMEM + Glutamax 
• FBS , 10% final concentration 
• 0.28 ug/ul final conc Gentamicin 
• SH-SY5Y cells 
• 75 cm3 culture flasks 
1. Prepare growth medium (50mL solution) 
a. 280 ul gentamicin 
b. 5mL FBS 
c. 44.72mL DMEM:F12 + glutamax 
2. Thaw cells at 37C water bath 
3. Remove cell suspension from the tube and add to 9mL culture medium in a 15 
mL tube. Spin at 100 x g for 7 minutes at RT.  
4. Warm up 15mL of culture medium in a T75 culture flask. Use this medium to 
resuspend cells and plate. 
5. Culture cells at 37C 5% CO2. Refresh medium every 4 days. When cells reach 
80-90% confluence, subculture. 
Proliferation Stage 
1. Plate cells at a concentration of 3.0 E 5 cells/well in _______ ul of complete 
growth media in 96 well plate.  
2. Allow to grow for 24-48 hours. 
3. Add the conditioned media and low serum media.  
a. Low Serum Media 5mL (1%) 
i. 4.922mL 1:1 Ham’s F12 and DMEM + Glutamax 
ii. 28ul of Gentamicin 
iii. 50ul FBS 
iv. Add conditioned media at 1:1 CM:SFM 
Sub-culturing Cells 
• 1:1 Ham’sF12 and DMEM + Glutamax 
• FBS , 10% final concentration 
• Gentamicin 
• SH-SY5Y cells 
• 75 cm3 culture flasks 
1. Prepare growth medium (50mL solution) 
a. 280 ul gentamicin 
b. 5mL FBS 
c. 44.72mL DMEM:F12 + glutamax 
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2. Aspirate medium. If floating cells are present, collect the medium and centrifuge 
and re-plate. 
3. Rinse adherent cells with 5mL sterile 1x PBS – pre-warmed. To prevent 
detaching, add PBS to the side of the flask with no cells. Do not add PBS 
directly onto the cell layer. Gently tip the flask so that the PBS washed over the 
cell monolayer. Aspirate PBS. 
4. Warm 5mL Trypsin in hands. Add 5mL trypsin to adherent cells for approximately 
2min in the incubator or until cells visibly detach from the culture flask. Agitate 
the plate to ensure all cells have detached.  
5. Check in the microscope if cells have balled up and detached. Work quickly. 
6. Neutralize trypsin by adding an equal volume of DMEM:F12 medium containing 
10% FBS. 
7. Collect detached cells and centrifuge at 1500 rpm for 5 min at room temp. 
8. Aspirate supernatant. 
9. Gently suspend pellet in DMEM:F12 10% FBS. 
10. Homogenize solution. 
11. Count cells and plate at approximately 3x10E3 – 1x10E5 cells/cm2. 
Freezing Cells 
• 1:1 Ham’sF12 and DMEM + Glutamax 
• FBS , 10% final concentration 
• Gentamicin 
• SH-SY5Y cells 
• 75 cm3 culture flasks 
1. Prepare growth medium (50mL solution) 
d. 280 ul gentamicin 
e. 5mL FBS 
f. 44.72mL DMEM:F12 + glutamax 
2. Obtain freeze medium from the freezer. If none made: 
a. 10mL 
i. 56ul gentamicin 
ii. 1mL DMSO 
iii. 2mL FBS 
iv. 6.944 mL DMEM:F12 +glutamax 
b. Aliquot into 1.5mL tubes  
3. Aspirate medium. If floating cells are present, collect the medium and centrifuge 
and re-plate some, but save some to freeze. 
4. Rinse adherent cells with 5mL sterile 1x PBS – pre-warmed. To prevent 
detaching, add PBS to the side of the flask with no cells. Do not add PBS 
directly onto the cell layer. Gently tip the flask so that the PBS washed over the 
cell monolayer. Aspirate PBS. 
5. Warm 5mL Trypsin in hands. Add 5mL trypsin to adherent cells for approximately 
2min in the incubator or until cells visibly detach from the culture flask. Agitate 
the plate to ensure all cells have detached.  
6. Check in the microscope if cells have balled up and detached. Work quickly. If 
cells are clumped, allow to sit in the incubator for 2-3 more minutes. Tap the 
bottom of the flask if needed. 
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7. Neutralize trypsin by adding an equal volume of DMEM:F12 medium containing 
10% FBS (growth media). 
8. Collect detached cells and centrifuge at 1500 rpm for 5 min at room temp. 
9. Aspirate supernatant. 
10. Suspend the cell pellet gently in 1mL  growth media with 20% FBS, 10% DMSO 
in a sterile 1.5mL cryo-vial. Submerge in liquid nitrogen. 
11. Store at least 1.0 E 6 (1 million) cells/tube. Submerge in cell freezing apparatus 
in isopropyl alcohol.  
12. Store cells at -80C.  
Changing Media 
1. Place sterile PBS and growth media in water bath. 
2. Take cells out of the incubator and check them on the microscope at 4x. 
3. Take cells to hood, and bring in PBS and Nb media. 
4. Carefully and slowly suck up old media with the serological pipet and put old 
media into “Nb Cells” 15ml tube. It should fill up 15mL. Centrifuge at 1500 rpm for 
5 minutes at RT. 
5. Turn the flask onto its side. Pipet 5mL of warm PBS on the side of the flask that 
has no cells adhered. Tilt the flask very slowly and make sure the 5mL of PBS 
touches at least every part of the side of the plate with cells. Discard PBS. 
6. Suck up only 10 mL of  new media and very slowly pipet into the culture flask.  
7. Suck off supernatant. With 5mL of new media, resuspend the cells very slowly, 
dropwise around the plate. Make sure there are no remaining cell clumps, as 












• 15mL tubes 
• 2.0ul tubes labeled 
• 5% FBS/PBS solution 
• Blood (2 EDTA tubes) 
 
Labeling 
• 8 Plasma tubes 
• each ID: 
o MSC cells 
o HSPC cells 
o CMP:CLP cells 
• CD10 Ab 
• CMP:CLP Ab 
• MSC Ab 
• HSPC Ab 
 
Protocol 
1. Mix blood 1:1 with PBS 
2. Layer 5mL diluted blood over 3mL Ficoll 
3. Spin for 40 minutes at RT at 400xg with the brake at 2. 
a. Make up pre made antibody cocktails with a total volume of 200ul of 5% 
FBS/PBS/sample. 200ul is enough for 1 sample. Adjust volume for total 
samples. 
b. CMP:CLP 
i. Lin-: 2ul 
ii. CD34: 2ul 
iii. CD38: 4ul 
iv. CD123: 2ul 
v. CD45RA: 2ul 
c. CD10 
i. CD10: 10ul 
d. MSC 
i. CD34: 2ul 
ii. CD105:  1ul 
iii. CD45: 1ul 
iv. CD31: 1ul 
e. HSPC + TLR4 + CCR2 
i. CD34: 2ul 
ii. CD45: 1ul 
iii. TLR4: 10ul 
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iv. CCR2: 1ul 
f. Store tubes on ice in the dark until use. 
4. Isolate buffy coat. Wash with 6mL PBS. Spin at 400xg 10 mins at RT with the brake 
on. 
5. Repeat PBS wash. 
6. Resuspend samples in 4mL of FBS/PBS. Distribute 1mL to each tube labeled 
“cells”. 
a. 1mL HSPC cells 
b. 1mL MSC cells 
c. 1mL CLP:CMP cells 
d. 1mL unstained 
7. Spin samples down at 400 x g 4C 10 minutes. 
8. Re-suspend HSPC, MSC, and CD10 (into the CLP:CMP cells tube) sample in the 
pre-made antibody cocktail, and unstained in 200ul of 5% FBS/PBS. Let sit on 
ice in the dark for 20 minutes. 
9. Wash in 1mL 5% FBS/PBS. Spin at 400xg 10 minutes at 4C. 
10. While spinning, put 3mL in pre-labeled flow tubes. 
11. Resuspend MSC and HSPC cells in 1mL 5% FBS/PBS. Transfer cells into 4mL 
of 5% FBS/PBS in flow tubes. Place tubes on ice and analyze by flow. 
Resuspend CLP:CMP tubes in CLP:CMP antibody cock tail. Let sit on ice in the 
dark for 20 minutes.  
12. Resuspend in 1mL 5% FBS/PBS and transfer to flow tubes. Place on ice and 
analyze by flow. 
Serum 
1. Let blood sit at RT for 60 minutes. 
2. Spin at 1300xg for 15 minutes at RT. 
3. Aliquot into 500ul aliquots. Store at -80C. 
 
MethoCult Assay Protocol for Human Blood 
 
Materials 
• MethoCult Methylcellulose medium (H4534) (in freezer must be thawed 
overnight) 
• 6cc luer lock syringe 
• 16 gauge blunt-end needle 
• Polystyrene round-bottom tube with a cap 
• Square petri dish 
• 4 35mm plates 
• Sterile pipet tips 
• Sterile water 
• IMDM supplemented with 2%FBS 
• Sterile Ficoll 
• 70% ethanol 
 




1. Thaw MethoCult medium overnight in the fridge. 
2. Shake bottle for a full 2 minutes. 
3. Let stand for 20 minutes at room temperature to allow bubbles to rise.  
4. Dispense 4mL of Methocult medium into a round-bottom tube using a 6cc luer 
lock syringe with a 16 gauge blunt-end needle. Repeat until all contents of the 
bottom are all dispensed. 
a. Remove air from the syringe before dispensing: Place the needle below 
the surface of the MethoCult medium. Draw up approximately 1mL of the 
medium. Gently depress plunger and expel medium completely. Repeat 
until no air space is visible. Draw medium up to 5mL mark and then 
dispense 4mL of medium into each tube by dispensing until 1mL mark. 
5. Cap tubes tightly. Store at -20C until use. Store at 4C for on month. 
 
EVERYTHING MUST BE DONE IN THE HOOD AND GENTLY TO PRESERVE CELLS 
 
IMDM Preparation 
1. For mixture of IMDM with cells before Ficoll-separation, add 2% FBS to IMDM in 
a 50mL tube 
a. 1mL FBS 
b. 49 mL IMDM 
Blood preparation 
 
1. Ensure that MethoCult media is thawed in the fridge overnight. 
2. Mix heparinized blood 1:1 with IMDM/FBS solution. Invert gently. 
3. Layer 5mL diluted blood over 3mL Ficoll. Spin at 400xg 40 minutes at RT with 
the brake set to 2. 
4. Isolate buffy coat. Wash cells in 6mL IMDM/FBS solution and spin at 400xg 10 
minutes at RT. 
5. Quickly but carefully discard the supernatant but don’t dislodge the cell pellet. 
Re-suspend in 6mL IMDM/FBS solution and spin at 400xg 10 minutes RT. 
6. Quickly but carefully discard the supernatant. Resuspend the cell pellet in 1mL 
IMDM/FBS solution medium.  
7. Perform a cell count. 
a. Count live cells from 10uL cells and 10uL Trypan Blue.  
8. Spin cells at 400xg for 10 minutes at 4C. 
9. Prepare culture dishes as follows: 
a. Get a square petri dish  
b. Get 4 35mm dishes with lids. Remove the lid off of one dish. This will be 
filled with sterile water. 
10. Resuspend cells at 2x106 cells/mL, which is 10x the final concentration required, 
with 1% PenStrep. Calculate the amount of PenStrep needed for the volume. 
a. Example: To achieve 2 x 10^5 cells/dish, prepare a cell suspension of 
2x106 cells/mL 
b. A sample of 2 full tubes of blood yielded about 2x106 cells/mL in 2 mL. 
11. Add 0.4 mL of diluted cells to a pre-aliquoted 4mL MethoCult Tube.  
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12. Vortex the tube vigorously for at least 4 seconds. Let stand for at least 5 minutes 
to allow the bubbles to rise to the top. 
13. Attach a sterile 16g blunt end needle to a sterile 3cc syringe.  
14. Remove air from the syringe before dispensing: 
a. Place the needle below the surface of the medium. Draw up 0.5mL of the 
medium. Gently depress plunger and expel medium completely to remove 
air bubbles. Repeat until no air space is visible. Draw medium up to 2.6mL 
mark then dispense 1.1mL of medium in the first dish by dispensing until 
1.5mL mark. Dispense 1.1mL of medium into the second dish by 
dispensing until the 0.4mL mark. Finally, draw up medium until 1.5mL 
mark then dispense 1.1 mL of medium into the third dish by dispensing 
until 0.4mL mark. Do not touch syringe to the dish. Replace all lids on 
dishes except the sterile water dish. 
15. Swirl dishes and gently tilt to allow medium to attach to all sides. Fill the fourth 
dish with sterile water. Replace plate on the square petri dish. 
16. Place in incubator for 14-16 days. Identify and count colonies.  
 
Counting Colonies: 
1. Prepare 60mm Gridded Scoring Dish by drawing two perpendicular lines across 
the center of the dish on the bottom. Count 8 squares from the center on one 
radius and a draw a short line crossing the radius. Repeat for each radius. Take 
cultures to be scores from incubator. 
2. Center a culture dish in the scoring dish. Place in the inverted microscope stage 
and adjust the focus under low power (2X objective) until the colonies are in 
focus. 
3. Scan entire dish on low power (2X objective – 20-25X magnification) for 
placement of colonies relative to one another. make note of the overall 
appearance of the culture to help with scoring and evaluation. 
a. Example: Are the colonies close to one another or far apart? Are colonies 
evenly distributed? What is the approximate number of colonies on the 
dish (i.e. overplated or underplated?)? Observe background for presence 
of absence of other cells or debris, general morphology and health. 
4. Count all the colonies in each dish. Continually adjust the microscope focus to 
identify all colonies present in the 3D culture and to distinguish individuals 
colonies that are close together but in different planes of focus. CFU-GM and 
CFU-GEMM colonies are usually scored at low magnification (2X objective – 20-
25X magnification). Switch to higher power to help with colony identification, if 
necessary. 
a. If you get motion sickness, try moving plate from top to bottom rather than 
side to side. 
 
General Colony Descriptions 
Human hematopoietic progenitors can be quantified in cell suspensions of BM, CB, 
mobilized PB, and PB. The classes of human hematopoietic progenitors detected using 
various formulations of MethoCult™ media include: 
CFU-E: Colony-forming unit-erythroid. Produces 1 - 2 cell clusters containing a total of 8 
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- 200 erythroblasts. CFU-E are relatively mature erythroid progenitors that require 
erythropoietin (EPO) for differentiation. CFU-E are usually detectable in BM, but absent 
in CB. 
BFU-E: Burst-forming unit-erythroid. Produces a colony containing > 200 erythroblasts 
in a single or multiple clusters and can be sub-classified based on the number of cells or 
cell clusters per colony, if desired. BFU-E are more immature progenitors than CFU-E. 
BFU-E require EPO and cytokines with burst-promoting activity such as Interleukin-3 
(IL-3) and Stem Cell Factor (SCF) for optimal colony growth. 
CFU-GM: Colony-forming unit-granulocyte, macrophage. Produces a colony containing 
at least 40 granulocytes (CFU-G), macrophages (CFU-M) or cells of both lineages 
(CFU-GM). Colonies arising from primitive CFU-GM may contain thousands of cells in 
single or multiple clusters. 
CFU-GEMM: Colony-forming unit-granulocyte, erythroid, macrophage, megakaryocyte. 
A multi-potential progenitor that produces a colony containing erythroblasts and cells of 
at least two other recognizable lineages. Due to their primitive nature, CFU-GEMM tend 




Figure G.1. CFU-GM derived colony 
Note the dense core of cells at the center of the 
colony and the individual cells distinguishable at the periphery. Monocyte/macrophage 
cells tend 
to be larger and more irregular in shape than 
granulocytes. The small piece of debris seen 






















Figure G.2. One CFU-GM-derived colony with 2 




















Figure G.3. CFU-GM-derived colony. 
Single CFU-GM-derived colony containing two 
distinct clusters. Note that each cluster is present 
on a similar plane with comparable cellular 
morphology. These features can be used to 
assist in distinguishing between individual 




















Figure G.4. CFU-GM-derived colony (left) and a 
large BFU-E-derived colony (right). 
 
This is not one colony derived from a single 
CFU-GEMM progenitor. Both of the colonies 
appear very distinct and only overlap in one 
area. Compare the two colonies in this photo to 
















Figure G.5. Colonies in culture with ‘runny’ methlcellulose. Colonies in ‘dried-up’ 
methylcellulose. The colonies appear distorted and “streaky.” The dishes were disturbed 
during culture or transport. Dehydrated or dried-up culture caused by low humidity during 
culture. To avoid dehydration, ensure that water dishes are used and the water-jacketed 










Figure G.6. Good plating density. Good distributions of colonies is required for 


















Figure G.7. Under-plating (Approximately 3x too low) and over-plating 
























ENC Blood Processing – Monocytes, CPCs, and ROS T1 – Day 1 
Prior to blood draw 
b. Dilute lysing buffer from 10X to 1X with DI water (Good for 30 days in 
fridge) 
c. Label 1.5 or 2.0 mL tubes with ID, sample, date, your initials, and T1 
i. ROS tube with ID, sample, and T1 
ii. ROS unstained with ID, pre 
iii. ROS antibody (1:2000) 




iv. PE Isotype 
v. FITC Isotype 
e. Label 2 15ml tubes with ID, sample, and T1 
i. ROS 
ii. ROS unstained 
Post Blood Draw 
Antibody Preparation 
11. Add 200 ul of blood per flow sample tube (ROS samples – will be in 15mL tube) 
12. Add antibodies 
a. Monocytes tube 
i. 2ul CD14 
ii. 2ul CD16 
iii. 2ul CCR2 
iv. 10ul TLR4 
b. CPCs 
i. 5ul CD34 
ii. 1ul CD45 
iii. 10 ul CD38 
iv. 1 ul VEGFR 
c. ROS (in 15mL tube) 
i. 5 ul CD34 
d. PE Isotype 
i. 2.5ul PE Isotype 
e. FITC Isotype 
i. 0.5ul FITC Isotype 
13. 20 minute incubation at room temperature protected from light. 
a. Prepare ROS antibody (1:2000) 
i. 0.5 ul of antibody into 1mL 5% FBS/PBS 
ii. Place into ice protected from light 
14. Add Secondary antibody (1:500) to sample containing VEGFR (CPCs tube). Let 
sit on ice for 30 minutes protected from light.  
a. After 30 minute incubation, add 4mL lysing buffer. Let sit on ice for 10 
minutes protected from light. Run experiment. 
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15. Add 4mL of 1X lysing solution to every sample except CPC tube (including ROS 
tubes!) 
16. Incubate for 10 minutes at room temperature protected from light. 
17. Place all tubes EXCEPT ROS and ROS unstained tubes into ice protected from 
light; run experiment (Run 600ul at 100ul/min 3 times for CPCs and Monocytes 
tube; run 100ul at 100ul/min for unstained; run 50ul for isotype controls at 
100ul/min) 
18. ROS and ROS Unstained TUBE: 
a. Spin cells down at 400xg at 4C for ten minutes.  
b. Resuspend samples in 1mL 5% FBS/PBS and transfer to labeled 1.5mL 
tubes 
c. Spin for 10 minutes at 400xg at 4C 
d. Resuspend 200ul of ROS stain (1:2000) into ROS tube. Resuspend 
unstained in 200 ul of 5% FBS/PBS 
e. Incubate in incubator for 1 hour 
f. Add 1mL of 5% FBS/PBS 
g. Spin for 10 minutes at 400xg at 4C 
h. Resuspend in 1mL and analyze by flow in 1.5mL tubes 
19. When all samples have been run, spin at 400xg for 10 minutes at 4C 
20. Resuspend each sample in 500ul of 5%FBS/PBS and 500ul of 10% neutral 
buffered-formalin. Let sit protected from light for 10 minutes. 
21. Wash every sample with 1mL 5%FBS/PBS. Spin at 400xg for 10 minutes at 4C.  
22. Resuspend in original amount (should be around 2ml). Wrap in foil and store in 
fridge. DO NOT FREEZE. Run one week later. 
Plasma 
1. With the unused EDTA blood (Pink tube), spin at 2400 rpm for 15 minutes at 4C. 
2. Aliquot into 500 ul aliquots. Store in -80 
Serum 
23. Let sit for 1 hour at room temperature 
24. Spin at 1300xg for 15 minutes at 22C. 




ENC Blood Processing – Monocytes, CPCs, and ROS T1 – Day 2/3 
Prior to blood draw 
f. Dilute lysing buffer from 10X to 1X with DI water (Good for 30 days in 
fridge) 
g. Label 4 Flow tubes with ID, sample, and timepoint 
i. Unstained 
ii. Monocytes 
iii. PE Isotype 
iv. FITC Isotype 
Post Blood Draw 
Antibody Preparation 
26. Add 200 ul of blood per flow sample tube (except ROS – will be in 15mL tube) 
27. Add antibodies 
a. Monocytes tube 
i. 2ul CD14 
ii. 2ul CD16 
iii. 2ul CCR2 
iv. 10ul TLR4 
b. PE Isotype 
i. 2.5ul PE Isotype 
c. FITC Isotype 
i. 0.5ul FITC Isotype 
28. 20 minute incubation at room temperature protected from light. 
29. Add 4mL of 1X lysing solution to every sample 
30. Incubate for 10 minutes at room temperature protected from light. 
31. Place all tubes into ice protected from light; run experiment 
32. When all samples have been run, spin at 400xg for 10 minutes at 4C 
33. Resuspend each sample in 500ul of 5%FBS/PBS and 500ul of 10% neutral 
buffered-formalin. Let sit in drawer for 10 minutes. 
34. Wash every sample with 1mL 5%FBS/PBS. Spin at 400xg for 10 minutes at 4C.  
35. Resuspend in original amount (should be around 2ml). wrap in foil and store in 
fridge. DO NOT FREEZE. 
Serum 
36. Let sit for 1 hour at room temperature 
37. Spin at 1300xg for 15 minutes at 22C. 
38. Aliquot into 500ul aliquots. Store in -80. 
Plasma 
1. With the unused EDTA blood (Pink tube), spin at 2400 rpm for 15 minutes at 4C. 




Wheelchair Racer Study 
Materials 
• Blood (1 10mL EDTA tube, Pre and Post per participant) 
• Ficoll 
• 5% FBS/PBS 
• Antibodies (CD34, 45, 38, 105, 31, VEGFR2+2ndary) 
• 2.0 tubes labeled for plasma and cells 
• 1X PBS 
 
Procedure 
1. Mix only 5mL blood 1:1 with 1X PBS. 
2. Layer 5mL blood over 3mL Ficoll (2 tubes). 
3. Spin at 400xg 40 minutes RT with the brake on 2 
a. While tubes are spinning (first group only), prepare antibody cocktails. 
i. HSPC – 3500ul 5%FBS/PBS (3.5mL) 
1. CD34: 35 ul 
2. CD45: 17.5ul 
3. CD38: 70uL 
ii. MSC/EPC – 3500ul 5%FBS/PBS (3.5mL) 
1. CD34: 35ul 
2. CD45: 17.5ul 
3. CD105: 17.5ul 
4. CD31: 17.5ul 
5. VEGFR2: 17.5ul 
iii. Secondary Antibody (QDOT 605) – 7mL 5%FBS/PBS (3.5mL) 
1. 14 uL 
b. Keep protected from light on ice until needed. 
4. Take buffy coat. Wash with 6mL PBS. Spin at 400xg 10 minutes at RT with the 
brake on 9. Save tube to aliquot plasma into pre-labeled 2.0mL tubes 
(~500ul/tube). 
5. Repeat PBS wash. 
6. Resuspend each participant time point in 4mL 5% FBS/PBS. Aliquot 1mL into 
unstained, HSPC, MSC/EPC, and 2ndary only pre-labeled 2.0mL tubes. 
7. Spin tubes at 400xg 10 minutes at 4C. 
8. Remove supernatant and resuspend each HSPC tube in 200ul of “HSPC 
antibody” and put on ice. Resuspend each MSC/EPC tube in 200ul of “MSC/EPC 
antibody” and put on ice. Let sit for 20 minutes. Resuspend each unstained and 
2ndary only tube in 200ul of 5%FBS/PBS. 
9. Wash each tube in 1mL 5% FBS/PBS and spin at 400xg for 5 minutes at 4C. 
10.  Repeat wash. 
11.   
a. HSPC 
i. Resuspend each sample in 1mL PBS.  
ii. Add 1ul of Aqua blue dead cell stain. Let sit on ice protected from 
light for 30 minutes. 
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b. MSC/EPC + 2ndary only 
i. Resuspend each MSC/EPC sample in 200uL of secondary 
antibody. Let sit for 20 minutes on ice. 
c. unstained 
i. Resuspend each sample in 1mL 5%FBS/PBS. Let sit on ice for 30 
minutes. 
12.   
a. HSPC 
i.  Add 1mL 5%FBS/PBS to each tube. Spin at 400xg 5mins 4C. 
b. MSC/EPC + 2ndary only 
i. Wash each sample in 1mL 5%FBS/PBS. Spin at 400xg 5 minutes 
at 4C. 
ii. Repeat wash step. 
c. unstained 
i. Add 1mL 5%FBS/PBS to each tube. Spin at 400xg 5 mins 4C. 
13.   
a. HSPC and unstained 
i. Resuspend each tube in 1mL 5%FBS/PBS and transfer to flow 
tubes with 3mL 5%FBS/PBS (Total volume will be 4mL). Analyze 
by flow. 
b. MSC/EPC + 2ndary only 
i. Resuspend each sample in 1mL PBS. Add 1ul Aqua Dead cell stain 
to each tube. Let sit on ice for 30 minutes protected from light. 
ii. Add 1mL 5%FBS/PBS to each tube. Spin at 400xg 5mins 4C. 
iii. Resuspend each tube in 1mL 5%FBS/PBS and transfer to flow 




Endurance Study (END Study) 
Materials: 
• Labeled tubes 
o Time points: pre, 20e, 40e, 60e, 15p, 60p, 120p 
o e=exercise, p=post exercise 
• 5% FBS/PBS 
• CD34, CD45, CD105, CD31, CD38 Ab’s 
• Ficoll-Paque 
• Serological Pipet 
 
Schedule: 
• 8:45 arrive 
o Get ice, go over protocol, ask questions 
• 9:30-10:45 am 
o Exercise start (125C) 
o Collect blood at pre time point, 20e, 40e, 60e, 15p 
o Place samples on ice while waiting. 
o Deliver to ESC Lab 
• 10:45 am – beyond 
o Collect blood at post time points (60p, 120p) 
o Place samples on ice while waiting 
o Deliver to ESC Lab 
Protocol 
1. Prepare antibody cocktail 
a. Time point 1 (pre, 20e, 40e, 60e, 15p) 
i. Place 1100ul of 5% FBS/PBS into 2 different microcentrifuge tubes. 
Label one MSC and the other HSC. 
ii. Add antibodies: 
1. MSC: 
a. CD105: 5.5ul 
b. CD31: 5.5ul 
c. CD45: 5.5ul 
d. CD34: 11ul 
2. HSC 
a. CD34: 11ul 
b. CD45: 5.5ul 
c. CD38: 22ul 
3. Place in the fridge wrapped in foil. 
b. Time point 2 (60p, 120p) 
i. Place 500 ul of 5% FBS/PBS into 2 different microcentrifuge tubes. 
ii. Add antibodies 
1. MSC: 
a. CD105: 2.5ul 
b. CD31: 2.5ul 
c. CD45: 2.5ul 
d. CD34: 5ul 
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2. HSC 
a. CD34: 5ul 
b. CD45: 2.5ul 
c. CD38: 10ul 
3. Place in the fridge wrapped in foil. 
2. MSC/HSC 
a. Mix 2mL EDTA blood 1:1 with PBS. 
b. Layer 4mL diluted blood over 3mL Ficoll Paque. 
c. Spin at 400 x g 40 minutes at RT with the brake on 2 
d. Take buffy coat. Wash with 6mL PBS. Spin at 400 x g 10 minutes at RT 
with the brake on. 
e. Repeat PBS wash. 
f. Resuspend every tube in 100ul 5% FBS. Add 5ul FcX to each tube. 
Incubate for 10 minutes. Top up to 200ul. 
g. Take 100ul of sample and put into HSC tube, other 100ul into MSC tube. 
i. Make sure to designate one sample for unstained. In this event, top 
up to 250 ul. Add 100ul/tube for MSC and HSC. The remaining 50ul 
will go into unstained, and add 50ul 5%FBS. 
h. Spin tubes for 10 minutes 400 x g 4 degrees C. 
i. Resuspend each sample in 200ul of pre-made antibody cocktail. Incubate 
in foil for 20 minutes in the fridge. Resuspend unstained in 200ul of 5% 
FBS. 
j. Wash each sample with 1mL 5% FBS/PBS. Centrifuge each at 300 x g 10 
minutes at 4 degrees C. 
k. Resuspend each sample in 1mL PBS. Spin at 300xg 10 minutes 4 
degrees C. 
l. Resuspend in 1mL PBS. Add 1ul Aqua Dead Cell Stain to every sample 
except unstained. Incubate on ice for 30 minutes in the dark. 
m. Wash each sample in 1mL PBS. Resuspend in 3mL 5% FBS/PBS. 
Analyze by flow.  
 
